var title_f37_57_38800="Cryoglobulinemic vasculitis";
var content_f37_57_38800=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F58586&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F58586&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cryoglobulinemic vasculitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ulcers are present on the lower legs in this patient with cryoglobulinemic vasculitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_57_38800=[""].join("\n");
var outline_f37_57_38800=null;
var title_f37_57_38801="Compression rotation test for SLAP lesion";
var content_f37_57_38801=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1124px;\">",
"  <div class=\"videoplayer\" h264=\"./images/EM/82890/Compression_rotation_video.mp4?title=Compression+rotation+test+for+SLAP+lesion\" style=\"width:480px;height:288px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Compression-rotation test for SLAP lesion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 282px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    To perform&nbsp;the compression-rotation test, the patient lays supine with their shoulder abducted 90 degrees directly to the side and their elbow flexed at 90 degrees. The examiner pushes the humerus into the glenoid by applying an axial load and then rotates the humerus internally and externally. A positive test produces a catching, popping, or snapping sensation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stephen Simons, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_57_38801=[""].join("\n");
var outline_f37_57_38801=null;
var title_f37_57_38802="Dermoscopy melanoma 1";
var content_f37_57_38802=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F79576&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F79576&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Dermoscopy of superficial spreading melanoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Melanoma 0.98 mm. Atypical network, peripheral streaks (solid arrows), blue white-veil, and off-centered blotch (dashed square) are observed.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Drs. Ashfaq Marghoob and Natalia Jaimes.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_57_38802=[""].join("\n");
var outline_f37_57_38802=null;
var title_f37_57_38803="NSAIDs: Electrolyte complications";
var content_f37_57_38803=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   NSAIDs: Electrolyte complications",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/57/38803/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/57/38803/contributors\">",
"     Richard H Sterns, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/57/38803/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/57/38803/contributors\">",
"     Michael Emmett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/57/38803/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/57/38803/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/57/38803/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal vasodilatory prostaglandins promote the secretion of renin, impair sodium reabsorption in the loop of Henle and cortical collecting tubule, and partially antagonize the ability of antidiuretic hormone to increase water reabsorption in the collecting tubules [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38803/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. Locally generated prostaglandins also may mediate part of the natriuretic effect of dopamine and of natriuretic peptides [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38803/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These actions are not of major importance in normal subjects in whom basal renal prostaglandin production is relatively low. However, they may become clinically significant when prostaglandin synthesis is stimulated by underlying renal disease or by the vasoconstrictors angiotensin II or norepinephrine. Secretion of these vasoconstrictors is increased in states of effective volume depletion: true volume depletion due to gastrointestinal or renal losses (as with diuretic therapy) or reduced tissue perfusion due to heart failure or cirrhosis.",
"   </p>",
"   <p>",
"    In the setting of effective volume depletion, nonsteroidal antiinflammatory drugs, which inhibit prostaglandin synthesis, can produce a variety of complications related to renal dysfunction, each of which is reversible with discontinuation of therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38803/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. These include hyperkalemia, hyponatremia, and edema. These complications are mediated in part by reductions in the secretion of renin and aldosterone and by increased activity of antidiuretic hormone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38803/abstract/1,2,7\">",
"     1,2,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, vasoconstriction due to decreased synthesis of vasodilator prostaglandins can impair renal function and exacerbate underlying hypertension and heart failure. These issues are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/0/24582?source=see_link\">",
"     \"NSAIDs: Acute kidney injury (acute renal failure) and nephrotic syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/43/42674?source=see_link\">",
"     \"NSAIDs and acetaminophen: Effects on blood pressure and hypertension\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/4/24648?source=see_link&amp;anchor=H7#H7\">",
"     \"Nonselective NSAIDs: Adverse cardiovascular effects\", section on 'Heart failure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/27/39351?source=see_link\">",
"     \"COX-2 selective inhibitors: Adverse cardiovascular effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ELECTROLYTE COMPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Hyperkalemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;NSAIDs have two effects that can promote the development of hyperkalemia: they lower renal renin secretion, which is normally mediated in part by locally produced prostaglandins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38803/abstract/1,2,8\">",
"     1,2,8",
"    </a>",
"    ]; and they impair angiotensin II-induced aldosterone release [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38803/abstract/8\">",
"     8",
"    </a>",
"    ]. The ensuing fall in aldosterone secretion will reduce urinary potassium excretion, which will tend to raise the plasma potassium concentration.",
"   </p>",
"   <p>",
"    The magnitude of the effect of NSAIDs on the plasma potassium concentration was illustrated in a study of 50 hospitalized patients in whom",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    therapy was initiated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38803/abstract/9\">",
"     9",
"    </a>",
"    ]. The plasma potassium rose by less than 0.5",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    in 40 percent, 0.5 to 0.9",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    in 34 percent, and by 1",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    or more in 26 percent; these changes began within the first few days of therapy. One would expect smaller elevations in plasma potassium in healthy individuals. On the other hand, the hyperkalemic effect may be more pronounced in two settings: if there is an NSAID-induced reduction in glomerular filtration rate, which can lead to reduced sodium and water delivery to the potassium secretory site in the collecting tubules; or if there is concurrent use of other drugs that raise the plasma potassium such as angiotensin inhibitors and potassium-sparing diuretics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38803/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/0/24582?source=see_link&amp;anchor=H2#H2\">",
"     \"NSAIDs: Acute kidney injury (acute renal failure) and nephrotic syndrome\", section on 'Hemodynamically-mediated acute kidney injury'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Hyponatremia",
"    </span>",
"    &nbsp;&mdash;&nbsp;NSAIDs diminish the normal inhibitory effect of prostaglandins on the activity of antidiuretic hormone (ADH), and can therefore reduce free water excretion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38803/abstract/3,10\">",
"     3,10",
"    </a>",
"    ]. In conditions associated with high and relatively nonsuppressible levels of ADH, such as the syndrome of inappropriate ADH secretion or effective volume depletion, as in patients with severe heart failure, NSAID-induced water retention can induce or worsen hyponatremia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38803/abstract/1,11\">",
"     1,11",
"    </a>",
"    ]. NSAIDs may also increase the susceptibility of elderly subjects to thiazide diuretic-induced hyponatremia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38803/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38742?source=see_link\">",
"     \"Hyponatremia in patients with heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/31/502?source=see_link\">",
"     \"Diuretic-induced hyponatremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Edema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Removal of the inhibitory effect of prostaglandins on sodium reabsorption with both nonselective and COX-selective NSAIDs can lead to sodium retention. With prolonged therapy, healthy individuals may have a weight gain of as much as 0.5 to 1 kg, while the degree of sodium and water retention may be more prominent in patients with underlying heart failure or cirrhosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38803/abstract/2,13\">",
"     2,13",
"    </a>",
"    ]. The increase in sodium reabsorption contributes to the relative resistance to diuretics associated with NSAID therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38803/abstract/2,14\">",
"     2,14",
"    </a>",
"    ]. NSAIDs may also exacerbate heart failure, an effect that is probably due more to increased afterload resulting from NSAID-induced systemic vasoconstriction than to sodium retention. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/4/24648?source=see_link&amp;anchor=H7#H7\">",
"     \"Nonselective NSAIDs: Adverse cardiovascular effects\", section on 'Heart failure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/27/39351?source=see_link\">",
"     \"COX-2 selective inhibitors: Adverse cardiovascular effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22536456\">",
"    <span class=\"h1\">",
"     CHOICE OF NSAID",
"    </span>",
"    &nbsp;&mdash;&nbsp;The above complications can generally be induced by any of the NSAIDs, although",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    may be the most potent. In comparison, renal prostaglandin synthesis may be relatively spared following therapy with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?43/17/44312?source=see_link\">",
"     sulindac",
"    </a>",
"    or low-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38803/abstract/2,15\">",
"     2,15",
"    </a>",
"    ]. With aspirin, for example, the inhibition of glomerular cyclooxygenase may only be partial and transient, in contrast to the irreversible acetylation in platelets [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38803/abstract/15\">",
"     15",
"    </a>",
"    ]. The possible mechanisms by which sulindac might, in some patients, spare renal prostaglandin synthesis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/0/24582?source=see_link&amp;anchor=H2#H2\">",
"     \"NSAIDs: Acute kidney injury (acute renal failure) and nephrotic syndrome\", section on 'Hemodynamically-mediated acute kidney injury'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H612385\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nonsteroidal antiinflammatory drugs (NSAIDs) inhibit prostaglandin synthesis. In the setting of effective volume depletion, this inhibition can cause hyperkalemia, hyponatremia, and edema. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      NSAIDs cause hyperkalemia by decreasing renin secretion and impairing angiotensin II-induced aldosterone release. The ensuing fall in aldosterone secretion reduces urinary potassium excretion, which raises the plasma potassium concentration. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Hyperkalemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      NSAIDs diminish the inhibitory effect of prostaglandins on the activity of antidiuretic hormone (ADH); the ensuing increase in ADH activity can reduce free water excretion, which can lead to water retention and induction or exacerbation of hyponatremia in conditions associated with high and nonsuppressible levels of ADH, such as the syndrome of inappropriate ADH secretion or effective volume depletion, as in patients with severe heart failure or cirrhosis. NSAIDs may also increase the susceptibility of elderly subjects to thiazide diuretic-induced hyponatremia. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Hyponatremia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      NSAIDs can cause sodium retention that is typically mild in healthy individuals, but can lead to exacerbation of edema and contribute to diuretic resistance in patients with underlying heart failure or cirrhosis. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Edema'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The above complications can generally be induced by any of the NSAIDs, although",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/50/36649?source=see_link\">",
"       indomethacin",
"      </a>",
"      may be the most potent and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?43/17/44312?source=see_link\">",
"       sulindac",
"      </a>",
"      or low-dose",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      the least potent. (See",
"      <a class=\"local\" href=\"#H22536456\">",
"       'Choice of NSAID'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38803/abstract/1\">",
"      Oates JA, FitzGerald GA, Branch RA, et al. Clinical implications of prostaglandin and thromboxane A2 formation (2). N Engl J Med 1988; 319:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38803/abstract/2\">",
"      Schlondorff D. Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int 1993; 44:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38803/abstract/3\">",
"      Kramer HJ, Gl&auml;nzer K, D&uuml;sing R. Role of prostaglandins in the regulation of renal water excretion. Kidney Int 1981; 19:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38803/abstract/4\">",
"      H&eacute;bert RL, Jacobson HR, Breyer MD. Prostaglandin E2 inhibits sodium transport in rabbit cortical collecting duct by increasing intracellular calcium. J Clin Invest 1991; 87:1992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38803/abstract/5\">",
"      Satoh T, Cohen HT, Katz AI. Intracellular signaling in the regulation of renal Na-K-ATPase. I. Role of cyclic AMP and phospholipase A2. J Clin Invest 1992; 89:1496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38803/abstract/6\">",
"      Gunning ME, Brady HR, Otuechere G, et al. Atrial natriuretic peptide(31-67) inhibits Na+ transport in rabbit inner medullary collecting duct cells. Role of prostaglandin E2. J Clin Invest 1992; 89:1411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38803/abstract/7\">",
"      Stichtenoth DO, Marhauer V, Tsikas D, et al. Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers. Kidney Int 2005; 68:2197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38803/abstract/8\">",
"      Campbell WB, Gomez-Sanchez CE, Adams BV, et al. Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors. J Clin Invest 1979; 64:1552.",
"     </a>",
"    </li>",
"    <li>",
"     Zimran, A, Kramer, M, Plaskin, M, Hershko, C. Incidence of hyperkalaemia induced by indomethacin in a hospital population. Br Med J (Clin Res Ed) 1985; 291:107.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38803/abstract/10\">",
"      Walker RM, Brown RS, Stoff JS. Role of renal prostaglandins during antidiuresis and water diuresis in man. Kidney Int 1982; 21:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38803/abstract/11\">",
"      Dzau VJ, Packer M, Lilly LS, et al. Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia. N Engl J Med 1984; 310:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38803/abstract/12\">",
"      Clark BA, Shannon RP, Rosa RM, Epstein FH. Increased susceptibility to thiazide-induced hyponatremia in the elderly. J Am Soc Nephrol 1994; 5:1106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38803/abstract/13\">",
"      Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984; 310:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38803/abstract/14\">",
"      Brater DC. Analysis of the effect of indomethacin on the response to furosemide in man: effect of dose of furosemide. J Pharmacol Exp Ther 1979; 210:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38803/abstract/15\">",
"      Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 1982; 69:1366.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2299 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-4D6C774D8A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_57_38803=[""].join("\n");
var outline_f37_57_38803=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H612385\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ELECTROLYTE COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Hyperkalemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Edema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22536456\">",
"      CHOICE OF NSAID",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H612385\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/27/39351?source=related_link\">",
"      COX-2 selective inhibitors: Adverse cardiovascular effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/31/502?source=related_link\">",
"      Diuretic-induced hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38742?source=related_link\">",
"      Hyponatremia in patients with heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/43/42674?source=related_link\">",
"      NSAIDs and acetaminophen: Effects on blood pressure and hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/0/24582?source=related_link\">",
"      NSAIDs: Acute kidney injury (acute renal failure) and nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/4/24648?source=related_link\">",
"      Nonselective NSAIDs: Adverse cardiovascular effects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_57_38804="HAE emergency care";
var content_f37_57_38804=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F70252&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F70252&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 585px\">",
"   <div class=\"ttl\">",
"    Instructions for emergency care of hereditary angioedema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 565px; height: 701px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_57_38804=[""].join("\n");
var outline_f37_57_38804=null;
var title_f37_57_38805="Omalizumab: Pediatric drug information";
var content_f37_57_38805=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Omalizumab: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?37/46/38629?source=see_link\">",
"    see \"Omalizumab: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/15/34036?source=see_link\">",
"    see \"Omalizumab: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5709181\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F203365\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Xolair&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F855143\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Xolair&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1060686\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Monoclonal Antibody, Anti-Asthmatic",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1060679\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?37/46/38629?source=see_link\">",
"      see \"Omalizumab: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dosage and frequency of administration are dependent upon the serum total IgE level and body weight. Measure total IgE level prior to beginning treatment. Total IgE levels are elevated during treatment and remain elevated for up to one year after the discontinuation of treatment. Remeasurement of IgE levels during omalizumab treatment should not be used as a guide to dosage.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Asthma: Children &ge;12 years and Adults: SubQ: 0.016 mg/kg/international unit of IgE  every 4 weeks.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     The following is the manufacturer's recommendation:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     IgE &ge;30-100 international units/mL:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     30-90 kg: 150 mg every 4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;90-150 kg: 300 mg every 4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     IgE &gt;100-200 international units/mL:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     30-90 kg: 300 mg every 4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;90-150 kg: 225 mg every 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     IgE &gt;200-300 international units/mL:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     30-60 kg: 300 mg every 4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;60-90 kg: 225 mg every 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;90-150 kg: 300 mg every 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     IgE &gt;300-400 international units/mL:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     30-70 kg: 225 mg every 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;70-90 kg: 300 mg every 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;90 kg: Do not use*",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     IgE &gt;400-500 international units/mL:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     30-70 kg: 300 mg every 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;70-90 kg: 375 mg every 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;90 kg: Do not use*",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     IgE &gt;500-600 international units/mL:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     30-60 kg: 300 mg every 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;60-70 kg: 375 mg every 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;70 kg: Do not use*",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     IgE &gt;600-700 international units/mL:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     30-60 kg: 375 mg every 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;60 kg: Do not use*",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     *Dosage has not been studied and approved for this weight and IgE level",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F203343\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xolair&reg;: 150 mg [contains sucrose 145.5 mg; derived from or manufactured using Chinese hamster ovary cells]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F203329\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874749\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/ucm089829.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/ucm089829.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1060690\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     SubQ: Reconstitute 150 mg vial with 1.4 mL SWI; swirl vial for approximately 1 minute to evenly wet powder; repeat swirling for 5-10 seconds every 5 minutes in order to dissolve remaining solids; dissolution time is at least 20 minutes. Reconstituted solution will be viscous with no visible gel-like particles present in solution. Do not use if contents of vial do not dissolve within 40 minutes. Resulting concentration is 150 mg/1.2 mL (125 mg/mL). Due to viscosity, injection may take 5-10 seconds to administer. Doses &gt;150 mg should be divided into more than one injection site.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1060682\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store in refrigerator at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F); omalizumab is provided in a single use vial with no preservatives; the reconstituted solution is stable for 4 hours at room temperature and 8 hours refrigerated",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1060689\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of moderate to severe, persistent allergic asthma not adequately controlled with inhaled corticosteroids",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9525624\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Omalizumab may be confused with ofatumumab",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F203387\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, fatigue, headache, pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Dermatitis, pruritus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, arm pain, fracture, leg pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Earache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Pharyngitis, sinusitis, upper respiratory tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Viral infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Alopecia; anaphylaxis (angioedema of the throat or tongue, bronchospasm, chest tightness, cough, cutaneous angioedema, dyspnea, hypotension, generalized pruritus, syncope, and urticaria); antibody formation to omalizumab, hot flushes, malignancy, throat edema, thrombocytopenia, tongue edema, urticaria, wheezing",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1060693\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to omalizumab or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1060678\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dosage and frequency of administration are dependent upon the serum total IgE level and body weight. Total IgE level must be measured prior to beginning treatment. Total IgE levels are elevated during treatment and remain elevated for up to one year after the discontinuation of treatment. Remeasurement of IgE levels during omalizumab treatment should not be used as a guide to dosage. Remeasurement of IgE levels may be used after treatment has been discontinued for at least one year.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1060677\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not indicated for use in the control of acute asthma symptoms. Anaphylaxis, including delayed-onset anaphylaxis, has been reported following administration",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; reactions usually occur within 2 hours of administration, but may occur up to 24 hours and in some cases &gt;24 hours after treatment. Patients should receive treatment only under direct medical supervision and be observed for a minimum of 2 hours following administration; providers and patients should have appropriate treatment for anaphylaxis available. Hypersensitivity reactions may occur following any dose, even during chronic therapy; discontinue therapy following any severe reaction. Injection site reactions typically occur within 1 hour postinjection, last &lt;8 days, and generally decrease in frequency after subsequent doses. Due to the risk of delayed anaphylaxis, patients should be fully prepared and trained on the appropriate emergency self-treatment of an anaphylactic reaction. Safety and efficacy in children &lt;12 years of age has not been established.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Malignant neoplasms of varying types (breast, nonmelanoma skin, prostate, and parotid) were observed in 0.5% of patients during clinical trials (compared with 0.2% in controls); the majority of these patients received omalizumab for &lt;1 year; risk of long-term exposure to omalizumab is not known. Systemic or inhaled corticosteroid use should not be abruptly discontinued upon initiation of omalizumab therapy; gradual tapering under medical supervision is recommended. In a one year clinical trial in Brazil, patients with increased risk of geohelminthic infections (roundworm, hookworm, whipworm, threadworm) experienced an increase in geohelminthic infections when compared with the control group (42% vs 53%).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Preliminary findings of an ongoing safety review suggest an increased risk of cardiovascular (eg, arrhythmias, cardiomyopathy, ischemic heart disease, heart failure, pulmonary hypertension), cerebrovascular, and thromboembolic adverse events in patients treated with omalizumab.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299788\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6221997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Immunosuppressants may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Coccidioidin Skin Test: Immunosuppressants may diminish the diagnostic effect of Coccidioidin Skin Test.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Echinacea: May diminish the therapeutic effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Immunosuppressants may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased.  Management: Consider not using a leflunomide loading dose in patients receiving other immunosuppressants.  Patients receiving both leflunomide and another immunosuppressant should be monitored for bone marrow suppression at least monthly.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Natalizumab: Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Roflumilast: May enhance the immunosuppressive effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sipuleucel-T: Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Immunosuppressants may enhance the immunosuppressive effect of Tofacitinib.  Management: Concurrent use with antirheumatic doses of methotrexate or other non-disease modifying antirheumatic drugs (non-DMARDs) is permitted, and this warning seems to particularly focused on more potent immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trastuzumab: May enhance the neutropenic effect of Immunosuppressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Inactivated): Immunosuppressants may diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immunosuppressants may enhance the adverse/toxic effect of Vaccines (Live). Vaccinial infections may develop. Immunosuppressants may diminish the therapeutic effect of Vaccines (Live).  Management: Avoid use of live organism vaccines with immunosuppressants; live-attenuated vaccines should not be given for at least 3 months after immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F203339\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F203350\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal studies. There are no adequate and well-controlled studies in pregnant women. IgG molecules are known to cross the placenta; use during pregnancy only if clearly needed. A registry has been established to monitor outcomes of women exposed to omalizumab during pregnancy or within 8 weeks prior to pregnancy (866-496-5247).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1060685\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Baseline total serum IgE, pulmonary function tests, anaphylactic/hypersensitivity reactions",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1060676\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Omalizumab is an IgG monoclonal antibody which binds to free (unbound) IgE and prevents the binding of IgE to the high-affinity IgE receptor on the surface of mast cells and basophils. By decreasing bound IgE, the activation and release of mediators in the allergic response (early and late phase) is limited. Both the free (unbound) IgE serum level and the number of high-affinity IgE receptors are decreased. Long-term treatment in patients with allergic asthma showed a decrease in asthma exacerbations and corticosteroid usage.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F5547075\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Response to therapy: &sim;12-16 weeks (87% of patients had measurable response in 12 weeks)",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1060692\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Slow after SubQ administration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 78 &plusmn; 32 mL/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic: IgG degradation by reticuloendothelial system and endothelial cells",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Absolute: 62%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: Adults: 1-4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: 7-8 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Primarily via hepatic degradation; intact IgG may be secreted in bile",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Clearance: 2.4 &plusmn; 1.1 mL/kg/day",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1060684\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/15/34036?source=see_link\">",
"      see \"Omalizumab: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not alter asthma medications without consulting physician. Patient should read the accompanying Medication Guide before starting treatment and before each subsequent treatment. Report any signs and symptoms of allergic reactions including difficulty breathing, difficulty swallowing, swelling of the throat or tongue, cough, chest tightness, and generalized itching to your healthcare provider immediately.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1060694\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Omalizumab was used successfully in a double-blind, randomized, placebo-controlled study of 334 children between the ages of 6-12 years; omalizumab dosage was based on body weight and initial serum total IgE. Patients received omalizumab at either 2- or 4-week intervals with a dosage equal to 0.016 mg/kg/IgE (international units/mL) per 4 weeks. 55% of patients were able to discontinue corticosteroid use (Milgrom, 2003). A registry has been established to monitor outcomes of women exposed to omalizumab during pregnancy or within 8 weeks prior to pregnancy (866-496-5247).",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Berger W, Gupta N, McAlary M, et al, &ldquo;Evaluation of Long-Term Safety of the Anti-IgE Antibody, Omalizumab, in Children with Allergic Asthma,&rdquo;",
"      <i>",
"       Ann Allergy Asthma Immunol",
"      </i>",
"      , 2003, 91(2):182-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/57/38805/abstract-text/12952113/pubmed\" id=\"12952113\" target=\"_blank\">",
"        12952113",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Casale TB, Condemi J, LaForce C, et al, &ldquo;Effect of Omalizumab on Symptoms of Seasonal Allergic Rhinitis: A Randomized Controlled Trial,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2001, 286(23):2956-67.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/57/38805/abstract-text/11743836 /pubmed\" id=\"11743836 \" target=\"_blank\">",
"        11743836",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Milgrom H, Berger W, Nayak A, et al, &ldquo;Treatment of Childhood Asthma With Anti-Immunoglobulin E Antibody (Omalizumab),&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(2):E36.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/57/38805/abstract-text/11483846/pubmed\" id=\"11483846\" target=\"_blank\">",
"        11483846",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Milgrom H, Fick RB Jr, Su JQ, et al, &ldquo;Treatment of Allergic Asthma With Monoclonal Anti-IgE Antibody. rhuMAb-E25 Study Group,&rdquo;",
"      <i>",
"       Engl J Med",
"      </i>",
"      , 1999, 341(26):1966-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/57/38805/abstract-text/10607813/pubmed\" id=\"10607813\" target=\"_blank\">",
"        10607813",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Strunk RC and Bloomberg GR, \"Omalizumab for Asthma,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2006, 354(25):2689-95.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/57/38805/abstract-text/16790701/pubmed\" id=\"16790701\" target=\"_blank\">",
"        16790701",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12905 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-91.202.164.29-FFA7B79098-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_57_38805=[""].join("\n");
var outline_f37_57_38805=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5709181\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203365\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F855143\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060686\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060679\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203343\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203329\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874749\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060690\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060682\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060689\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9525624\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203387\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060693\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060678\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060677\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299788\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6221997\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203339\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203350\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060685\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060676\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5547075\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060692\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060684\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060694\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12905\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12905|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?37/46/38629?source=related_link\">",
"      Omalizumab: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/15/34036?source=related_link\">",
"      Omalizumab: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_57_38806="Acetaminophen and phenyltoloxamine: Drug information";
var content_f37_57_38806=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Acetaminophen and phenyltoloxamine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/34/28196?source=see_link\">",
"    see \"Acetaminophen and phenyltoloxamine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F129619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      RhinoFlex&trade; [DSC];",
"     </li>",
"     <li>",
"      RhinoFlex&trade;-650 [DSC];",
"     </li>",
"     <li>",
"      Zgesic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F129627\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Analgesic, Miscellaneous",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F129620\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pain (Analgesic):",
"     </b>",
"     Oral: Based on acetaminophen component: 325-650 mg every 4-6 hours as needed (maximum: 4 g/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Product-specific labeling:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      RhinoFlex&trade;, RhinoFlex&trade;-650:",
"     </i>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     -1 tablet every 4 hours (maximum: 5 tablets/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Zgesic:",
"     </i>",
"     1-2 tablets every 8-12 hours (maximum: 6 tablets/24 hours)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F129625\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Analgesic:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Based on acetaminophen component:",
"     </i>",
"     10-15 mg/kg/dose every 4-6 hours as needed (maximum: 5 doses/24 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Product-specific labeling:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      RhinoFlex&trade;, RhinoFlex&trade;-650:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children 6 to &lt;12 years:",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     tablet every 4 hours (maximum: 2.5 tablets/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Zgesic:",
"     </i>",
"     Children &gt;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F129621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F2998725\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     Specific dosing adjustment not available. Monitor renal function with severe impairment.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F129622\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution. Limited, low-dose therapy is usually well tolerated in hepatic disease/cirrhosis; however, cases of hepatotoxicity at daily acetaminophen dosages &lt;4 g/day have been reported. Avoid chronic use in hepatic impairment.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F129613\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet: Acetaminophen 325 mg and phenyltoloxamine citrate 30 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     RhinoFlex&trade;: Acetaminophen 500 mg and phenyltoloxamine citrate 50 mg [DSC]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     RhinoFlex&trade;-650: Acetaminophen 650 mg and phenyltoloxamine citrate 50 mg [DSC]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, prolonged release, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zgesic: Acetaminophen 600 mg and phenyltoloxamine citrate 66 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F129604\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Tablet",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F6783064\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be administered with food or milk.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prolonged release tablet (Zgesic): Swallow whole; do not chew or crush.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F129614\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of mild-to-moderate pain",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F129630\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Percogesic&reg; may be confused with paregoric, Percodan&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Duplicate therapy issues: This product contains acetaminophen, which may be a component of other combination products. Do not exceed the maximum recommended daily dose of acetaminophen.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F6783015\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Dizziness, drowsiness, lassitude",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dermatologic: Pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ocular: Blurred vision",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Miscellaneous: Diaphoresis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F2998656\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Hypersensitivity to acetaminophen, phenyltoloxamine, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F2998657\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatotoxicity: May cause severe hepatic toxicity on acute overdose; in addition, chronic daily dosing in adults has resulted in liver damage in some patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ethanol use: Use with caution in patients with alcoholic liver disease; consuming &ge;3 alcoholic drinks/day may increase the risk of liver damage.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; G6PD deficiency: Use with caution in patients with known G6PD deficiency.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Glaucoma: Use with caution in patients with glaucoma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia/urinary stricture: Use with caution in patients with prostatic hyperplasia and/or urinary stricture.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory disease: Use with caution in patients with pre-existing respiratory compromise (hypoxia and/or hypercapnia), COPD or other obstructive pulmonary disease, and kyphoscoliosis or other skeletal disorder which may alter respiratory function; critical respiratory depression may occur, even at therapeutic dosages.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; may be more sensitive to adverse effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in children &lt;6 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dosage limit: Limit acetaminophen dose to &lt;4 g/day.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Self-medication (OTC use): When used for self-medication, patients should be instructed to contact healthcare provider if used for fever lasting &gt;3 days or for pain lasting &gt;10 days in adults or &gt;5 days in children.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F129626\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F129609\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May diminish the sedative effect of Antihistamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticonvulsants (Hydantoin): May increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzylpenicilloyl Polylysine: Antihistamines may diminish the diagnostic effect of Benzylpenicilloyl Polylysine.  Management: Suspend systemic H1 antagonists for benzylpenicilloyl-polylysine skin testing and delay testing until systemic antihistaminic effects have dissipated. A histamine skin test may be used to assess persistent antihistaminic effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Betahistine: Antihistamines may diminish the therapeutic effect of Betahistine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Busulfan: Acetaminophen may increase the serum concentration of Busulfan.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cholestyramine Resin: May decrease the absorption of Acetaminophen. Effect is minimal if cholestyramine is administered 1 hour after acetaminophen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: Acetaminophen may enhance the hepatotoxic effect of Dasatinib. Dasatinib may increase the serum concentration of Acetaminophen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Antihistamines may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving antihistamines (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Imatinib: Acetaminophen may enhance the hepatotoxic effect of Imatinib. Imatinib may increase the serum concentration of Acetaminophen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoniazid: May enhance the adverse/toxic effect of Acetaminophen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrapone: May increase the serum concentration of Acetaminophen. More importantly, by inhibiting the conjugative metabolism of acetaminophen, metyrapone may shift the metabolism towards the oxidative route that produces a hepatotoxic metabolite.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mipomersen: Acetaminophen may enhance the hepatotoxic effect of Mipomersen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prilocaine: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Prilocaine. Combinations of these agents may increase the likelihood of significant methemoglobinemia.  Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when prilocaine is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine in infants receiving such agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Acetaminophen. Probenecid may also limit the formation of at least one major non-toxic metabolite, possibly increasing the potential for formation of the toxic NAPQI metabolite.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     SORAfenib: Acetaminophen may enhance the hepatotoxic effect of SORAfenib. SORAfenib may increase the serum concentration of Acetaminophen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Acetaminophen may enhance the anticoagulant effect of Vitamin K Antagonists. Most likely with daily acetaminophen doses &gt;1.3 g for &gt;1 week.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F129618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Excessive intake of ethanol may increase the risk of acetaminophen-induced hepatotoxicity. Avoid ethanol or limit to &lt;3 drinks/day.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Rate of absorption may be decreased when given with food.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F129610\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F6783010\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reproduction studies have not been conducted with this combination.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F6783012\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F6783013\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acetaminophen is excreted in breast milk. Excretion of phenyltoloxamine is not known.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F6783063\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken with food or milk.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322959\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Liquid",
"     </b>",
"     (Dologesic Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     30-500 mg/15 mL (180 mL): $18.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Dologesic Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     30-500 mg (100): $18.30",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Percogesic Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     12.5-325 mg (50): $5.10",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Rhinoflex-650 Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50-650 mg (100): $49.90",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Staflex Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     55-500 mg (100): $58.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Zflex Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     55-500 mg (100): $65.70",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F2998723\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Acetaminophen inhibits the synthesis of prostaglandins in the central nervous system and peripherally blocks pain impulse generation; produces antipyresis from inhibition of hypothalamic heat-regulating center. Phenyltoloxamine is an antihistamine (H",
"     <sub>",
"      1",
"     </sub>",
"     -blocking agent) which acts primarily to inhibit secretions in the nose, mouth, and pharynx, as well as causing CNS depression.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Antlitz AM, Mead JA Jr, and Tolentino MA, &ldquo;Potentiation of Oral Anticoagulant Therapy by Acetaminophen,&rdquo;",
"      <i>",
"       Curr Ther Res Clin Exp",
"      </i>",
"      , 1968, 10(10):501-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/57/38806/abstract-text/4971464/pubmed\" id=\"4971464\" target=\"_blank\">",
"        4971464",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bagheri H, Bernhard NB, and Montastruc JL, &ldquo;Potentiation of the Acenocoumarol Anticoagulant Effect by Acetaminophen,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 1999, 33(4):506.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/57/38806/abstract-text/10332548/pubmed\" id=\"10332548\" target=\"_blank\">",
"        10332548",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Barker JD Jr, de Carle DJ, and Anuras S, &ldquo;Chronic Excessive Acetaminophen Use in Liver Damage,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 1977, 87(3):299-301.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/57/38806/abstract-text/900673/pubmed\" id=\"900673\" target=\"_blank\">",
"        900673",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bartle WR and Blakely JA, &ldquo;Potentiation of Warfarin Anticoagulation by Acetaminophen,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1991, 265(10):1260.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/57/38806/abstract-text/1995971/pubmed\" id=\"1995971\" target=\"_blank\">",
"        1995971",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Boeijinga JJ, Boerstra EE, Ris P, et al, &ldquo;Interaction Between Paracetamol and Coumarin Anticoagulants,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1982, 1(8270):506.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/57/38806/abstract-text/6121161/pubmed\" id=\"6121161\" target=\"_blank\">",
"        6121161",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dionne RA, Campbell RA, Cooper SA, et al, &ldquo;Suppression of Postoperative Pain by Preoperative Administration of Ibuprofen in Comparison to Placebo, Acetaminophen, and Acetaminophen Plus Codeine,&rdquo;",
"      <i>",
"       J Clin Pharmacol",
"      </i>",
"      , 1983, 23(1):37-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/57/38806/abstract-text/6341415/pubmed\" id=\"6341415\" target=\"_blank\">",
"        6341415",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gadisseur AP, Van Der Meer FJ, and Rosendaal FR, &ldquo;Sustained Intake of Paracetamol (Acetaminophen) During Oral Anticoagulant Therapy With Coumarins Does Not Cause Clinically Important INR Changes: A Randomized Double-Blind Clinical Trial,&rdquo;",
"      <i>",
"       J Thromb Haemost",
"      </i>",
"      , 2003, 1(4):714-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/57/38806/abstract-text/12871405/pubmed\" id=\"12871405\" target=\"_blank\">",
"        12871405",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gebauer MG, Nyfort-Hansen K, Henschke PJ, et al, &ldquo;Warfarin and Acetaminophen Interaction,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2003, 23(1):109-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/57/38806/abstract-text/12523469/pubmed\" id=\"12523469\" target=\"_blank\">",
"        12523469",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hylek EM, Heiman H, Skates SJ, et al, &ldquo;Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1998, 279(9):657-62.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/57/38806/abstract-text/9496982/pubmed\" id=\"9496982\" target=\"_blank\">",
"        9496982",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kwan D, Bartle WR, and Walker SE, &ldquo;The Effects of Acute and Chronic Acetaminophen Dosing on the Pharmacodynamics and Pharmacokinetics of (R)- and (S)-Warfarin,&rdquo;",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 1995, 57:212.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Licht H, Seeff LB, and Zimmerman HJ, &ldquo;Apparent Potentiation of Acetaminophen Hepatotoxicity by Alcohol,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 1980, 92(4):511.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mokhlesi B, Leikin JB, Murray P, et al, &ldquo;Adult Toxicology in Critical Care: Part II: Specific Poisonings,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2003, 123(3):897-922.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/57/38806/abstract-text/12628894/pubmed\" id=\"12628894\" target=\"_blank\">",
"        12628894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rubin RN, Mentzer RL, and Budzynski AZ, &ldquo;Potentiation of Anticoagulant Effect of Warfarin by Acetaminophen (Tylenol&reg;),&rdquo;",
"      <i>",
"       Clin Res",
"      </i>",
"      , 1984, 32:698a.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      van den Bemt PM, Geven LM, Kuitert NA, et al, &ldquo;The Potential Interaction Between Oral Anticoagulants and Acetaminophen in Everyday Practice,&rdquo;",
"      <i>",
"       Pharm World Sci",
"      </i>",
"      , 2002, 24(5):201-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/57/38806/abstract-text/12426965/pubmed\" id=\"12426965\" target=\"_blank\">",
"        12426965",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9187 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-26F47D8889-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_57_38806=[""].join("\n");
var outline_f37_57_38806=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F129619\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F129627\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F129620\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F129625\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F129621\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2998725\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F129622\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F129613\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F129604\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6783064\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F129614\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F129630\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6783015\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2998656\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2998657\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F129626\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F129609\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F129618\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F129610\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6783010\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6783012\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6783013\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6783063\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322959\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2998723\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9187\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9187|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/34/28196?source=related_link\">",
"      Acetaminophen and phenyltoloxamine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_57_38807="Overview of dermoscopy";
var content_f37_57_38807=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of dermoscopy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/57/38807/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/57/38807/contributors\">",
"     Ashfaq A Marghoob, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/57/38807/contributors\">",
"     Natalia Jaimes, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/57/38807/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/57/38807/contributors\">",
"     Hensin Tsao, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/57/38807/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/57/38807/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/57/38807/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H620916022\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dermoscopy is a noninvasive, in vivo technique primarily used for the examination of pigmented skin lesions; however, it can also assist observers in assessing many amelanotic lesions. Dermatoscopy, epiluminescence microscopy, incident light microscopy, and skin-surface microscopy are synonyms. &nbsp;",
"   </p>",
"   <p>",
"    Dermoscopy is performed with a handheld instrument called a dermatoscope. The procedure allows the visualization of subsurface skin structures in the epidermis, dermoepidermal junction, and upper dermis; these structures are usually not visible to the naked eye [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The dermoscopic images may be photographed or recorded digitally for storage or sequential analysis.",
"   </p>",
"   <p>",
"    The basic principles of dermoscopy will be discussed in this topic. The dermoscopic diagnosis of skin lesions is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/11/13497?source=see_link\">",
"     \"Dermoscopic evaluation of skin lesions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H620916050\">",
"    <span class=\"h1\">",
"     DERMOSCOPY PHYSICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Natural light is reflected, scattered, or absorbed by objects. Under normal conditions, most of the light is reflected by the skin surface because of the higher refractive index (RI) of the stratum corneum (1.55) compared with that of the air (1.0).",
"   </p>",
"   <p>",
"    Reduction of the skin surface reflection allows the visualization of deeper epidermal and dermal structures. This reduction can be achieved by attaching a glass plate (RI: 1.52) to the stratum corneum (RI: 1.55) using an RI matched immersion fluid as an interface [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Several immersion fluids have been used, including water, alcohols (ethanol and isopropanol), oils (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/0/13316?source=see_link\">",
"     mineral oil",
"    </a>",
"    , immersion oil, and olive oil), and water-soluble gels (ultrasound gel, cosmetic gels). Alcohols (in particular ethanol 70 percent) are the preferred immersion liquid due to their low viscosity, amphiphilic properties (ie, both water and lipid soluble), disinfectant capabilities, and image clarity. However, on some specific sites such as the mucosae and areas around the eyes and nails, water-soluble gels are preferred over alcohol since they are noncaustic and have higher viscosity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Alternatively, reduction of the skin surface reflection can be obtained by using polarized light [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/7\">",
"     7",
"    </a>",
"    ]. Polarized light dermoscopy utilizes two orthogonal filters in a process called cross-polarization (",
"    <a class=\"graphic graphic_figure graphicRef59248 \" href=\"mobipreview.htm?2/15/2290\">",
"     figure 1",
"    </a>",
"    ). After reaching the skin surface, part of the polarized light is reflected by the stratum corneum maintaining its polarization, whereas part enters the skin and is scattered back from the deeper layers, losing its polarization. The light reflected by the skin surface, responsible for the glare of the skin, is blocked by the cross-polarized filter, since this light maintains its polarization. The backscattered light from the deeper layers passes through the cross-polarized filter since some of the polarized light has lost its angle of polarization. This makes the subsurface structures visible to the eye [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H620916057\">",
"    <span class=\"h1\">",
"     TYPES OF DERMATOSCOPES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dermatoscopes consist of a transilluminating light source and magnifying optics. The most commonly used dermatoscopes have a 10-fold magnification [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Three types of dermatoscopes are available:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nonpolarized light, contact",
"     </li>",
"     <li>",
"      Polarized light, contact",
"     </li>",
"     <li>",
"      Polarized light, noncontact",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Noncontact dermoscopy can only be performed using polarized light. Although nonpolarized and polarized light dermoscopy are not equivalent, they appear to provide complementary information (",
"    <a class=\"graphic graphic_table graphicRef71894 \" href=\"mobipreview.htm?25/1/25628\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/4,6,8,9\">",
"     4,6,8,9",
"    </a>",
"    ]. For example, epidermal structures, such as comedo-like openings in seborrheic keratoses, are more conspicuous with nonpolarized dermoscopy, whereas blood vessels, red color areas, white areas, or white shiny streaks are better visualized with polarized light dermoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/4,6,10\">",
"     4,6,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H355860\">",
"    <span class=\"h1\">",
"     COLORS AND STRUCTURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The visualization of colors and structures in the epidermis and papillary dermis has generated a new terminology for the morphologic description of skin lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/11\">",
"     11",
"    </a>",
"    ]. A histologic correlation has been established for most of the structures seen under dermoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H355867\">",
"    <span class=\"h2\">",
"     Colors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The colors seen by dermoscopy include yellow, red, brown, blue, gray, black, and white (",
"    <a class=\"graphic graphic_figure graphicRef71482 \" href=\"mobipreview.htm?41/40/42630\">",
"     figure 2D",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Melanin is the most important chromophore in pigmented lesions. The color of melanin depends upon its localization in the skin: it usually appears black in the stratum corneum, dark brown in the upper epidermis, tan to brown in the dermoepidermal junction, and",
"    <span class=\"nowrap\">",
"     gray/blue",
"    </span>",
"    to blue in the dermis. The red color is determined by vascularity; a thrombus will appear black. The white color is associated with collagen remodeling as seen in regression or scarring, the yellow with keratin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H355874\">",
"    <span class=\"h2\">",
"     Structures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The structures visualized in skin lesions are determined by the distribution and amount of pigment, keratin, collagen, and vascularity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/9,11,14,16-18\">",
"     9,11,14,16-18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The pigment network, negative network, streaks, aggregated globules and homogeneous blue pigmentation are the hallmark of melanocytic lesions (",
"      <a class=\"graphic graphic_picture graphicRef53263 graphicRef55387 graphicRef78335 \" href=\"mobipreview.htm?8/30/8682\">",
"       picture 1A-C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Arborizing vessels, leaf-like structures, spoke-wheel-like structures, large",
"      <span class=\"nowrap\">",
"       blue/gray",
"      </span>",
"      ovoid nests, multiple",
"      <span class=\"nowrap\">",
"       blue/gray",
"      </span>",
"      non-aggregated globules, and shallow ulceration are features of basal cell carcinomas (",
"      <a class=\"graphic graphic_picture graphicRef61313 \" href=\"mobipreview.htm?24/25/24982\">",
"       picture 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Milia-like cysts, comedo-like openings, finger print-like structures, moth-eaten borders, gyri and sulci, and sharp demarcation are characteristic of seborrheic keratoses (",
"      <a class=\"graphic graphic_picture graphicRef78870 \" href=\"mobipreview.htm?11/27/11703\">",
"       picture 3",
"      </a>",
"      ). Red or",
"      <span class=\"nowrap\">",
"       blue/purple/black",
"      </span>",
"      lagoons are seen in cherry angiomas or angiokeratomas (",
"      <a class=\"graphic graphic_picture graphicRef66439 \" href=\"mobipreview.htm?39/19/40242\">",
"       picture 4",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/11/13497?source=see_link&amp;anchor=H19871430#H19871430\">",
"       \"Dermoscopic evaluation of skin lesions\", section on 'First step: Melanocytic versus nonmelanocytic'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Atypical pigment network, blue-white veil, atypical vascular pattern, irregular streaks, atypical dots or globules, and regression structures are some of the features associated with melanoma (",
"      <a class=\"graphic graphic_picture graphicRef79576 graphicRef60407 graphicRef73202 \" href=\"mobipreview.htm?12/2/12329\">",
"       picture 5A-C",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/11/13497?source=see_link&amp;anchor=H18480302#H18480302\">",
"       \"Dermoscopic evaluation of skin lesions\", section on 'Second step: benign nevus versus suspicious lesion or melanoma'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A detailed description of the dermoscopic structures visualized in melanocytic and nonmelanocytic lesions and their histologic correlates is provided in the figures (",
"    <a class=\"graphic graphic_figure graphicRef77673 graphicRef63870 graphicRef74019 \" href=\"mobipreview.htm?0/1/16\">",
"     figure 2A-C",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The diagnostic criteria for benign and malignant melanocytic and nonmelanocytic skin lesions are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/11/13497?source=see_link\">",
"     \"Dermoscopic evaluation of skin lesions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H355881\">",
"    <span class=\"h2\">",
"     Vascular structures",
"    </span>",
"    &nbsp;&mdash;&nbsp;In amelanotic and hypomelanotic lesions, the vascular structures may provide the only clues to the diagnosis. In pigmented lesions, the vascular morphology provides additional clues to the diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Noncontact polarized light is the preferred type of dermatoscope for the visualization of blood vessels. However, if a contact dermatoscope is utilized, an ultrasound gel should be used as a liquid interface since the gel acts as a cushion and reduces the pressure applied to the skin, preventing the blanching of the vessels.",
"   </p>",
"   <p>",
"    The dermoscopic evaluation of vascular structures includes morphology (hairpin, glomerular, or arborizing), distribution (focal, diffuse, central, or peripheral), arrangement (crown, in a string, clustered, or radial), and presence of a white or pink halo.",
"   </p>",
"   <p>",
"    Melanocytic tumors may exhibit distinctive vascular morphologies, including comma, dotted, linear-irregular (also known as serpentine), and corkscrew (also known as tortuous) vessels (",
"    <a class=\"graphic graphic_table graphicRef79290 \" href=\"mobipreview.htm?38/17/39193\">",
"     table 2A",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/19,21,22\">",
"     19,21,22",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Nonmelanocytic lesions commonly present a variety of vascular morphologies, including glomerular, hairpin, or arborizing vessels (",
"    <a class=\"graphic graphic_table graphicRef56826 \" href=\"mobipreview.htm?32/56/33674\">",
"     table 2B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/17,19,22-25\">",
"     17,19,22-25",
"    </a>",
"    ]. Glomerular vessels are most commonly associated with bowenoid actinic keratosis, Bowen disease, squamous cell carcinoma, and clear cell acanthoma. Hairpin vessels with a white halo are typically seen in seborrheic keratoses and keratoacanthoma. &nbsp;",
"   </p>",
"   <p>",
"    It is important to be aware that a given vessel morphology may not be exclusive to a particular type of lesion. For example, dotted vessels can be seen in melanocytic tumors, squamous cell carcinoma, basal cell carcinoma, porokeratosis, clear cell acanthoma, and psoriasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/21,24-27\">",
"     21,24-27",
"    </a>",
"    ]. Polymorphous vessels are typically associated with melanoma, but can also be seen in basal cell carcinoma (BCC) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/24\">",
"     24",
"    </a>",
"    ]. Arborizing vessels are commonly seen in BCC, but they can also be seen in melanoma and intradermal nevi. Hairpin vessels are commonly associated with seborrheic keratoses, although they can also be seen in melanoma. Despite this overlap, the positive predictive value for a given vessel morphology can help guide the clinician to the correct diagnosis (",
"    <a class=\"graphic graphic_table graphicRef79290 \" href=\"mobipreview.htm?38/17/39193\">",
"     table 2A",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef56826 \" href=\"mobipreview.htm?32/56/33674\">",
"     table 2B",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/11/13497?source=see_link&amp;anchor=H18480302#H18480302\">",
"     \"Dermoscopic evaluation of skin lesions\", section on 'Second step: benign nevus versus suspicious lesion or melanoma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H620916064\">",
"    <span class=\"h1\">",
"     CLINICAL ROLE OF DERMOSCOPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The importance of dermoscopy in the in-vivo diagnosis of skin lesions has been increasingly recognized, following the identification of a large set of dermoscopic features in benign and malignant lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/14,28\">",
"     14,28",
"    </a>",
"    ]. Dermoscopy is widely used in Europe and Australia and is gaining popularity in the United States, where a survey of fellows of the US American Academy of Dermatology in 2010 found that at least 40 percent used dermatoscopy in their clinical practice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Dermoscopy requires some formal training to be effectively practiced. Online tutorials on dermoscopy can be found at",
"    <a class=\"external\" href=\"file://www.dermnetnz.org/doctors/dermoscopy-course/introduction.html\">",
"     www.dermnetnz.org/doctors/dermoscopy-course/introduction.html",
"    </a>",
"    ;",
"    <a class=\"external\" href=\"file://www.dermoscopy-ids.org/index.php/education/podcasts\">",
"     www.dermoscopy-ids.org/index.php/education/podcasts",
"    </a>",
"    ; or",
"    <a class=\"external\" href=\"file://www.genomel.org/dermoscopy\">",
"     www.genomel.org/dermoscopy",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Cross-sectional studies, randomized trials and systematic reviews of dermoscopy have indicated that dermoscopic examination has a higher discriminatory power than naked eye examination to detect melanoma either in experimental or real-life clinical settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/11,30-38\">",
"     11,30-38",
"    </a>",
"    ]. For clinicians with at least minimal training in dermoscopy, the addition of this procedure to the clinical examination increases the accuracy of the in-vivo diagnosis of skin cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/52/10054?source=see_link\">",
"     \"Evaluating diagnostic tests\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H354166\">",
"    <span class=\"h2\">",
"     Diagnostic accuracy for melanoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meta-analysis of nine studies performed in clinical settings reported an odds ratio for the diagnosis of melanoma of 9.0 (95% CI 1.5-54.6) for dermoscopy plus clinical examination, compared to clinical examination alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/33\">",
"     33",
"    </a>",
"    ]. The summary sensitivity was 90 percent (95% CI 80-95) and the specificity was 90 percent (95% CI 57-98) for dermoscopy plus clinical examination; sensitivity was 71 percent (95% CI 59-82) and specificity was 81 percent (95% CI 48-95) for clinical examination alone. Sensitivity improved without a decrease in specificity, meaning that a higher rate of melanoma detection did not increase the number of unnecessary excisions for benign lesions.",
"   </p>",
"   <p>",
"    Several factors may affect the diagnostic performance of dermoscopy:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Experience of the examiner",
"     </li>",
"     <li>",
"      Diagnostic algorithm and threshold for a positive test",
"     </li>",
"     <li>",
"      Prevalence of melanoma in the patient population examined",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a systematic review of 27 studies performed in clinical and experimental settings, the diagnostic accuracy of dermoscopy was lower for inexperienced examiners compared with experts, and was inversely proportional to the prevalence of melanoma in the sample [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/34\">",
"     34",
"    </a>",
"    ]. The degree of experience improved the diagnostic accuracy of complex algorithms, such as pattern analysis, whereas it did not affect the performance of simpler algorithms such as the ABCD rule of dermoscopy.",
"   </p>",
"   <p>",
"    Two clinical trials performed in primary care settings have shown that a short training in dermoscopy enables non-dermatologists to use simplified diagnostic algorithms and improve their accuracy in the diagnosis of melanoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/31,39\">",
"     31,39",
"    </a>",
"    ]. In one trial, 73 primary care physicians received one-day training in skin cancer detection and dermoscopy and were subsequently randomly assigned to use a polarized light handheld dermatoscope or the naked eye to assess the pigmented lesions of their patients for a period of 16-months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/31\">",
"     31",
"    </a>",
"    ]. All patients were also independently evaluated by expert dermatologists. The sensitivity for the referral of suspicious lesions was significantly higher in the dermoscopy group, compared to the naked eye examination group (79 and 54 percent, respectively), without difference in specificity (71 and 72 percent, respectively). &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9978115\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dermoscopic examination may be useful for patients with multiple common",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    atypical nevi who are at increased risk of melanoma. In those patients, dermoscopic examination of their nevi may help identify suspicious lesions not found with naked-eye preselection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although it will be beneficial to examine as many lesions as possible in patients with multiple nevi, special attention should be paid to the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/41\">",
"     41",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lesions with reported history of change",
"     </li>",
"     <li>",
"      Any lesions that are a concern for the patient",
"     </li>",
"     <li>",
"      Skin lesions which are clinically different from the other lesions (the &ldquo;ugly duckling&rdquo; sign)",
"     </li>",
"     <li>",
"      Lesions that appear clinically suspicious for melanoma",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H786228\">",
"    <span class=\"h2\">",
"     Purposes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dermoscopy may have different purposes depending upon the clinical setting in which it is used.",
"   </p>",
"   <p>",
"    In general dermatology and in primary care practices, the primary purpose of dermoscopy is the evaluation of pigmented and nonpigmented skin lesions to decide whether or not a lesion should be biopsied or referred. For this purpose, a minimal amount of training is needed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/31,42-44\">",
"     31,42-44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In specialized dermatologic settings, which include management of high-risk patients (eg, patients with the",
"    <span class=\"nowrap\">",
"     dysplastic/atypical",
"    </span>",
"    nevus syndrome), the main purposes of dermoscopy are to differentiate early melanoma from benign skin lesions and to minimize the unnecessary excision of benign nevi. Subtle signs of melanoma may be detected on dermoscopy by experienced clinicians before they become clinically evident to the naked eye.",
"   </p>",
"   <p>",
"    Digital dermoscopy may also be useful for long- or short-term follow-up of patients with multiple common and atypical nevi [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/45-50\">",
"     45-50",
"    </a>",
"    ]. Sequential digital dermoscopy imaging (SDDI) involves the capture and comparison of sequential dermoscopic images of one or more melanocytic lesions for short-term (less than 6 months) or long-term (6 to 12 months) surveillance. Several studies have indicated that SDDI has high sensitivity and specificity for detecting in situ or thin invasive melanomas that are difficult to diagnose otherwise [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/47-49,51\">",
"     47-49,51",
"    </a>",
"    ]. One study showed that in the primary care setting the combination of dermoscopy and short-term digital monitoring reduced the excision or referral of benign pigmented skin lesions by 56 percent and increased the sensitivity for diagnosing melanoma from 38 to 72 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H105442158\">",
"    <span class=\"h2\">",
"     Benefits",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dermoscopy improves the diagnosis of melanocytic lesions in clinical practice. Several meta-analyses of studies performed in experimental and clinical settings have indicated that dermoscopy increases the sensitivity for the diagnosis of melanoma without decreasing the specificity, compared with the naked eye examination [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/32-34\">",
"       32-34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dermoscopy improves the confidence in the diagnosis of benign pigmented lesions, reducing the number of unnecessary biopsies. In a randomized trial, dermatologists using dermoscopy, compared to those using naked eye examination, referred fewer patients for excision of benign lesions (9 versus 16 percent) without missing malignant lesions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/35\">",
"       35",
"      </a>",
"      ]. Several retrospective studies examined the numbers of excised benign and malignant lesions in dermatologic practices before and after the introduction of dermoscopy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/52,53\">",
"       52,53",
"      </a>",
"      ]. In one study, the ratio between benign and malignant excised lesions decreased from 18:1 to 4:1 over a three-year period [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dermoscopy allows digital surveillance and monitoring of melanocytic lesions in patients with multiple common or atypical nevi [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/45-50\">",
"       45-50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dermoscopy is useful in the diagnosis and differentiation of nonmelanocytic benign and malignant tumors such as basal cell carcinoma, dermatofibroma, seborrheic keratosis, and hemangioma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/9,17,21,23\">",
"       9,17,21,23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H105442166\">",
"    <span class=\"h2\">",
"     Limitations",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnostic accuracy of dermoscopy may be poorer than naked-eye examination when performed by individuals with limited experience in the interpretation of dermoscopy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Even in expert hands, dermoscopy may fail to recognize melanomas that lack specific dermoscopic criteria (featureless melanomas) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dermoscopy alone cannot establish the diagnosis of malignancy; histopathologic examination remains the gold standard for skin cancer diagnosis.",
"     </li>",
"     <li>",
"      Dermoscopy requires at least a minimal amount of training to provide advantage over the clinical examination [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/55\">",
"       55",
"      </a>",
"      ]. The correct interpretation of dermoscopic images depends upon knowledge of the significance of colors and structures manifested by a lesion. In addition, examining a lesion with reference to the clinical context and comparison to surrounding lesions is also important for rendering a correct diagnosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Although digital dermoscopic images are suitable for distance consultation, interpretation of dermoscopic photographs may be slightly less accurate than in-vivo dermoscopy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38807/abstract/57,58\">",
"       57,58",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H354158\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dermoscopy is a noninvasive, in vivo technique primarily used for the examination of skin lesions. A handheld instrument called a dermatoscope, consisting of a light source and magnifying optics, allows the visualization of subsurface skin structures that are usually not visible to the naked eye. (See",
"      <a class=\"local\" href=\"#H620916050\">",
"       'Dermoscopy physics'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H620916057\">",
"       'Types of dermatoscopes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Colors and structures visualized in skin lesions are mainly related to the amount, distribution and localization of melanin, vasculature structures, collagen and keratin (",
"      <a class=\"graphic graphic_figure graphicRef71482 graphicRef77673 graphicRef63870 graphicRef74019 \" href=\"mobipreview.htm?0/8/135\">",
"       figure 2A-D",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef79290 graphicRef56826 \" href=\"mobipreview.htm?42/58/43946\">",
"       table 2A-B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The pigment network, negative network, streaks, aggregated globules, and homogeneous blue pigmentation are the hallmark of melanocytic lesions (",
"      <a class=\"graphic graphic_picture graphicRef53263 graphicRef55387 graphicRef78335 \" href=\"mobipreview.htm?8/30/8682\">",
"       picture 1A-C",
"      </a>",
"      ). Arborizing vessels, leaf-like structures, spoke-wheel-like structures, and ovoid or round",
"      <span class=\"nowrap\">",
"       blue/gray",
"      </span>",
"      non-aggregated areas are features of basal cell carcinomas (",
"      <a class=\"graphic graphic_picture graphicRef61313 \" href=\"mobipreview.htm?24/25/24982\">",
"       picture 2",
"      </a>",
"      ). Milia-like cysts, comedo-like openings, and gyri and sulci are characteristic of seborrheic keratoses (",
"      <a class=\"graphic graphic_picture graphicRef78870 \" href=\"mobipreview.htm?11/27/11703\">",
"       picture 3",
"      </a>",
"      ), whereas red or",
"      <span class=\"nowrap\">",
"       blue/purple/black",
"      </span>",
"      lagoons are seen in cherry angiomas or angiokeratomas (",
"      <a class=\"graphic graphic_picture graphicRef66439 \" href=\"mobipreview.htm?39/19/40242\">",
"       picture 4",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/11/13497?source=see_link&amp;anchor=H19871430#H19871430\">",
"       \"Dermoscopic evaluation of skin lesions\", section on 'First step: Melanocytic versus nonmelanocytic'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Atypical pigment network, negative network, blue-white veil, atypical vascular pattern, irregular streaks, atypical dots or globules, regression structures, and peripheral tan structureless areas are some of the features associated with melanoma (",
"      <a class=\"graphic graphic_picture graphicRef79576 graphicRef60407 graphicRef73202 \" href=\"mobipreview.htm?12/2/12329\">",
"       picture 5A-C",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/11/13497?source=see_link&amp;anchor=H18480302#H18480302\">",
"       \"Dermoscopic evaluation of skin lesions\", section on 'Second step: benign nevus versus suspicious lesion or melanoma'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For clinicians who have been formally trained, the addition of dermoscopy to clinical examination improves the sensitivity and specificity of the in-vivo diagnosis of melanoma. In particular, dermoscopy improves the confidence in the diagnosis of benign lesions and reduces the number of unnecessary biopsies. However, even in expert hands, dermoscopy may fail to recognize melanomas lacking specific dermoscopic features. &nbsp;(See",
"      <a class=\"local\" href=\"#H354166\">",
"       'Diagnostic accuracy for melanoma'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H105442158\">",
"       'Benefits'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H105442166\">",
"       'Limitations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dermoscopy may be useful in patients with multiple common or atypical nevi who are at increased risk for melanoma. Special attention should be paid to lesions with reported history of change and lesions appearing clinically different from the other lesions (the &ldquo;ugly duckling&rdquo; sign) or clinically suspicious of melanoma. (See",
"      <a class=\"local\" href=\"#H9978115\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/1\">",
"      Marghoob AA, Swindle LD, Moricz CZ, et al. Instruments and new technologies for the in vivo diagnosis of melanoma. J Am Acad Dermatol 2003; 49:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/2\">",
"      Menzies SW, Ingvar C, McCarthy WH. A sensitivity and specificity analysis of the surface microscopy features of invasive melanoma. Melanoma Res 1996; 6:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/3\">",
"      Argenziano G, Soyer HP. Dermoscopy of pigmented skin lesions--a valuable tool for early diagnosis of melanoma. Lancet Oncol 2001; 2:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/4\">",
"      Benvenuto-Andrade C, Dusza SW, Agero AL, et al. Differences between polarized light dermoscopy and immersion contact dermoscopy for the evaluation of skin lesions. Arch Dermatol 2007; 143:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/5\">",
"      Gewirtzman AJ, Saurat JH, Braun RP. An evaluation of dermoscopy fluids and application techniques. Br J Dermatol 2003; 149:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/6\">",
"      Wang SQ, Dusza SW, Scope A, et al. Differences in dermoscopic images from nonpolarized dermoscope and polarized dermoscope influence the diagnostic accuracy and confidence level: a pilot study. Dermatol Surg 2008; 34:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/7\">",
"      Anderson RR. Polarized light examination and photography of the skin. Arch Dermatol 1991; 127:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/8\">",
"      Pan Y, Gareau DS, Scope A, et al. Polarized and nonpolarized dermoscopy: the explanation for the observed differences. Arch Dermatol 2008; 144:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/9\">",
"      Agero AL, Taliercio S, Dusza SW, et al. Conventional and polarized dermoscopy features of dermatofibroma. Arch Dermatol 2006; 142:1431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/10\">",
"      Marghoob AA, Cowell L, Kopf AW, Scope A. Observation of chrysalis structures with polarized dermoscopy. Arch Dermatol 2009; 145:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/11\">",
"      Argenziano G, Soyer HP, Chimenti S, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol 2003; 48:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/12\">",
"      Massi D, De Giorgi V, Soyer HP. Histopathologic correlates of dermoscopic criteria. Dermatol Clin 2001; 19:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/13\">",
"      Ferrara G, Argenziano G, Soyer HP, et al. Dermoscopic-pathologic correlation: an atlas of 15 cases. Clin Dermatol 2002; 20:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/14\">",
"      Pehamberger H, Steiner A, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Am Acad Dermatol 1987; 17:571.",
"     </a>",
"    </li>",
"    <li>",
"     Cabo H. Estructuras y colores. In: Dermatoscopia, Cabo H (Ed), Ediciones Journal, Buenos Aires 2008. Vol 364.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/16\">",
"      Braun RP, Rabinovitz HS, Oliviero M, et al. Dermoscopy of pigmented skin lesions. J Am Acad Dermatol 2005; 52:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/17\">",
"      Braun RP, Rabinovitz HS, Krischer J, et al. Dermoscopy of pigmented seborrheic keratosis: a morphological study. Arch Dermatol 2002; 138:1556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/18\">",
"      Scope A, Benvenuto-Andrade C, Agero AL, Marghoob AA. Nonmelanocytic lesions defying the two-step dermoscopy algorithm. Dermatol Surg 2006; 32:1398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/19\">",
"      Zalaudek I, Kreusch J, Giacomel J, et al. How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part I. Melanocytic skin tumors. J Am Acad Dermatol 2010; 63:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/20\">",
"      Menzies SW, Kreusch J, Byth K, et al. Dermoscopic evaluation of amelanotic and hypomelanotic melanoma. Arch Dermatol 2008; 144:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/21\">",
"      Zalaudek I, Kreusch J, Giacomel J, et al. How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part II. Nonmelanocytic skin tumors. J Am Acad Dermatol 2010; 63:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/22\">",
"      Argenziano G, Zalaudek I, Corona R, et al. Vascular structures in skin tumors: a dermoscopy study. Arch Dermatol 2004; 140:1485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/23\">",
"      Pan Y, Chamberlain AJ, Bailey M, et al. Dermatoscopy aids in the diagnosis of the solitary red scaly patch or plaque-features distinguishing superficial basal cell carcinoma, intraepidermal carcinoma, and psoriasis. J Am Acad Dermatol 2008; 59:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/24\">",
"      Altamura D, Menzies SW, Argenziano G, et al. Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis. J Am Acad Dermatol 2010; 62:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/25\">",
"      Ka VS, Clark-Loeser L, Marghoob AA. Vascular pattern in seborrheic keratoses and melanoma. Dermatol Surg 2004; 30:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/26\">",
"      Pizzichetta MA, Canzonieri V, Massone C, Soyer HP. Clinical and dermoscopic features of porokeratosis of Mibelli. Arch Dermatol 2009; 145:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/27\">",
"      Zalaudek I, Giacomel J, Argenziano G, et al. Dermoscopy of facial nonpigmented actinic keratosis. Br J Dermatol 2006; 155:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/28\">",
"      Soyer HP, Smolle J, H&ouml;dl S, et al. Surface microscopy. A new approach to the diagnosis of cutaneous pigmented tumors. Am J Dermatopathol 1989; 11:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/29\">",
"      Engasser HC, Warshaw EM. Dermatoscopy use by US dermatologists: a cross-sectional survey. J Am Acad Dermatol 2010; 63:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/30\">",
"      Argenziano G, Fabbrocini G, Carli P, et al. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol 1998; 134:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/31\">",
"      Argenziano G, Puig S, Zalaudek I, et al. Dermoscopy improves accuracy of primary care physicians to triage lesions suggestive of skin cancer. J Clin Oncol 2006; 24:1877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/32\">",
"      Bafounta ML, Beauchet A, Aegerter P, Saiag P. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol 2001; 137:1343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/33\">",
"      Vestergaard ME, Macaskill P, Holt PE, Menzies SW. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol 2008; 159:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/34\">",
"      Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol 2002; 3:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/35\">",
"      Carli P, de Giorgi V, Chiarugi A, et al. Addition of dermoscopy to conventional naked-eye examination in melanoma screening: a randomized study. J Am Acad Dermatol 2004; 50:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/36\">",
"      Bono A, Tolomio E, Trincone S, et al. Micro-melanoma detection: a clinical study on 206 consecutive cases of pigmented skin lesions with a diameter &lt; or = 3 mm. Br J Dermatol 2006; 155:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/37\">",
"      Bono A, Bartoli C, Cascinelli N, et al. Melanoma detection. A prospective study comparing diagnosis with the naked eye, dermatoscopy and telespectrophotometry. Dermatology 2002; 205:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/38\">",
"      Stanganelli I, Serafini M, Bucch L. A cancer-registry-assisted evaluation of the accuracy of digital epiluminescence microscopy associated with clinical examination of pigmented skin lesions. Dermatology 2000; 200:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/39\">",
"      Westerhoff K, McCarthy WH, Menzies SW. Increase in the sensitivity for melanoma diagnosis by primary care physicians using skin surface microscopy. Br J Dermatol 2000; 143:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/40\">",
"      Seidenari S, Longo C, Giusti F, Pellacani G. Clinical selection of melanocytic lesions for dermoscopy decreases the identification of suspicious lesions in comparison with dermoscopy without clinical preselection. Br J Dermatol 2006; 154:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/41\">",
"      Bowling J, Argenziano G, Azenha A, et al. Dermoscopy key points: recommendations from the international dermoscopy society. Dermatology 2007; 214:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/42\">",
"      Zalaudek I, Argenziano G, Soyer HP, et al. Three-point checklist of dermoscopy: an open internet study. Br J Dermatol 2006; 154:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/43\">",
"      Dolianitis C, Kelly J, Wolfe R, Simpson P. Comparative performance of 4 dermoscopic algorithms by nonexperts for the diagnosis of melanocytic lesions. Arch Dermatol 2005; 141:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/44\">",
"      Menzies SW, Emery J, Staples M, et al. Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial. Br J Dermatol 2009; 161:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/45\">",
"      Kittler H, Pehamberger H, Wolff K, Binder M. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi. J Am Acad Dermatol 2000; 43:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/46\">",
"      Argenziano G, Mordente I, Ferrara G, et al. Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols. Br J Dermatol 2008; 159:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/47\">",
"      Altamura D, Avramidis M, Menzies SW. Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma. Arch Dermatol 2008; 144:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/48\">",
"      Robinson JK, Nickoloff BJ. Digital epiluminescence microscopy monitoring of high-risk patients. Arch Dermatol 2004; 140:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/49\">",
"      Menzies SW, Gutenev A, Avramidis M, et al. Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions. Arch Dermatol 2001; 137:1583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/50\">",
"      Holz RW. Exchange diffusion of dopamine induced in planar lipid bilayer membranes by the ionophore X537A. J Gen Physiol 1977; 69:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/51\">",
"      Kittler H, Guitera P, Riedl E, et al. Identification of clinically featureless incipient melanoma using sequential dermoscopy imaging. Arch Dermatol 2006; 142:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/52\">",
"      Carli P, De Giorgi V, Crocetti E, et al. Improvement of malignant/benign ratio in excised melanocytic lesions in the 'dermoscopy era': a retrospective study 1997-2001. Br J Dermatol 2004; 150:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/53\">",
"      Terushkin V, Warycha M, Levy M, et al. Analysis of the benign to malignant ratio of lesions biopsied by a general dermatologist before and after the adoption of dermoscopy. Arch Dermatol 2010; 146:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/54\">",
"      Skvara H, Teban L, Fiebiger M, et al. Limitations of dermoscopy in the recognition of melanoma. Arch Dermatol 2005; 141:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/55\">",
"      Binder M, Schwarz M, Winkler A, et al. Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol 1995; 131:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/56\">",
"      Argenziano G, Catrical&agrave; C, Ardigo M, et al. Dermoscopy of patients with multiple nevi: Improved management recommendations using a comparative diagnostic approach. Arch Dermatol 2011; 147:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/57\">",
"      Carli P, De Giorgi V, Argenziano G, et al. Pre-operative diagnosis of pigmented skin lesions: in vivo dermoscopy performs better than dermoscopy on photographic images. J Eur Acad Dermatol Venereol 2002; 16:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38807/abstract/58\">",
"      Warshaw EM, Gravely AA, Nelson DB. Accuracy of teledermatology/teledermoscopy and clinic-based dermatology for specific categories of skin neoplasms. J Am Acad Dermatol 2010; 63:348.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13521 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-22FFA76FCA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_57_38807=[""].join("\n");
var outline_f37_57_38807=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H354158\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H620916022\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H620916050\">",
"      DERMOSCOPY PHYSICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H620916057\">",
"      TYPES OF DERMATOSCOPES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H355860\">",
"      COLORS AND STRUCTURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H355867\">",
"      Colors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H355874\">",
"      Structures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H355881\">",
"      Vascular structures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H620916064\">",
"      CLINICAL ROLE OF DERMOSCOPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H354166\">",
"      Diagnostic accuracy for melanoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9978115\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H786228\">",
"      Purposes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H105442158\">",
"      Benefits",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H105442166\">",
"      Limitations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H354158\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/13521\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13521|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?2/15/2290\" title=\"figure 1\">",
"      Polarized light physics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/42/26282\" title=\"figure 2A\">",
"      Dermoscopic structures 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/1/12314\" title=\"figure 2B\">",
"      Dermoscopic structures 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?38/5/39002\" title=\"figure 2C\">",
"      Dermoscopic structures 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/40/42630\" title=\"figure 2D\">",
"      Dermoscopy colors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13521|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?26/4/26691\" title=\"picture 1A\">",
"      Melanocytic lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?24/13/24799\" title=\"picture 1B\">",
"      Parallel pattern",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?35/13/36053\" title=\"picture 1C\">",
"      Pigmented melanocytic lesions II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?24/25/24982\" title=\"picture 2\">",
"      Dermoscopy basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?11/27/11703\" title=\"picture 3\">",
"      Dermoscopy seborrheic keratosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/19/40242\" title=\"picture 4\">",
"      Hemangioma and angiokeratoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?37/57/38802\" title=\"picture 5A\">",
"      Dermoscopy melanoma 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?20/2/20512\" title=\"picture 5B\">",
"      Dermoscopy melanoma 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?14/40/14977\" title=\"picture 5C\">",
"      Dermoscopy melanoma 3",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13521|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?25/1/25628\" title=\"table 1\">",
"      Polarized and non-polarized dermoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/17/39193\" title=\"table 2A\">",
"      Vascular structures 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?32/56/33674\" title=\"table 2B\">",
"      Vascular structures 2",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/11/13497?source=related_link\">",
"      Dermoscopic evaluation of skin lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/52/10054?source=related_link\">",
"      Evaluating diagnostic tests",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_57_38808="Bullous pemphigoid direct immunofluorescence 400X";
var content_f37_57_38808=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86372%7EDERM%2F86950&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86372%7EDERM%2F86950&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Linear IgG basement membrane zone antibody staining in bullous pemphigoid by direct immunofluorescence microscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 380px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Direct immunofluorescence microscopy of perilesional skin from a patient with bullous pemphigoid reveals characteristic linear IgG basement membrane zone staining.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kristin M Leiferman, MD, Immunodermatology Laboratory, Department of Dermatology, University of Utah, Salt Lake City, Utah.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Linear C3 basement membrane zone antibody staining in bullous pemphigoid by direct immunofluorescence microscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 407px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Direct immunofluorescence microscopy of perilesional skin from a patient with bullous pemphigoid reveals characteristic linear C3 basement membrane zone staining.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kristin M Leiferman, MD, Immunodermatology Laboratory, Department of Dermatology, University of Utah, Salt Lake City, Utah.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_57_38808=[""].join("\n");
var outline_f37_57_38808=null;
var title_f37_57_38809="Pancreatic debridement";
var content_f37_57_38809=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pancreatic debridement",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/57/38809/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/57/38809/contributors\">",
"     Thomas J Howard, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/57/38809/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/57/38809/contributors\">",
"     Stanley W Ashley, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/57/38809/contributors\">",
"     John R Saltzman, MD, FACP, FACG, FASGE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/57/38809/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/57/38809/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/57/38809/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 25, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H20486491\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic debridement is indicated for patients with pancreatic necrosis and progressive clinical sepsis as a complication of severe acute pancreatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Pancreatic and peripancreatic necrosis occur in approximately 20 percent of patients with pancreatitis, as a result of inflammation and vascular compromise [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will focus on the indications and techniques for pancreatic debridement. The etiology, diagnosis, and the general approach to the treatment of acute pancreatitis are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/61/14297?source=see_link\">",
"     \"Etiology of acute pancreatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/5/20569?source=see_link\">",
"     \"Clinical manifestations and diagnosis of acute pancreatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/29/44504?source=see_link\">",
"     \"Predicting the severity of acute pancreatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/35/7738?source=see_link\">",
"     \"Treatment of acute pancreatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20486505\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR PANCREATIC DEBRIDEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic necrosis can result in secondary infection or symptomatic sterile necrosis, which is characterized by chronic low grade fever, nausea, lethargy, and inability to eat [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. Both infected pancreatic necrosis and symptomatic sterile necrosis are accepted indications for debridement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/5,8,9\">",
"     5,8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The goal of pancreatic debridement is to excise all dead and devitalized pancreatic and peripancreatic tissue while preserving viable functioning pancreas, controlling resultant pancreatic fistulas, and limiting extraneous organ damage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/1,7\">",
"     1,7",
"    </a>",
"    ]. For patients with biliary pancreatitis, cholecystectomy with intraoperative cholangiography is an important secondary objective of the surgery because it will prevent recurrent disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20486512\">",
"    <span class=\"h2\">",
"     Infected pancreatic necrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Secondary infection of the necrotic pancreatic or peripancreatic tissue with either bacteria or fungus occurs soon after the initial inflammatory reaction subsides and is heralded by tachycardia, hypotension, fevers,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    deteriorating organ function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/11\">",
"     11",
"    </a>",
"    ]. Bacterial or fungal infections occur either by bacterial translocation from the gastrointestinal tract or via seeding through transient bacteremia that can occur in the setting of invasive intravenous lines, endotracheal intubation, or prolonged bladder catheterization. The risk of secondary bacterial infections can be minimized with early enteral feeding, central line catheter maintenance programs, ventilator protocols, and early urinary catheter removal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/12-14\">",
"     12-14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no benefit from probiotics, protease inhibitors, or early surgical debridement for the prevention of infected pancreatic necrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/15-19\">",
"     15-19",
"    </a>",
"    ]. The use of prophylactic systemic antibiotics in acute pancreatitis is controversial and is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/35/7738?source=see_link&amp;anchor=H10#H10\">",
"     \"Treatment of acute pancreatitis\", section on 'Prophylactic antibiotics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20486519\">",
"    <span class=\"h2\">",
"     Symptomatic sterile pancreatic necrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptomatic sterile necrosis is characterized by chronic low grade fever, nausea, lethargy, and inability to eat. These patients typically have a large volume of retroperitoneal necrosis, and often harbor occult infections identified only after debridement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/9\">",
"     9",
"    </a>",
"    ]. Medical treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/40/42628?source=see_link\">",
"     total parenteral nutrition",
"    </a>",
"    and antibiotics is",
"    <strong>",
"     ineffective",
"    </strong>",
"    and pancreatic debridement should be strongly considered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/8,9,20\">",
"     8,9,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1549588\">",
"    <span class=\"h1\">",
"     TIMING OF DEBRIDEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal timing for pancreatic debridement is at least three to four weeks following the onset of acute pancreatitis. Delayed debridement allows clinical stabilization of the patient, resolution of early organ failure, and a decrease in the intense inflammatory reaction in the retroperitoneum (",
"    <a class=\"graphic graphic_algorithm graphicRef66576 \" href=\"mobipreview.htm?31/58/32687\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Pancreatic necrosis is a dynamic disease process that evolves in two distinct clinical phases (early and late), which affect the timing of debridement (",
"    <a class=\"graphic graphic_figure graphicRef76564 \" href=\"mobipreview.htm?41/53/42845\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/1\">",
"     1",
"    </a>",
"    ]. For the reasons described in the next section, late debridement is preferred, if possible.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Early phase",
"      </strong>",
"      &mdash; The early phase of illness (first two weeks) is characterized by an acute systemic inflammatory response syndrome, organ dysfunction or failure, and variable amounts of pancreatic and peripancreatic ischemia, leading to tissue necrosis. The underlying mechanism for this phase of disease is believed to be the host&rsquo;s inflammatory and cytokine response, resulting in organ dysfunction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/23\">",
"       23",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      During the first few days of critical illness, early death from irreversible organ failure accounts for up to 60 percent of mortality in patients with severe acute pancreatitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/24,25\">",
"       24,25",
"      </a>",
"      ]. This early organ failure, which is predominately renal and pulmonary, can be treated by aggressive volume resuscitation, enteral feeding, and support [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/7\">",
"       7",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/35/7738?source=see_link&amp;anchor=H2#H2\">",
"       \"Treatment of acute pancreatitis\", section on 'Supportive care'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Infrequently, exploratory laparotomy is considered to confirm the diagnosis of severe acute pancreatitis, and to exclude other potentially treatable causes of recalcitrant multiorgan system failure such as infarcted bowel, gangrenous gallbladder, or perforated viscus. In patients who survive this early inflammatory storm, increased morbidity and mortality rates are due to persistent organ failure, pancreatic necrosis,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/1,7\">",
"       1,7",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      If treatable causes of organ failure are not identified and the etiology is confirmed to be severe acute pancreatitis with necrosis, early pancreatic debridement is rarely helpful. Early debridement is often complicated by intra-abdominal hypervascularity, altered anatomic relationships, and an inability to discriminate dead from surrounding live tissue, making debridement imprecise, bloody, and ineffective. When infected necrosis necessitates early debridement, the debridement often is associated with incomplete removal of necrotic tissue and a high rate of injury to normal surrounding tissues [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/19,21,22\">",
"       19,21,22",
"      </a>",
"      ]. These patients have a higher morbidity and mortality rate and frequently require multiple surgical procedures for persistent pancreatic necrosis or repair of iatrogenic damage to the surrounding organs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Late phase",
"      </strong>",
"      &mdash; The optimal time for surgical debridement is approximately four weeks after the onset of pancreatitis, when vascular inflammation has decreased, organization of the process has occurred, and delineation of live from dead tissue is complete. At this point, the retroperitoneal inflammatory response decreases and the necrotic areas are demarcated from the surrounding viable tissue, which usually permits definitive operative debridement. The organized, demarcated collection is termed walled-off pancreatic necrosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/27,28\">",
"       27,28",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H265589\">",
"       'Walled-off pancreatic necrosis'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20486533\">",
"    <span class=\"h1\">",
"     PREOPERATIVE EVALUATION AND PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The preoperative evaluation and preparation of patients with pancreatic necrosis will depend upon the etiology of the pancreatitis. However, all patients need a preoperative CT scan to define the extent and location of the disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/61/14297?source=see_link\">",
"     \"Etiology of acute pancreatitis\"",
"    </a>",
"    .) &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1551551\">",
"    <span class=\"h2\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients suspected of having biliary pancreatitis require preoperative ultrasound evaluation to confirm the presence of gallstones. In those suspected of having choledocholithiasis, preoperative liver function tests are also important [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/61/14297?source=see_link&amp;anchor=H3#H3\">",
"     \"Etiology of acute pancreatitis\", section on 'Gallstones'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1551834\">",
"    <span class=\"h2\">",
"     ERCP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with evidence of cholangitis should undergo prompt endoscopic retrograde cholangiopancreatography (ERCP) to ameliorate the severity of the pancreatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/13/24790?source=see_link&amp;anchor=H11#H11\">",
"     \"Acute cholangitis\", section on 'Establishment of biliary drainage'",
"    </a>",
"    .) &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1551948\">",
"    <span class=\"h2\">",
"     CT scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of infected pancreatic necrosis is made by the identification of air bubbles in retroperitoneal necrosis on computed tomography (CT) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef54160 \" href=\"mobipreview.htm?13/3/13362\">",
"     image 1",
"    </a>",
"    )",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    with CT directed fine needle aspiration of pancreatic necrosis for gram stain and culture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/27,30\">",
"     27,30",
"    </a>",
"    ]. The use of CT directed fine needle aspiration confirms the diagnosis of infected pancreatic necrosis and supports the decision for surgical debridement. However, because of potential adverse effects, fine needle aspiration should be performed",
"    <strong>",
"     only",
"    </strong>",
"    when the results will affect intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/35/7738?source=see_link&amp;anchor=H11#H11\">",
"     \"Treatment of acute pancreatitis\", section on 'Percutaneous CT-guided aspiration'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    All patients with pancreatic necrosis undergoing debridement should have contrast enhanced CT scanning of the abdomen and pelvis to define the extent and location of necrotic areas as this will affect the surgical approach. In some cases, CT placement of drains should be considered as a bridging technique to decompress retroperitoneal fluid collections and to allow stabilization of patients with sepsis prior to operative debridement. (See",
"    <a class=\"local\" href=\"#H263650\">",
"     'Percutaneous CT guided catheter drainage'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H265509\">",
"    <span class=\"h3\">",
"     Estimating the extent of disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Accurate quantification of the extent of pancreatic parenchymal and peripancreatic necrosis, documentation of diffuse or walled-off necrosis, and identification of infection are critical for prediction of a patient's clinical course and choice of the most appropriate therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/1,5,32-34\">",
"     1,5,32-34",
"    </a>",
"    ]. Areas of necrosis are manifested on contrast-enhanced CT by a lack of tissue contrast enhancement (less than 50 Hounsfield units) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62632 \" href=\"mobipreview.htm?12/55/13169\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/32,35\">",
"     32,35",
"    </a>",
"    ]. The lack of contrast is due to capillary thrombosis and documents the lack of blood supply to the area of necrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/36\">",
"     36",
"    </a>",
"    ]. Use of CT findings to predict outcome are outlined in the table and discussed in detail elsewhere (",
"    <a class=\"graphic graphic_table graphicRef68191 \" href=\"mobipreview.htm?12/41/12956\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/29/44504?source=see_link&amp;anchor=H22#H22\">",
"     \"Predicting the severity of acute pancreatitis\", section on 'CT severity index'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H265555\">",
"    <span class=\"h3\">",
"     Disconnected pancreatic segment",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with isolated necrosis of the pancreatic neck or body, note should be made of the presence of a disconnected pancreatic segment. A disconnected segment will remain viable after debridement and will require adequate external drainage to create a controlled external pancreatic fistula and prevent internal leaking of pancreatic fluids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/20/23878?source=see_link\">",
"     \"Treatment of pancreatic fistulas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H265575\">",
"    <span class=\"h3\">",
"     Extension into mesenteric root",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extension of the necrotic process into the mesenteric root and down the right and left paracolic gutters should be treated with mobilization of the splenic flexure of the colon for adequate debridement (",
"    <a class=\"graphic graphic_algorithm graphicRef65906 \" href=\"mobipreview.htm?35/55/36725\">",
"     algorithm 2",
"    </a>",
"    ). Occasionally, the necrotic process involves the mesocolon to such an extent that adequate debridement skeletonizes the colonic blood supply, leaving the colon vulnerable to ischemic injury. In this situation, partial colectomy with end ileostomy and Hartmann's procedure is the safest and most expedient way to remove jeopardized colon, divert the fecal stream, and ensure prompt recovery and the ability to establish early enteral feeding. Patients potentially at risk for this outcome should be informed of this possibility preoperatively and be visited by an enterostomal therapist for marking. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/10/2218?source=see_link\">",
"     \"Management of patients with a colostomy or ileostomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H265589\">",
"    <span class=\"h3\">",
"     Walled-off pancreatic necrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Walled-off pancreatic necrosis is an increasingly well-recognized entity in which encapsulation of the process within the lesser sac bound by the stomach, duodenum, transverse mesocolon, and omentum creates a localized mature collection analogous to a pancreatic pseudocyst (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66932 \" href=\"mobipreview.htm?10/0/10244\">",
"     image 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77288 \" href=\"mobipreview.htm?36/32/37381\">",
"     image 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/34\">",
"     34",
"    </a>",
"    ]. It is best defined by cross sectional imaging (contrast-enhanced CT). Walled-off pancreatic necrosis is well-suited to minimally invasive debridement techniques including endoscopic transgastric drainage, external percutaneous drainage with irrigation (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66786 \" href=\"mobipreview.htm?14/13/14549\">",
"     image 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68937 \" href=\"mobipreview.htm?42/9/43159\">",
"     image 6",
"    </a>",
"    ), and laparoscopic video-assisted retroperitoneal debridement. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H263623\">",
"    <span class=\"h1\">",
"     MINIMALLY INVASIVE APPROACH TO PANCREATIC DEBRIDEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Minimally invasive techniques, such as percutaneous CT guided catheter drainage or endoscopic debridement can be employed in selected cases (",
"    <a class=\"graphic graphic_algorithm graphicRef77684 graphicRef53604 \" href=\"mobipreview.htm?40/20/41286\">",
"     algorithm 3A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H263650\">",
"    <span class=\"h2\">",
"     Percutaneous CT guided catheter drainage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Temporary percutaneous drainage can be used to decompress retroperitoneal fluid collections and allow stabilization of patients with sepsis prior to formal operative debridement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/32,39,40\">",
"     32,39,40",
"    </a>",
"    ]. CT guidance is used to establish percutaneous access into pancreatic fluid collections using the most direct transperitoneal route available, thereby avoiding intervening bowel and solid organs. The number and size of catheters placed is dictated by the size and location of the space containing the necrosis, the viscosity of the fluid aspirated, and the amount of particulate debris. The procedure is performed with local anesthesia.",
"   </p>",
"   <p>",
"    After placement, the catheters undergo vigorous manual irrigation with isotonic saline every several days, combined with contrast CT scans to follow the removal of necrotic debris, assess changes in the cavity dimension, and ensure catheter lumen patency. Over time, small diameter drains are upsized to larger bore catheters (24 to 28-French) for removal of necrotic debris. CT guided catheter drainage requires a dedicated interventional radiologist who will perform sequential interventions as necessary [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/34,41,42\">",
"     34,41,42",
"    </a>",
"    ]. A drawback to this approach is that all mechanical debridement and tissue evacuation must be performed through limited diameter catheters, which require frequent replacement and meticulous maintenance.",
"   </p>",
"   <p>",
"    Percutaneous catheter drainage is primarily a bridging technique for patients who are too unstable to undergo surgical debridement, although about one-third of patients can be managed with percutaneous drainage alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. The PANTER study (PAncreatitis, Necrosectomy versus sTEp up appRoach), a randomized trial of percutaneous catheter drainage in 88 patients, found that 35 percent of patients were treated successfully with percutaneous catheter drainage alone, while the remainder required percutaneous drainage followed by open debridement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. Compared with open pancreatic debridement alone, preoperative drainage followed by open debridement significantly decreased the rate of new onset multiple organ failure (12 versus 40 percent), incisional hernias (7 versus 24 percent) and new onset diabetes (16 versus 38 percent) but did not significantly affect mortality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H263672\">",
"    <span class=\"h2\">",
"     Endoscopic debridement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic debridement is typically performed via a transgastric approach and is limited to patients with walled-off pancreatic necrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/34,38,47\">",
"     34,38,47",
"    </a>",
"    ]. This approach is similar to endoscopic drainage of pancreatic pseudocysts. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/0/27655?source=see_link\">",
"     \"Endoscopic management of pseudocysts of the pancreas: Technique\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pancreatic debridement is accomplished through the stomach or duodenum without the need for a transabdominal incision. Under conscious sedation or anesthesia, a therapeutic echo-endoscope is placed in the stomach, and the area of pancreatic necrosis is identified and characterized by endoscopic ultrasound. Working through the scope with both endoscopic ultrasound and fluoroscopic guidance, a transluminal puncture into the walled-off collection is made using a 19 gauge needle and fluid is aspirated for gram stain and culture. Water soluble contrast dye is injected into the collection to confirm that entry has been made into the walled-off cavity.",
"   </p>",
"   <p>",
"    After correct placement of the puncture is confirmed, a guidewire is placed into the cavity to facilitate advancement of a large (up to 20 mm) hydrostatic balloon into the gastric wall for hydrostatic dilatation. Once the gastrostomy is established, direct endoscopic debridement can be carried out using a standard forward-viewing gastroscope and a combination of irrigation, snares, baskets, and stone retrieval balloons. &nbsp;Following mechanical debridement, two 10-French double pigtail stents are placed into the cavity, and some physicians also place a 7-French pigtail nasocystic tube alongside the stents for postoperative lavage.",
"   </p>",
"   <p>",
"    Serial abdominal CT scans are performed every one to two weeks after the intervention to follow the resolution of necrosis. Endoscopic examinations and interventions are carried out as deemed necessary based upon radiologic imaging data and the patient's clinical response.",
"   </p>",
"   <p>",
"    The endoscopic technique provides a targeted approach to focal pancreatic necrosis with a reduction in the systemic inflammatory response and avoidance of the wound complications that are associated with major laparotomy incisions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/34,41\">",
"     34,41",
"    </a>",
"    ]. A meta-analysis of endoscopic drainage for pancreatic necrosis reported a 69 percent success rate, 34 percent morbidity rate, and 2 percent mortality rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/47\">",
"     47",
"    </a>",
"    ]. One-third of patients initially treated with endoscopic debridement ultimately need open surgical debridement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/36,47\">",
"     36,47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1171338\">",
"    <span class=\"h1\">",
"     SURGEON'S SAFETY CHECKLIST FOR PANCREATIC DEBRIDEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following issues should be addressed by the surgical team prior to pancreatic debridement.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Informed consent ",
"      </strong>",
"      The indications for debridement and the planned method of debridement should be discussed with the patient. The discussion should include the potential need for multiple interventions or reoperations to drain intra-abdominal fluid collections, remove additional necrotic tissue, or control a pancreatic fistula.",
"      <br/>",
"      <br/>",
"      Patients with biliary pancreatitis should be informed that cholecystectomy done in the setting of retroperitoneal inflammation is associated with an increased incidence of postoperative bile leak or biliary injury. Patients with involvement of the mesocolon should be informed of the potential need for colon resection and a colostomy.",
"     </li>",
"     <li>",
"      <strong>",
"       Antibiotics",
"      </strong>",
"      &minus; Patients with pancreatic necrosis should receive preoperative antibiotics. If percutaneous CT-guided fine needle aspiration has been performed, the antibiotic choices should reflect the culture and sensitivity results. The most common organisms causing infection in necrotizing pancreatitis include Escherichia coli, Pseudomonas, Klebsiella, and Enterococcus, and the initial recommended antibiotic coverage is with a carbapenem [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/4,48\">",
"       4,48",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/47/44789?source=see_link&amp;anchor=H3#H3\">",
"       \"Combination beta-lactamase inhibitors, carbapenems, and monobactams\", section on 'Carbapenems'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Antibiotics should be administered after the patient arrives in the operating room and before the incision is made. The efficacy of antibiotic prophylaxis decreases if administered more than one hour before surgery. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=see_link&amp;anchor=H7#H7\">",
"       \"Overview of control measures to prevent surgical site infection\", section on 'Antimicrobial prophylaxis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Equipment",
"      </strong>",
"       Appropriate drains and a jejunal feeding tube should be available; a T-tube or low profile feeding tube is usually used for the jejunal tube. For laparoscopic surgery, video cameras, a videoscope, and laparoscopic equipment are needed. Intraoperative ultrasound equipment is very useful for localization of the retroperitoneal necrosis and the identification of major vascular anatomy.",
"     </li>",
"     <li>",
"      <strong>",
"       Deep venous thrombosis prophylaxis &mdash;",
"      </strong>",
"      For patients undergoing general anesthesia, primary prophylaxis for prevention of deep venous thrombosis should be employed (",
"      <a class=\"graphic graphic_table graphicRef50947 \" href=\"mobipreview.htm?34/54/35693\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=see_link\">",
"       \"Prevention of venous thromboembolic disease in surgical patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Imaging ",
"      </strong>",
"      CT scan images should be reviewed and be readily available in the operating room. (See",
"      <a class=\"local\" href=\"#H1551948\">",
"       'CT scan'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <strong>",
"       Surgical time-out &mdash;",
"      </strong>",
"      A surgical time-out should be performed with the entire operating room team (anesthesiologist, surgeon, nurse, scrub technician) to assure correct patient identity, intended operation, and the informed consent (",
"      <a class=\"graphic graphic_table graphicRef59666 \" href=\"mobipreview.htm?39/28/40395\">",
"       table 3",
"      </a>",
"      ). A preoperative checklist is a good way to assure that all safety issues have been addressed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1179953\">",
"    <span class=\"h1\">",
"     SURGICAL APPROACHES TO PANCREATIC DEBRIDEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical pancreatic debridement can be performed with open or laparoscopic techniques [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/1,7\">",
"     1,7",
"    </a>",
"    ]. Open debridement remains the gold standard and is usually performed with external drainage. Some surgeons prefer internal drainage with a cystgastrostomy. Laparoscopic surgery can be considered in selected patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20486554\">",
"    <span class=\"h2\">",
"     Open debridement with external drainage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Open debridement under general anesthesia with closure over drains is the gold standard for pancreatic debridement. In an observational series of 102 patients, this approach resulted in operative morbidity in 72 percent and mortality in 4 percent; the mean hospital length of stay was 26 days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/22\">",
"     22",
"    </a>",
"    ]. These results are consistent with those reported from other large surgical series utilizing this technique [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/9,49\">",
"     9,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following steps are performed with open debridement with external drainage:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Incision",
"      </strong>",
"      &mdash; The abdomen is opened through either an upper midline or bilateral subcostal incision. If a colostomy is anticipated, the site should be marked preoperatively.",
"     </li>",
"     <li>",
"      <strong>",
"       Entry into the retroperitoneum",
"      </strong>",
"      &mdash; The retroperitoneum is entered through the lesser sac by mobilizing the omentum off the transverse colon. Alternatively, entrance to the lesser sac can be accomplished through an avascular plane in the transverse mesocolon to the right or left of the middle colic vessels [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/9\">",
"       9",
"      </a>",
"      ]. Utilizing preoperative CT imaging as a guide, specific areas of pancreatic and peripancreatic necrosis and associated fluid collections are identified.",
"     </li>",
"     <li>",
"      <strong>",
"       Debridement",
"      </strong>",
"      &mdash; Once the main site of necrosis is entered, fluid is evacuated and debridement is begun by pulling the loosely organized debris away from the firm, inflamed, viable tissue using blunt dissection, finger pinching, ring forceps, and infrequent sharp dissection. Necrotic debris should be cultured for fungus as well as aerobic and anaerobic bacteria.",
"      <br/>",
"      <br/>",
"      Viable tissue should be preserved and can be identified by its firm, indurated appearance and consistency, as well as bleeding with manipulation. Major vascular structures are characteristically well-preserved, allowing careful skeletonization during the debridement.",
"      <br/>",
"      <br/>",
"      Once the main cavity is debrided, any extension of the process is identified by gentle digital palpation from within the main cavity, exploring communicating spaces and extensions of the necrosis throughout the retroperitoneum. Debridement often extends into the fat of the mesocolon or small bowel mesentery. In both of these sites, meticulous care should be taken to avoid vascular injury, particularly to the colic, superior, or inferior mesenteric vessels.",
"     </li>",
"     <li>",
"      <strong>",
"       Cholecystectomy",
"      </strong>",
"      &mdash; For patients with biliary pancreatitis, a cholecystectomy should be performed if technically possible, dissecting the gallbladder retrograde from the fundus to the infundibulum. The need for an intraoperative cholangiogram will depend upon whether endoscopic retrograde cholangiopancreatography (ERCP) was performed prior to surgery.",
"     </li>",
"     <li>",
"      <strong>",
"       Feeding tube",
"      </strong>",
"      &mdash; Enteral access should be established through a gastrojejunal feeding tube (18 or 22-French T-tube or a low profile feeding tube) placed via a Stamm-type gastrostomy, directing the distal jejunal feeding port past the pylorus and ligament of Trietz into the first portion of the jejunum (",
"      <a class=\"graphic graphic_figure graphicRef76417 \" href=\"mobipreview.htm?17/4/17473\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Drain placement",
"      </strong>",
"      &mdash; Two to four large (19-French) closed suction drains are placed at the time of operation, with the number and positioning dictated by the extent of debridement and concern for the development of a postoperative pancreatic fistula.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H290573\">",
"    <span class=\"h2\">",
"     Open debridement with internal drainage and cystgastrostomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Open debridement with internal drainage is favored by some surgeons, when feasible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/50\">",
"     50",
"    </a>",
"    ]. This procedure is only appropriate for patients with walled-off pancreatic necrosis. The surgery is performed via a midline incision into the peritoneal cavity. (See",
"    <a class=\"local\" href=\"#H265589\">",
"     'Walled-off pancreatic necrosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A longitudinal gastrotomy is made along the greater curvature and the posterior gastric wall is exposed. A needle is used to identify the walled-off pancreatic collection posterior to the stomach. The cavity is then opened with cautery and an endovascular stapling device is used to create a generous (8 cm) cystgastrostomy. Debridement is then performed. A nasogastric tube is placed in the cavity. A gastrostomy drainage tube (Foley catheter) is placed and the gastrotomy is closed. The nasogastric tube is then flushed with isotonic saline every four hours for two to three days.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1552920\">",
"    <span class=\"h2\">",
"     Open packing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Open packing with planned reoperation every 48 to 72 hours until the necrosis is adequately removed is only appropriate when early surgical intervention is required or when the necrosis is too poorly demarcated to permit complete debridement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H1549588\">",
"     'Timing of debridement'",
"    </a>",
"    above.) The open packing method is effective in controlling intra-abdominal sepsis but mandates multiple laparotomies, which increases overall mortality, the length of hospital stay, and the incidence of postoperative enterocutaneous fistulas and incisional hernias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/50\">",
"     50",
"    </a>",
"    ]. Because of these concerns, open packing should be utilized sparingly, and is primarily indicated for patients with large collections extending across the retroperitoneum and into the retrocolic spaces or when bleeding is difficult to control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A nonadherent gauze should be placed over the exposed stomach and colon to prevent inadvertent debridement of the intestinal tract [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/36\">",
"     36",
"    </a>",
"    ]. Packing is kept moist. Drains are placed at the time of final laparotomy and secondary closure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H885824\">",
"    <span class=\"h2\">",
"     Laparoscopic debridement",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two laparoscopic approaches for pancreatic debridement: video-assisted retroperitoneal debridement and transperitoneal debridement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/27,29,52\">",
"     27,29,52",
"    </a>",
"    ]. Both techniques utilize laparoscopes, video cameras, and similar instrumentation, but significant differences between the two techniques exist. Most published experience is with video-assisted retroperitoneal debridement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1171691\">",
"    <span class=\"h3\">",
"     Video-assisted retroperitoneal debridement",
"    </span>",
"    &nbsp;&mdash;&nbsp;The video-assisted retroperitoneal debridement approach requires preoperative percutaneous access to the retroperitoneal space, which is established via interventional radiology. Before surgery, a 12 to 14-French catheter is placed into the dominant fluid collection through a direct access site in the left upper quadrant or flank under radiologic guidance. This catheter provides an anatomic access route, which guides the subsequent operation.",
"   </p>",
"   <p>",
"    The surgery is performed through an incision made directly over the drain site, which is extended directly down into the necrotic cavity. Long grasping forceps are used for debridement under direct vision. When the debridement extends into the retroperitoneum, a videoscope is inserted through the incision to allow visualization and deep mechanical debridement through the scope. Two large-bore single lumen drains are then placed in the retroperitoneum under direct vision using the videoscope.",
"   </p>",
"   <p>",
"    Continuous retroperitoneal lavage with isotonic saline or dialysis fluid is continued postoperatively at a rate of 125",
"    <span class=\"nowrap\">",
"     ml/hr",
"    </span>",
"    and patients are followed for clinical progression, declining serum CRP levels, and improvement of necrosis on contrast enhanced CT scans. Repeated debridements are done every 7 to 10 days until the necrosis cavity is seen to be clear of debris and lined by healthy granulation tissue. At this point, irrigation is stopped and external drainage is continued until the output stops and the drains can be removed.",
"   </p>",
"   <p>",
"    The advantage of video-assisted retroperitoneal debridement is minimizing the risk of peritoneal contamination. The main drawback of this approach is the limited access and visualization, which limits the amount of debris that can be retrieved and leads to multiple interventions. In addition, limited visualization precludes simultaneous cholecystectomy, intraoperative cholangiography, or feeding jejunostomy placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/47\">",
"     47",
"    </a>",
"    ]. A meta-analysis of video-assisted retroperitoneal debridement reported a 64 percent success rate, 47 percent morbidity, and 14 percent mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H885831\">",
"    <span class=\"h3\">",
"     Laparoscopically-assisted transperitoneal debridement",
"    </span>",
"    &nbsp;&mdash;&nbsp;The laparoscopic transperitoneal approach to pancreatic debridement uses conventional laparoscopic intraperitoneal access followed by transmesocolic debridement, utilizing one port for the video camera and two additional working ports.",
"   </p>",
"   <p>",
"    The main drawback of this approach is the potential for peritoneal contamination. In addition, reintervention is usually not possible because of scar tissue. For these reasons, laparoscopic transperitoneal debridement is most appropriate as a single stage procedure for patients with walled-off pancreatic necrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/27,53\">",
"     27,53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20486603\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early postoperative management after pancreatic debridement focuses on volume replacement, blood glucose control, maintenance of normothermia, and adequate pain control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. Patients require large volumes of fluid to maintain tissue perfusion and renal function, since they have massive third-space losses. Most patients remain intubated upon leaving the operating room because of the anticipated large fluid shifts over the initial 24 to 36 hours. In the absence of preoperative pulmonary failure, most should be candidates for early ventilator weaning protocols. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/39/21112?source=see_link\">",
"     \"Weaning from mechanical ventilation: Readiness testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    After the first 48 hours of resuscitation, early aggressive enteral feeding can be started through the operatively placed gastrojejunal feeding tube. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/17/34073?source=see_link\">",
"     \"Nutrition support in critically ill patients: Enteral nutrition\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20486610\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reported mortality rate in patients undergoing debridement for pancreatic necrosis ranges from 4 to 25 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/4,21,22,49\">",
"     4,21,22,49",
"    </a>",
"    ]. The mortality rate is related to the extent of necrosis, underlying organ failure, and infection of the necrotic tissue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/1,5,32-34\">",
"     1,5,32-34",
"    </a>",
"    ]. Complications after pancreatic debridement include intra-abdominal fluid collections, bleeding, pancreatic fistulas, incisional hernias, and pancreatic insufficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20486619\">",
"    <span class=\"h2\">",
"     Intra-abdominal fluid collections",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common postoperative complication requiring intervention after debridement is a residual fluid collection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/1\">",
"     1",
"    </a>",
"    ]. These collections are frequently infected and can result from a pancreatic leak inadequately controlled by the drains placed at surgery or from a hollow viscus injury. Intra-abdominal fluid collections can be identified on CT scan and are managed with percutaneous drainage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/1,5,7\">",
"     1,5,7",
"    </a>",
"    ]. Reoperation is rarely necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20486626\">",
"    <span class=\"h2\">",
"     Postoperative bleeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bleeding is the most common indication for early re-exploration after pancreatic debridement. Bleeding can occur early or late in the postoperative period and can lead to hemodynamic instability.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early postoperative bleeding is usually due to laceration or avulsion of peripancreatic arteries or veins. This complication appears to be more common after minimally invasive debridement, presumably due to the limited field of vision and lack of tactile feedback during necrotic tissue removal. Prompt reoperation and control of bleeding is indicated.",
"     </li>",
"     <li>",
"      Late postoperative bleeding is usually caused by rupture of a retroperitoneal pseudoaneurysm, either into the free peritoneal cavity or out of operatively placed drains. Patients who earlier appeared well and have the abrupt onset of tachycardia, hypotension, mental status change, and increased bloody output from their surgically placed drains should be considered to have a visceral pseudoaneurysm until proven otherwise. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/32/17928?source=see_link&amp;anchor=H11#H11\">",
"       \"Diagnosis and management of pseudocysts of the pancreas\", section on 'Possible presence of a pseudoaneurysm'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The choice of therapy depends upon whether or not the patient is hemodynamically stable. In unstable patients, emergency reoperation is indicated. In patients in whom volume resuscitation leads to a period of cardiovascular stability, visceral angiography with transcatheter embolization is an option. Once control of bleeding is obtained through direct operative ligation, transcatheter embolization, or stent placement, a careful assessment of the retroperitoneum is essential. The retroperitoneum should be evaluated for possible causes of pseudoaneurysm formation, such as sepsis from an infected fluid collection or an uncontrolled pancreatic fistula, or a mechanical process, such as erosion of drains into an artery. Common areas for pseudoaneurysm formation in the setting of pancreatic necrosis are the splenic artery, gastroduodenal artery, pancreaticoduodenal arcade, and dorsal pancreatic artery (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef79244 \" href=\"mobipreview.htm?4/23/4467\">",
"       image 7",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef53264 \" href=\"mobipreview.htm?17/62/18406\">",
"       image 8",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/2/24616?source=see_link&amp;anchor=H4#H4\">",
"       \"Angiographic control of nonvariceal gastrointestinal bleeding in adults\", section on 'Embolization'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20486633\">",
"    <span class=\"h2\">",
"     Pancreatic fistula",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic fistulas commonly occur following pancreatic debridement and are usually identified by the high volume and amylase content coming from operatively placed drains, or following percutaneous drainage of postoperative intra-abdominal or retroperitoneal fluid collections.",
"   </p>",
"   <p>",
"    Monitoring drain tube output for volume, color, and consistency of effluent should be performed routinely and a high index of suspicion should be maintained for the development of a postoperative pancreatic fistula, which is defined as drain amylase concentration greater than three times the upper limit of normal for serum amylase. When pancreatic fistulas are identified at a drain site, maintaining adequate external drainage is essential. Our practice is to place additional securing sutures on the fistula drain using a local anesthetic at the bedside to prevent inadvertent dislodgement.",
"   </p>",
"   <p>",
"    Pancreatic fistulas are characterized by their anatomic relationship to the pancreatic duct as either a side or end fistula (",
"    <a class=\"graphic graphic_figure graphicRef68919 \" href=\"mobipreview.htm?32/54/33638\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with side pancreatic fistulas retain the possibility of fistula closure, either spontaneously or with the help of a decompressive endoscopically-placed pancreatic duct stent.",
"     </li>",
"     <li>",
"      Patients with an end fistula usually have a disconnected pancreatic segment. If the segment is large, it will continue to secrete amylase-rich fluid indefinitely, unless the fistula flow is either redirected into the gastrointestinal tract with a fistula-jejunostomy or the offending segment is removed with a distal pancreatectomy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/57\">",
"       57",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/20/23878?source=see_link\">",
"       \"Treatment of pancreatic fistulas\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/32/2569?source=see_link\">",
"       \"Distal pancreatectomy: Techniques\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H134523348\">",
"    <span class=\"h2\">",
"     Biliary injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholecystectomy is required for patients with biliary pancreatitis. However, cholecystectomy performed in the setting of retroperitoneal inflammation is associated with an increased incidence of postoperative bile leak or biliary injury. The risk of biliary injury can be reduced by dissecting the gallbladder retrograde from the fundus to the infundibulum. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/22/18792?source=see_link&amp;anchor=H10#H10\">",
"     \"Complications of laparoscopic cholecystectomy\", section on 'Diagnosis and management of biliary injuries'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20486640\">",
"    <span class=\"h2\">",
"     Hernias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Open operations for pancreatic debridement have a high rate of incisional hernia. In one study, for example, incisional hernias developed in 42 percent of 149 patients who underwent pancreatic debridement for necrotizing pancreatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/49/43801?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of abdominal hernias\", section on 'Incisional hernia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1340783\">",
"    <span class=\"h2\">",
"     Pancreatic insufficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depending upon the volume of pancreatic necrosis as well as any disconnected pancreatic segments, patients are at risk for both endocrine and exocrine pancreatic insufficiency. Glandular destruction from the inflammatory process results in long-term endocrine and exocrine insufficiencies in 15 to 60 percent of patients of patients who undergo pancreatic debridement, with the degree of dysfunction associated with the magnitude of pancreatic injury and the overall length of follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/57/38809/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/13/30935?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical manifestations and diagnosis of chronic pancreatitis in adults\", section on 'Pancreatic insufficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Endocrine insufficiency is indicated by the need for supplemental insulin for hyperglycemia early in the postoperative course. As the patient transitions into the late postoperative period, insulin requirements are covered with a twice a day long-acting insulin as well as a sliding scale around meals based on carbohydrates consumed. Long-term therapy is similar to that in patients with diabetes mellitus. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/55/15225?source=see_link\">",
"     \"General principles of insulin therapy in diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Exocrine insufficiency may only become apparent when the patient begins to take a regular diet. Oral pancreatic enzyme replacement therapy is warranted. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/40/31369?source=see_link&amp;anchor=H8#H8\">",
"     \"Treatment of chronic pancreatitis\", section on 'Pancreatic enzyme supplements'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6126666\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pancreatic debridement is indicated for patients with pancreatic necrosis and progressive clinical sepsis as a complication of severe acute pancreatitis. Pancreatic and peripancreatic necrosis occur when inflammation and vascular compromise result in the death of pancreatic parenchyma and peripancreatic fat. (See",
"      <a class=\"local\" href=\"#H20486491\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infected pancreatic necrosis and symptomatic sterile necrosis are both accepted indications for debridement. The goal of pancreatic debridement is to excise all dead and devitalized pancreatic and peripancreatic tissue, while preserving viable functioning pancreas, controlling resultant pancreatic fistulas, and limiting extraneous organ damage. For patients with biliary pancreatitis, cholecystectomy with intraoperative cholangiography is an important secondary objective of the surgery because this will prevent recurrent disease. (See",
"      <a class=\"local\" href=\"#H20486505\">",
"       'Indications for pancreatic debridement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The optimal timing for pancreatic debridement is three to four weeks following the onset of acute pancreatitis. Delayed debridement allows clinical stabilization of the patient, resolution of early organ failure, and a decrease in the intense inflammatory reaction in the retroperitoneum. (See",
"      <a class=\"local\" href=\"#H1549588\">",
"       'Timing of debridement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All patients with pancreatic necrosis undergoing debridement should have contrast enhanced computer tomography (CT) scanning of the abdomen and pelvis to define the extent and location of necrotic areas as this will affect the surgical approach. (See",
"      <a class=\"local\" href=\"#H1551948\">",
"       'CT scan'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Walled-off pancreatic necrosis is encapsulation of the process, which creates a localized mature collection analogous to a pancreatic pseudocyst. (See",
"      <a class=\"local\" href=\"#H265589\">",
"       'Walled-off pancreatic necrosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Minimally invasive techniques can be employed in selected patients. Percutaneous catheter drainage is primarily a bridging technique for patients who are too unstable to undergo surgical debridement, although one-third of patients can be managed with percutaneous drainage alone. Endoscopic debridement is performed via a transgastric approach and is limited to patients with walled-off pancreatic necrosis. (See",
"      <a class=\"local\" href=\"#H263623\">",
"       'Minimally invasive approach to pancreatic debridement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Preoperative discussion with patients and their families should include the potential need for reoperations to drain intra-abdominal fluid collections, remove additional necrotic tissue, or to control a pancreatic fistula. Patients with biliary pancreatitis should be informed that there is an increased risk of postoperative bile leak or biliary injury when a cholecystectomy is performed in the setting of retroperitoneal inflammation. If the CT scan shows involvement of the mesocolon, patients should be informed of the potential need for colon resection and a colostomy. (See",
"      <a class=\"local\" href=\"#H1171338\">",
"       'Surgeon's safety checklist for pancreatic debridement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Open surgical debridement is the gold standard for management of pancreatic necrosis. Laparoscopic debridement is primarily limited to patients with walled-off pancreatic necrosis. (See",
"      <a class=\"local\" href=\"#H1179953\">",
"       'Surgical approaches to pancreatic debridement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The reported mortality rate in patients undergoing debridement for pancreatic necrosis ranges from 4 to 25 percent. The mortality rate is related to the extent of necrosis, underlying organ failure, and infection of the necrotic tissue. Complications after pancreatic debridement include intra-abdominal fluid collections, bleeding, pancreatic fistulas, incisional hernias, and pancreatic insufficiency. (See",
"      <a class=\"local\" href=\"#H20486610\">",
"       'Postoperative complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/1\">",
"      Werner J, Feuerbach S, Uhl W, B&uuml;chler MW. Management of acute pancreatitis: from surgery to interventional intensive care. Gut 2005; 54:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/2\">",
"      Beger HG, Rau BM. Severe acute pancreatitis: Clinical course and management. World J Gastroenterol 2007; 13:5043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/3\">",
"      Gaisano HY, Gorelick FS. New insights into the mechanisms of pancreatitis. Gastroenterology 2009; 136:2040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/4\">",
"      Whitcomb DC. Clinical practice. Acute pancreatitis. N Engl J Med 2006; 354:2142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/5\">",
"      B&uuml;chler MW, Gloor B, M&uuml;ller CA, et al. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg 2000; 232:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/6\">",
"      Bradley EL 3rd, Allen K. A prospective longitudinal study of observation versus surgical intervention in the management of necrotizing pancreatitis. Am J Surg 1991; 161:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/7\">",
"      Uhl W, Warshaw A, Imrie C, et al. IAP Guidelines for the Surgical Management of Acute Pancreatitis. Pancreatology 2002; 2:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/8\">",
"      Rattner DW, Legermate DA, Lee MJ, et al. Early surgical d&eacute;bridement of symptomatic pancreatic necrosis is beneficial irrespective of infection. Am J Surg 1992; 163:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/9\">",
"      Rodriguez JR, Razo AO, Targarona J, et al. Debridement and closed packing for sterile or infected necrotizing pancreatitis: insights into indications and outcomes in 167 patients. Ann Surg 2008; 247:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/10\">",
"      Larson SD, Nealon WH, Evers BM. Management of gallstone pancreatitis. Adv Surg 2006; 40:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/11\">",
"      Besselink MG, van Santvoort HC, Boermeester MA, et al. Timing and impact of infections in acute pancreatitis. Br J Surg 2009; 96:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/12\">",
"      Eatock FC, Chong P, Menezes N, et al. A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis. Am J Gastroenterol 2005; 100:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/13\">",
"      Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004; 32:2014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/14\">",
"      Tablan OC, Anderson LJ, Besser R, et al. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/15\">",
"      Isenmann R, R&uuml;nzi M, Kron M, et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology 2004; 126:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/16\">",
"      Dellinger EP, Tellado JM, Soto NE, et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann Surg 2007; 245:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/17\">",
"      Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/18\">",
"      McKay CJ, Curran F, Sharples C, et al. Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitis. Br J Surg 1997; 84:1239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/19\">",
"      Mier J, Le&oacute;n EL, Castillo A, et al. Early versus late necrosectomy in severe necrotizing pancreatitis. Am J Surg 1997; 173:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/20\">",
"      Rau B, Pralle U, Uhl W, et al. Management of sterile necrosis in instances of severe acute pancreatitis. J Am Coll Surg 1995; 181:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/21\">",
"      Hartwig W, Maksan SM, Foitzik T, et al. Reduction in mortality with delayed surgical therapy of severe pancreatitis. J Gastrointest Surg 2002; 6:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/22\">",
"      Howard TJ, Patel JB, Zyromski N, et al. Declining morbidity and mortality rates in the surgical management of pancreatic necrosis. J Gastrointest Surg 2007; 11:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/23\">",
"      Guzman EA, Rudnicki M. Intricacies of host response in acute pancreatitis. J Am Coll Surg 2006; 202:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/24\">",
"      McKay CJ, Imrie CW. The continuing challenge of early mortality in acute pancreatitis. Br J Surg 2004; 91:1243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/25\">",
"      Frey CF, Zhou H, Harvey DJ, White RH. The incidence and case-fatality rates of acute biliary, alcoholic, and idiopathic pancreatitis in California, 1994-2001. Pancreas 2006; 33:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/26\">",
"      Tsiotos GG, Smith CD, Sarr MG. Incidence and management of pancreatic and enteric fistulas after surgical management of severe necrotizing pancreatitis. Arch Surg 1995; 130:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/27\">",
"      Wysocki AP, McKay CJ, Carter CR. Infected pancreatic necrosis: minimizing the cut. ANZ J Surg 2010; 80:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/28\">",
"      Wysocki AP. Walled-off pancreatic necrosis: wishing our pancreatitis nomenclature was correct. World J Gastroenterol 2010; 16:4497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/29\">",
"      Behrns KE, Ashley SW, Hunter JG, Carr-Locke D. Early ERCP for gallstone pancreatitis: for whom and when? J Gastrointest Surg 2008; 12:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/30\">",
"      Banks PA, Gerzof SG, Langevin RE, et al. CT-guided aspiration of suspected pancreatic infection: bacteriology and clinical outcome. Int J Pancreatol 1995; 18:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/31\">",
"      Pappas TN. Con: Computerized tomographic aspiration of infected pancreatic necrosis: the opinion against its routine use. Am J Gastroenterol 2005; 100:2373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/32\">",
"      Balthazar EJ. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology 2002; 223:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/33\">",
"      Sakorafas GH, Tsiotos GG, Sarr MG. Extrapancreatic necrotizing pancreatitis with viable pancreas: a previously under-appreciated entity. J Am Coll Surg 1999; 188:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/34\">",
"      Papachristou GI, Takahashi N, Chahal P, et al. Peroral endoscopic drainage/debridement of walled-off pancreatic necrosis. Ann Surg 2007; 245:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/35\">",
"      Alhajeri A, Erwin S. Acute pancreatitis: value and impact of CT severity index. Abdom Imaging 2008; 33:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/36\">",
"      Bradley EL 3rd, Dexter ND. Management of severe acute pancreatitis: a surgical odyssey. Ann Surg 2010; 251:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/37\">",
"      Sandrasegaran K, Tann M, Jennings SG, et al. Disconnection of the pancreatic duct: an important but overlooked complication of severe acute pancreatitis. Radiographics 2007; 27:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/38\">",
"      Navaneethan U, Vege SS, Chari ST, Baron TH. Minimally invasive techniques in pancreatic necrosis. Pancreas 2009; 38:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/39\">",
"      Baril NB, Ralls PW, Wren SM, et al. Does an infected peripancreatic fluid collection or abscess mandate operation? Ann Surg 2000; 231:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/40\">",
"      Ocampo C, Or&iacute;a A, Zandalazini H, et al. Treatment of acute pancreatic pseudocysts after severe acute pancreatitis. J Gastrointest Surg 2007; 11:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/41\">",
"      Mueller PR. Percutaneous drainage of pancreatic necrosis: is it ecstasy or agony? AJR Am J Roentgenol 1998; 170:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/42\">",
"      Traverso LW, Kozarek RA. Pancreatic necrosectomy: definitions and technique. J Gastrointest Surg 2005; 9:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/43\">",
"      Freeny PC, Hauptmann E, Althaus SJ, et al. Percutaneous CT-guided catheter drainage of infected acute necrotizing pancreatitis: techniques and results. AJR Am J Roentgenol 1998; 170:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/44\">",
"      Mortel&eacute; KJ, Girshman J, Szejnfeld D, et al. CT-guided percutaneous catheter drainage of acute necrotizing pancreatitis: clinical experience and observations in patients with sterile and infected necrosis. AJR Am J Roentgenol 2009; 192:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/45\">",
"      Besselink MG, van Santvoort HC, Nieuwenhuijs VB, et al. Minimally invasive 'step-up approach' versus maximal necrosectomy in patients with acute necrotising pancreatitis (PANTER trial): design and rationale of a randomised controlled multicenter trial [ISRCTN13975868]. BMC Surg 2006; 6:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/46\">",
"      van Santvoort HC, Besselink MG, Bakker OJ, et al. A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med 2010; 362:1491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/47\">",
"      Bradley EL 3rd, Howard TJ, van Sonnenberg E, Fotoohi M. Intervention in necrotizing pancreatitis: an evidence-based review of surgical and percutaneous alternatives. J Gastrointest Surg 2008; 12:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/48\">",
"      Villatoro E, Mulla M, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev 2010; :CD002941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/49\">",
"      Ashley SW, Perez A, Pierce EA, et al. Necrotizing pancreatitis: contemporary analysis of 99 consecutive cases. Ann Surg 2001; 234:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/50\">",
"      Harrison S, Kakade M, Varadarajula S, et al. Characteristics and outcomes of patients undergoing debridement of pancreatic necrosis. J Gastrointest Surg 2010; 14:245.",
"     </a>",
"    </li>",
"    <li>",
"     Bradley, EL, III. Management of infected pancreatic necrosis by open packing. In: The Pancreas, Berger, HG (Eds), Blackwell, 1998. p.1439.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/52\">",
"      Parekh D. Laparoscopic-assisted pancreatic necrosectomy: A new surgical option for treatment of severe necrotizing pancreatitis. Arch Surg 2006; 141:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/53\">",
"      Horvath K, Freeny P, Escallon J, et al. Safety and efficacy of video-assisted retroperitoneal debridement for infected pancreatic collections: a multicenter, prospective, single-arm phase 2 study. Arch Surg 2010; 145:817.",
"     </a>",
"    </li>",
"    <li>",
"     The Surgical Care Improvement Project (SCIP) file://www.medqic.org (Accessed on April 27, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/55\">",
"      Hasibeder WR, Torgersen C, Rieger M, D&uuml;nser M. Critical care of the patient with acute pancreatitis. Anaesth Intensive Care 2009; 37:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/56\">",
"      Howard TJ, Stonerock CE, Sarkar J, et al. Contemporary treatment strategies for external pancreatic fistulas. Surgery 1998; 124:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/57\">",
"      Howard TJ, Rhodes GJ, Selzer DJ, et al. Roux-en-Y internal drainage is the best surgical option to treat patients with disconnected duct syndrome after severe acute pancreatitis. Surgery 2001; 130:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/58\">",
"      Al-Azzawi HH, Kuhlenschmidt H, Howard TJ, et al. The burden of incisional hernia in necrotizing pancreatitis: how can we improve? Am J Surg 2010; 199:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/59\">",
"      Hochman D, Louie B, Bailey R. Determination of patient quality of life following severe acute pancreatitis. Can J Surg 2006; 49:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/57/38809/abstract/60\">",
"      Gupta R, Wig JD, Bhasin DK, et al. Severe acute pancreatitis: the life after. J Gastrointest Surg 2009; 13:1328.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15110 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-3918385851-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_57_38809=[""].join("\n");
var outline_f37_57_38809=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6126666\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20486491\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20486505\">",
"      INDICATIONS FOR PANCREATIC DEBRIDEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20486512\">",
"      Infected pancreatic necrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20486519\">",
"      Symptomatic sterile pancreatic necrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1549588\">",
"      TIMING OF DEBRIDEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20486533\">",
"      PREOPERATIVE EVALUATION AND PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1551551\">",
"      Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1551834\">",
"      ERCP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1551948\">",
"      CT scan",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H265509\">",
"      - Estimating the extent of disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H265555\">",
"      - Disconnected pancreatic segment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H265575\">",
"      - Extension into mesenteric root",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H265589\">",
"      - Walled-off pancreatic necrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H263623\">",
"      MINIMALLY INVASIVE APPROACH TO PANCREATIC DEBRIDEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H263650\">",
"      Percutaneous CT guided catheter drainage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H263672\">",
"      Endoscopic debridement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1171338\">",
"      SURGEON'S SAFETY CHECKLIST FOR PANCREATIC DEBRIDEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1179953\">",
"      SURGICAL APPROACHES TO PANCREATIC DEBRIDEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20486554\">",
"      Open debridement with external drainage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H290573\">",
"      Open debridement with internal drainage and cystgastrostomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1552920\">",
"      Open packing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H885824\">",
"      Laparoscopic debridement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1171691\">",
"      - Video-assisted retroperitoneal debridement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H885831\">",
"      - Laparoscopically-assisted transperitoneal debridement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20486603\">",
"      POSTOPERATIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20486610\">",
"      POSTOPERATIVE COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20486619\">",
"      Intra-abdominal fluid collections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20486626\">",
"      Postoperative bleeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20486633\">",
"      Pancreatic fistula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H134523348\">",
"      Biliary injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20486640\">",
"      Hernias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1340783\">",
"      Pancreatic insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6126666\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/15110\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15110|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?31/58/32687\" title=\"algorithm 1\">",
"      Management algorithm for severe acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?35/55/36725\" title=\"algorithm 2\">",
"      Pancreatitis extending to the root of the mesentery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?16/39/17012\" title=\"algorithm 3A\">",
"      Approach to pancreatic necrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?10/59/11199\" title=\"algorithm 3B\">",
"      Approach to pancreatic necrosis in SAP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15110|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?13/3/13362\" title=\"diagnostic image 1\">",
"      CT scan showing infected pancreatic necrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?12/55/13169\" title=\"diagnostic image 2\">",
"      CT scan showing pancreatic necrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?10/0/10244\" title=\"diagnostic image 3\">",
"      CT scan showing walled off pancreatic necrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?36/32/37381\" title=\"diagnostic image 4\">",
"      Acute pancreatitis with pseudocyst formation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?14/13/14549\" title=\"diagnostic image 5\">",
"      Pancreatic necrosis drainage CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?42/9/43159\" title=\"diagnostic image 6\">",
"      Percutaneous drainage of pseudocyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?4/23/4467\" title=\"diagnostic image 7\">",
"      Pseudoaneurysm of the splenic artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?17/62/18406\" title=\"diagnostic image 8\">",
"      Gastric artery aneurysm associated with pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15110|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/53/42845\" title=\"figure 1\">",
"      Bimodal distribution of organ failure in pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?17/4/17473\" title=\"figure 2\">",
"      Feeding jejunostomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?32/54/33638\" title=\"figure 3\">",
"      End versus side pancreatic fistulas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15110|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/41/12956\" title=\"table 1\">",
"      CT grading acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/54/35693\" title=\"table 2\">",
"      Perioperative VTE prevention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/28/40395\" title=\"table 3\">",
"      JCAHO protocol for surgical timeout",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/13/24790?source=related_link\">",
"      Acute cholangitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/2/24616?source=related_link\">",
"      Angiographic control of nonvariceal gastrointestinal bleeding in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/5/20569?source=related_link\">",
"      Clinical manifestations and diagnosis of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/13/30935?source=related_link\">",
"      Clinical manifestations and diagnosis of chronic pancreatitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/47/44789?source=related_link\">",
"      Combination beta-lactamase inhibitors, carbapenems, and monobactams",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/22/18792?source=related_link\">",
"      Complications of laparoscopic cholecystectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/32/17928?source=related_link\">",
"      Diagnosis and management of pseudocysts of the pancreas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/32/2569?source=related_link\">",
"      Distal pancreatectomy: Techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/0/27655?source=related_link\">",
"      Endoscopic management of pseudocysts of the pancreas: Technique",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/61/14297?source=related_link\">",
"      Etiology of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/55/15225?source=related_link\">",
"      General principles of insulin therapy in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/10/2218?source=related_link\">",
"      Management of patients with a colostomy or ileostomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/17/34073?source=related_link\">",
"      Nutrition support in critically ill patients: Enteral nutrition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/49/43801?source=related_link\">",
"      Overview of abdominal hernias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/29/44504?source=related_link\">",
"      Predicting the severity of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/35/7738?source=related_link\">",
"      Treatment of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/40/31369?source=related_link\">",
"      Treatment of chronic pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/20/23878?source=related_link\">",
"      Treatment of pancreatic fistulas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/39/21112?source=related_link\">",
"      Weaning from mechanical ventilation: Readiness testing",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_57_38810="MDAS I";
var content_f37_57_38810=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F56787%7EONC%2F69509&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F56787%7EONC%2F69509&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 626px\">",
"   <div class=\"ttl\">",
"    Memorial Delirium Assessment Scale (MDAS)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 606px; height: 776px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Breitbart, W, Rosenfield, B, Roth, A, Smith, M, Cohen, K, Passik, S. The memorial delirium assessment scale. J Pain Symptom Manage 1997; 13:128. Copyright &copy;1997 The US Cancer Pain Relief Committee.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 624px\">",
"   <div class=\"ttl\">",
"    Memorial Delirium Assessment Scale (MDAS) cont.",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 604px; height: 786px; background-image: url(data:image/gif;base64,R0lGODlhXAISA8QAAP///z8/P7+/v39/fwAAAO/v78/Pz9/f35+fny8vL29vb19fXx8fH09PT4+Pj6+vrw8PDwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAABcAhIDAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSkzMHAgI2lpgjBZcFLQYCBoeho0UHCDyoKJdCq18IB0GvIrRGsWa4aAMEvQQCvr4CAcGYvakFEAQDJQXEvSfBDaPAws6+EKMIygQQqQDPBAzfBgzYpga9DiO9zMDMwQPVvvLBAQDzEAufI7zBBOB+4SNwLx6AdgOZ8WKmgMCCeb+qYeKFqdw5FQsYsAiwidW9YSwQfEsB8sQAZisA/8a4h48li5MnDCiQUXJlRx81WwKASUOlC445XNbwCQOoDgWmlBxwQCCBgAMn2w04QGzBSVm97jFdVoLYOlkmegnYBuFAJ7EFGhD4quBS0wIHEgj0iqAbgGRrARxoK6JhU3a9LHEVINfBAagDFqgDxuBkKmBOeSUgISCxOJjEMAH7WBhr4Hc7lz34e/ZXaY0U8bKteFNEAQYBHrh2IK+EgU9PB4ysPOBeAVOVEcCl/W3BQ9y6R/AWKgJBYma374763Qmf9ModnT8lceBXKI61m4cfcRiAgaUOPiFwKgtqer2HQ/E7/1tEcPsi0PETEdvBuur27UcdJg9cZR9Usjkny/8wlVFzT3nn+ccPVAi0Rpl01WmmXnhAFUCbLOfVcptz7/2GnV7epaBgfr+BhZ+J4Xk4gCkrgvOAhLUMUOJtmMgoC4w9JuCAhUZsRgI0/K3VykHKlKMMSrWIs0AA64SlElMLiICkWlSaotg3dWWZWQF2hXkCBAnIZYo4BIEWUEcFyNXAQE5tZyQAao1kH0EjeCUAUyxlpqU5HHHFywIQlAXYnuZENZZDJhBjAgILUCqCkA/MSQJQBLTlFAAONCCAAh/ds96fDjxQoVXgBDAVAqIqMFOoozLXgDyugqPZRwwkUBA+jT3AwCe3DgNlQhUGOywAVg0jWz/MBNDAA6wO0Jj/KLGtt1OaCjTwDQPfAQDrqDMlMAoEskGwHziiLjATA+1ppFyv97Ql7CedElapAx95I6wl92A2LasGJKAqUSUAJAC9BwUQgAHNxqarMwg8kMBSWTLrgAFD8gvsAPe+o+emIH8agK96KqxsAXGmOqerFmMiLbXQZTvZwr5SbLElKx/AAKtL3KmlT+GoRFCanXKl3GXKjOXwwwepdCeSFvWSwDWbGElMAuakslCrUI/mX6dauuqQ0oKKoNjVA9EzEEtfU8ZnkvYkuQlBhxrqy0yLJlTVL18/PQqpJkybjAjonsCpCDDBqxNIjo/A8ZQ7ocTAA24B4HhOPjMe7a74sH2Q/066dl55wvYF+hQDl3gMra6Ps9QsYZVl/ECpOl2euQKpGhdXVz1CsNNMChxLGD8FFMj66KePXhLvIGEGeqVapqCw6ATE2/o9HI0rgFXJsLwsKryQvjgKvwNALTgjO6+6pbVMpr6Y08tD+/Hiivo9rvzJTGSRcxtan5R0twCEKW57CtgyeDOVqIlgNJpCkn2stYwvNQdSxCCGusQFKQpiQi3GsUvDXoOQNzGuG8BpyiUWNLeGVGlpLvEToOxWNhLqzRwESAqS3pEOsZjJgygg00kuh48GQIA554OJ1HBHlAVMy2M8WcZJ4JE6ysDtc7Fjh/kucUXUbXFhU9ST9LIIDv+rXIUnmjsA9UAiRZhQawFUeQDf+nS3u6hrg8phSTmG9CmVRJF0J4keFkFiFIQdiXTMA6NjdNWbKWKiUpZaT4UUpjrmnaAkhLQQJfuHRkxyD3QBMONUStLIQJYEKEYJWgAdmKQhCQBfASjAjBCIOHXlyUp6kcvdVFIpYhFgkheLy1x+wSU7/vJN3YFNALrWMA6iTSCjWaAoIHMJavBJAIla19sGqJm5pY1PddFbVJbFStAoxjTKSIWgCEcC7yXmLpe6SRKZsTncLe8uS2zePT9RT+7Ia4wgqckmS/fPYyVSdQfA47oAijtmQUmWUHJARqq4z7skYE7dehYdzSO/KWX/LI+e6x/z/liSaQkSdiChHvMOkJTqCbQWCtUVAlzyiYJBrZBbtCRLSXA4cc0klVo8pdNc01ME/LR+nCjJTJNaSaAiwR8SlGDRjOESWjoTUlbqhTfaJpZz9oJv29DqN8akjHVUDYVMARMB5uRNrsQDqlmByEeCAS4TCE1QRjJIWxXCFWKIqhigwUtFcIjCgJRgWq4RHgNkJTqR+pEZ6xlAA3BnscRItAGk4tWMysFYcSVAssxxIqkgm4DMInKgQBHtZ7uygCFVEgGNMQ4JGGpHkMXJKuZCoxCryFkFyI9K5iGANh02AIPlJ3slKEk5JLu8x7oUAgqg3EmBApLlKkZt/y90qUt8AtvE0I9ZrmpAlXzVnM+qJaehXEdrS9Ab38rCqe4TaSiLu5MAuBelvkkAbsOltvC6VqTtXYImloSPjoTiEq/ER1Is4aKktpQyCE4qgj/RiQRDmATy0QuBS5EfC1dYwbWwE4IPg+BqVriad0Hwgx0suQR3ghojBrGG27OdCg/4lZ0AS4Y7nJRQJBfDuLFQdDZRHr3cZjqmyLF9jhxi5XSEpfWxzWF0zOQoWyfK0THPXrJ7ICwjTxQlgBCFk2zhDBeZRa5JCoHNgh8pWxiRnFjwK4dcC7D0yAB4TjN8zDNm17xSeJrT5p2Vw1Mw8znELjqzjwd9aHzIgpzcMf+wNq+snw6TR9LSaXGfL/2jSptnxZQItSDcRapJrwG+RbqVAfXyUSmoUdSwjjUVPiyH/xkhFA2Wta53zete+1oQBL6BQbMwbDMEewY1UoEu4HBsOyxbCc3+dRHQeANDokAkQUCKSMPyE1vbANs/qaIJqC2DxGxnBah0grVh8DMUkPsF2oYdC+INBVRLbo4+eLcQ4m1vPFTmPRF64X0mOBLnyMYxDQwijqzz5oMgSMsiIoFxXrmU5MCnRhTahI8OlJyWVeQTBUr4uu9Cm1HcZkDikQ2RO90gD5WINo88TsW/cZgVdUcU9Zl5SFkRniknxeMFINEnirwJjtx8xyGSXIv/8GFxnZO85xYH0otCMR7t5NqKCoX56Tqxrtw8ywCBtOiQDr1xR3dcSDcJuo60iRg795x8cLG4uGqDZfz0p0RC9+y5R2Bw8YCl5gOIOznQE9KNJ32nlAHZKIg+m4T/m2VoJ/vCc9M+N8TMP+z63kzGJav8kYtZD2lLcRHgOhO8RiTLIgjU2CEPg8FPpfxx1QFUtb9tkf4eBTvYXQy4s4N4anWsAoq9Uh9ETL3sEgybeFucC0ZhKYBmADB+q6ZC+2ol4PbIAkn1FVLsnYjqVtsqLXl+NqOOBQwlKuGIyFQaOf6gjPMz2X70XRa6Amn2Xs5bGZ5w1X1mUeob0ncSt5Uw/60nG6lCOz4TfK/EexfjewhIfhhmfv6kKjMhWQIAfqPnAKVFOw7lLIeTDr8xGTNDMBJoLeMBeqNiLDFjexr4e5nnLpWjMxdTDodRV/0QK+dXPTI4e07hHwn4OacHW/jignIQKi7SIYqFOcCgOUqYPfKyc+tmVH2RCsjlRZkSPuEzW1AyOTk4OioFEN7DKs5lFB2iPMZwba2mfmxjOtVzOkKlE4mzc+YhUV1oNOLGhc1jAsvyGjvRattGPgDxR7AjNZNxO13xLU2YH3QIAHHILM9yMW+IWqsjhyagLpmCOBp1ErJlhZpSGblChmOhP2IYUvAFiBhmg4F2F6iBfp7jM//bE30yAUlHRTqmmBN68YTpsz6COEaH4xiiSFqrRgL99EdhqCMNcIRFNxZ8owBUSIlvIEsJkDg41UbwMEX88zqWxF4ooUTRUEXF4wD41jxOdCN1KG+B6CphN4bJuEccuG7Upn4skRPMV0kBZURdOI5QxIoHxSxP1IXcVj3vBhSStISCeD7Rd4EatW3UyI/kWERHJG/w6Fhf1EUnICxRgRv2uBPZ9I/DECdtoYCchI61oY4lMJAIM1NupUW7KA+NsUjMGABq9Hz45VmTBGeI5EnNQ5KjM0UiWXSackg68UelJA/QKI3JyBPcmIdwwA+GCBQFozkaB5WukVDII4iI90D/mrIAsmFtVzITPtN+UFhFf/SF4kJTI4VFjIQS55N0zcESnxCReqFQ8yhSIMEPkaGPJ8U8+ZRPMAEgI2AuuaSU8lVHBXmGbfmEGyWV8JRPdjkqVTIskbhFptOXrTE73gJPBzkAzNhYbQiOpISW3WOWOpmYRIE8AAGYv7OSVOka6oNZrfKWoFRHtriacdkcFaiPY/SUjmGWMxWMIzCMrLhURPVAn9Q/l+iIZzkH/DJ602dcvTUZz1lfvQF2+rhem2IcLMGV7tKAeOKHHwMxmOUwOWkescVL/pWcAcYRy9UAzSUCqMgfuKUrNdFID+NEC7Babwg5jNUJjQGeplWQrZVS/+GZg7BSApVlXAGJCZF1XgklWeknM9a5VcCTH4vlW/xoWhV6NXExWjkliReKnwiDR5eYoRDFLJzpEO7lkfepEPYFO1MiWevgXAHGd+ZFFOuZJQd6cLgJWbGVMTkEKr8FOgsKEMkAMrPlKg/TXg24ks2po+AFo+UAF+8ZWeLZoOf1pOK1nNdXX7MYSpSTnHPAYPyBOV13E2uWYIyXirahZpdkCZtCJG6qYDlnZ37WUzPWZkWWZ9FhCdRhHeljG5twci3FpwdSHl6WaQV2aUs2p23maFGGc4snC1ppehZ2ZkpnaUSmGWjmaKo4aVlmHx0BqaBKGWBxqIyWZefBOynGU/8tlTUrdyBHEqcpNmX5YXITcm6v+mmAah2F9nOVSqd7lmI9pmdkhw6ammJsV6lPBqzlERu/imgQZ2Rhxl9u+mTnJqa12mh5hqdXNwf9JgOvlgO2SBOqVnnfZq5kwBxGoG9LQGqx5AMjJwnf+gLjGmufSgWWSgO4Jm04cK9OQGs4sWv+SgNWxq8Ge7AIm7BkwDET5G2ngK4YhgAGALE38Gx+YAsrgLE0oLEbaxipkpAKG7JPAJi0A2pIUK+mNyzycjInsw82MEZnQG81EFDqalc1SxO4A27sigK0QRtx0q0iG7S3gBITxzILd2QNtnFlZhZ5ByO3gSOAhxvxKHfjViD/smEU2vJ0YOEc3yAjtnoezXojAke10bpTFEKs0YG0PFVyvFoePodyZUd5Ypd2VPe078F0u3ESvgEcusEyeWeLXut3+YEe/LAcmVa0RVYjAbcusfSu3yO0kJsE7zp95YB6b4kynMCAqFCIV8Mxf3J/iwV9xXUjN2MqsRKOnGAW79UR3rKD0ZWCLXOJLOsc0dIum3e67ZQxlUIY9odemOsa0iej3IIzjVsxDZgv7AGB8wIyocsq8AcqOKgTp+IfnusxORG7L1MyMjMwzEArhENIsocZ2ssu0Cc55vGXkZu+RSA/pyOFAMCM7FOSvwh6NliL9NiF5gI5ibgRHeGLl2AV/7fCD/DDH9/Ai0mYOZygLuEzqdEHMPI1MgOMnhmDP8WYnE6Vn/egO0vYT5DTYPabu+QhP+tDXRm8ILiDlFMhwt+Fsn3hsOr7wjVQVdxHiq0xlHdTJSaZU3kZkQvJvyPAjDasRgwAL++4CTALED38wzoyi/LZVDV8LDKKEqTUkxbcGhh8ENa4j2zUTte3hDnRSfFYnFucRSiMkySsAicIw2qMAzLcmmpzta0hnPDkLnWFU1fME+oCOVGJD6a2bVEqxyzTF7rhlvKWm5NRUf7kOKoaaG/oVMKJLyHFE0olmjScXPermPxkwrmjcXYsFI9cVLPYwWS8jYEHaFJ4xn5JAv/adpVr3MoycIw756WVVAIvKl5LZTFBV6M6HDCNkSvVlaG1mQLzdZ9e4l8NYBV1HJ9GgRmu4pzAfFgZs6G5ojndsjzwNV+TYZ+rJckuUcsxGsktClIzGZ0LSlmf1VpDapPYzKUNeMbl/Dj9CRNKurqPY23y0xuunM8x8LjBqqubGmZ2Mh8goqmHWh+BVKpqtgnuiwIH9mDYumPmEagTAiKE6mSKY6YuwnVpa2o+VqjtgdCRxqxUxqpoZmVrVmVkpmMEvWIdrWGXGmVQhmRNVmSyGh31kcriEXH6vNMt4JtLsLMSB7RRwML5HKU8fdQugNNJkK9jwNQ8zZZIHdVSPdX/VF3VVn3VWJ3VWr3VXN3VXv3VYB3WYj3WRVA0//APLkzWar3WUzCv8rYCLb2wXAYEElsE0YYD/acEed0CHNscQn0DrbAxbI0Hbu3W3WKhZQCYLCAT4gbXc4RHQ8Cubm09O8DYQwHYNws7k813FAsTTznYdlDYLgxoojK4YUY+fxd1VJcdafwDzlFnzkFheXcqZsG3NIfaejd7zNB2JWlxXsd3VRfcOppsaPZ4YaYjP7Jw2SN32sEiITJwgCcLtI1hYadlC0chhlQZD8C3Gve36upyn0JnCdbcKYeCG8LaQEO2oA0Hor0Cn8kfBpWBnNG7zbcsEQOyPjC5o6uBc/i5/ztxLSDxvPL93/Kgupez0O8besZQgB0oMfeNgqJ3faVnnD2YXeVAgUGYei744LMr4BLOyyd4gCbDvRyleyTgvQHzfdAhgYB7fcLiPw1Tn7giG8o3DLL34MUyzc6w3nTQ3irw3tGKjQDBwJCIUKzj30LAvjyBms4xUPqbOSQlFOWwYgGsRa3pip+L5fzChuP5pkZoArDnvvD7WFrOPYgI5axYr544SPdAlsKoyXsoLx9Mu6iQMahkDNqT5YgJE2U+mVDCvjzO3i48r0BuEqwIikKlSOrdA20sU13s5AWRxVFeksRwLELsOEuk6MkSRl+sj3RUlAmZSih8lppujpKe5v/M4ZG1d8Y4BZRjPDo5XF2ewBN3nkgtqRud/jGOUeiZHehp4OMqQNqBmmt/tMiQiVAxJQSNri6dTFFROemc4BqlKcjMA460CRcKde2C+OnEKXEokTxZuZWtGFNGUVHQLs605ea/qcmoKYKyyRzwU+sqce3avtvZXlB94utxAOwpcNjsO81Cnksc+obdtYlBAMsEnivpXKSYg3vA/EcMT6GS1WrHbC2jgKINWPBZovHSmaSe3j9aqicbGl1l9KXOxfFGEZ0QDwFGCrzRtVpnvFwNUZKfJZ456lkOapMeqQDWbJji0qMdHwr9yfGiNc0H8JP63gb8ngJxDdXBGqog3Wj/L0YE/HzQLcarXGfSuapxbzb1gMoP2ZN2hiaslzZ0wHqp2JpcPcamwer197okacp1hUarNk1mvModBnCcco+piJpcfUpnLBZit+pnPUarzJLWSS8GS7/vXrPXRxCvhyBRxWWyVSDHic8Gi7+UmODUQSMJnuAFDXf5apD5ol/6pv8TZ536AnH6rN/6rv/6sO8DtGuNtD9Ffx37uO/r81X7tH9Puf/7l0/6zUCxyoYVXmQEJM8CME38fe/7QsCuFqsCAMGxttgRkL9RuLAeV+MwtNECns12t89RF+yPasD5O7D8TwAT0f/WwQrUJ+BbC2BTmHYDBdsEws934kkDuIAw/9cPAoA4kqVpHsF5CipwIGvZiql84+swrMiRjwivmIlGEoqQuYAA4ANACgCHQsTL7QDMUhbXeLBUXSC5bD6Pz2UjTO2+ZZ+m7aibzhkSom+J/hYZ/QmS+MkUrhg4uIgoEI0gKAQwQEpKKRgAIC0kBCgNAi00OSk0TALkBSTELEAEIBhUFQSkYlIyOACwuj40KSQwXImgMvwEDKRKoQYkcy6fciYcDDRI4pJcykqCjQz/CMG+zAZUCSQ0mDsRjGfmYgIoiIo4cEL0GiCoKzAwBBi4+CYYAO4dph0GIHAisa+fv1nuhCFctikBGBpZHiRIsKDAgQUACjT4GPKdIxEIHP8sqAIwRjctxxJIwajRUiQGTRBk/JeRJSdiCvkZaNiPSzNMLhDEyJagVs5crV5VEVqrJq6Wj6DVQqlyZwlfwABkuTSlqJYFkposNLBDQJVTHkcUmAhGl4KI3Oz6mmUJQQMf4tqudOrq06BDJwyHuVYSrMcCBH4owLVFCJUkhMnosdI4ipSPEAAYodGgyQEGjD2DXgQ680MtYDhm+jGgCgMpCDzWduIRAiaOAzb3ETBbGKHX3lID4EOjnJSl7CyjfPGZW+Ytk61coTzSgJEtWQ51GQ165IgtDngUMG2RR+4BuKIgYMB9ZCMuDB4kukIsgPHYYGlL4Z4WMTwQEgHJTKH/Xwr91XGFeAKQ94wI14HFg3ilZYJgaCo8GNJvqPH30Q9wiVAgWPflJ4JPgLBWoRYC5DFhE4OZaAcPEPywgDXyoKeeC4fQ0VlkWjBxgHIqnKfiAYFc9gZiwQHB5AldIPFdE0LQ4UmTKyzSBRNxzSLEhpmIIwSVyMHFQAMDjCgPA/U914IAraTCBJ2cMHkmIQIIwICOnbkJp5gqILHcj1cG8VFtaXg5I6IusuNHd01YyUV2ie75oozrjTlaXzvsaIKXzdTjwJtEFMqECzRsIVpAM5IqgKlwNmiZrdjJ+FwW6oSZ3Kto0qCEmZfOupgB1CQ06iz1pLmmbDww0aim6+G6/0N6gGr64qRQAvDALF9lCYgKdQZQj5RbmvFkpjmca6mtlWIpipbo9lErAEs1YM2g4mZIwpnnsmUaCTCo8lyB5ZCA8AgK4/pceU0UUOBbIxAcw76poknhczqu2LB1j54ZIr+aVurvFVGIMN3DyW3Tz3oxjpdgSAE00Jq7rpVQscE1ZwbhtC4kgqPIFONUUhcoQ2FyrlXycGAJQS+5qgpIf6anziPwhpyX27Cgj4vRXvGx1ldkcQAEt5XAhxbcHQqlAe1BKy+/Q6NJ7xnqrsyuarQ2zLSm2oE2r90T1uFRn8nhgs8pphVAgwIbFYDLmW9/JAxLKk/xQ76xgRRDAri08f/5EADcB5pal+7JyxQROqA5LvtufkzGTeAoBRIHEDCxMLWV5qiulyKwTAE+1NYnpRYigG10cfHwYaZ8Ne6jizZ1Lt0qmTkRKqQY/YBf64hz3hfpAlTfqhgFpGcA990m4joJyy/QvO5vc2QT6QakwMPj6EuOvnyUN04F8TvNmb63OawZoACR2F402MeNy30NRryzn/mm0JguLOAxJYDe4bZFgr4UgH75y1bsVLA+/ABwcGXAW65wEAmHMGIxSCGcE2IgFhccw1sqFBURjhGABfwAJPzBIX8GoogAJI4IRNyGAmnWmgIZIwlmIUIT+VBFMHRkHMNTYleCYpaNkACKYTv/RSwWsCYVDEQs3oLWCORjgjWK5YYm4aITaAYGRcymFixpQITAdIACHGMA2CKISX74A3DMMIuOaIAU2JK3RzgCigqIGDWyM8UaXJKQ4DjiNiRJySiSwI+ANMYg15iAJrRAR0Q4Ii44aYUixiKQtuGiGJ9GM0jUcASehEskapZLNRrjlJosYwBgQAS+nCB4QCQjI2x2rJAo0wE2dEdczlgiakwSLHTboSHi0U1ugpMMBYAJpMKJA8GZUwb4e0cw9JbOd+ZAYG9AJzy5VU8VYjE3ZGDhZdapgHbeEwf85GdA6YXLGRaUEAldQQtASYYBeHOh6VySIFQj0WZedEtm8SUZ/zpizoYCNKPrugFBRWrSk6I0pSpdKUtb6lInxW8HMp3pDuz30pviNKc63SlPe+pTk9A0qDJt008FcYciuCGi4TzqGZRaGKeaIR70zNliRBBCN4RUBjgpKle76tWvmoGpR3DDVAcn1jKUVQ0llYGwOlrVuoU1rG8FK13ralecHqMUMUCoCvCxjkdQxQoZ4YFf22KSpsQlI1xjRE0ghI40YgIV0ZhGNbrSDEv8op2FBctgN0gKU8BCdgPoLMlIO45KrGYWJdksAWrCDL2QAJGB1YUNuRJaJB5TMozgCkSncMfXYO+uwh0ucUU6nAJEQU/z+hByT/EjTMzLaZhIUnr6QP8gci5lW1nzDXBCyQgHKMxmSPDHhFrD3CjMCbzkXduL1jsUDQ4JZXcQFmRwkRu0LUwMwDFCkki3JAiAV2HCpIyCKkMz9iaHqMVdMIMbrMJGKVdUl7KRw0Zwjt7SoRAV1Nah8oQ6XX5LkGpiUwn8Vk5IMcEIFAYbrpimYoC2tUJzmkVC8gupfWkhVoH4X2awFCt/wEIPKuutg4ts5CO/oQtLifDNKNMWAQkOamobysomZeXg6ml3AbpCwEosjyeHSsls+7IVJCMrMP/uxV5+F0SDmzAxXKo7iw3EbQSFMxJAQCDnIQ+RkeznPwO6cKAxDTIVB4U/Ko0dpTnAog+NLUH/po+D8szVpEoTPbRU5HS3WhxHjHGPU2DO0YtutKA76IJR+6RIxGi033gDEoDW7nf3Al1JqMUOAJ5wzFbdR2eEkOtc6KE0O2JkoIttbAffxpAiMIsOu+XQXGoBEHwUxRrfN4ttKFPBYoHsFIwhlixOkq8b/KE0q2izakNIPP6axTIHMh51iyXdojjKHhcwwDBGkd4f6eViEUnHHHYLmyE0LFh25IJdPsAaC3CHDY7t8IdD/Mhn/QP5ZAFVnKo74hrfOMe9itAtufKnuOw4yVHaCQKgPOUqT/nFS+7yl8M85p8YaMuF4R4Ff+Lj4By5MGJhM3pdlQzuNoFYBFH0leoc/11Jz8HRfdp0Lgli6DcIOmGoboYEXubpg5B6Qmmegy8gAGmXmfiUspqDcWKLBlxH19oZatEM13wJ3iR7Pen+B7uPFJ54lzuX5AaHkGIMCGtvFw7a7sKfOynuUbVo1+O+VjogIKICeIBZ1PdDTA7mBWYB5THAyCekQOiHUpgFiTs/yClRMa8qaMOxQJntIQjn3SQOnusL1IAftGGmshH9R1Q/MD9BywF8DKIsnYB7IqSbxEgcPpHY1HqAKtIkiZi7E51g+86Y/pVgBNMkZ2MWyVPD8wKYobc4ChezdB89ZrnCC7fBJjYxQXWgmTPlhwKD2Lfe/dUH0xUQYPtiGAPOnf9CJYGGKFxB60mG8N3e7w0QAXjLW4QeGJFemwgAAQxA5BkDElnV+lHV/H3fifRW+WHC5/mfKExeG2gTGPWfbRDVE+RVa8DAMfSQNDBaJrXKtFnBA1rVMcBJ9o0SNYiU1wEBco3Is2nTARxEDIgP9YiPMA3QPzkbWEBAI6xTdNgb+UBhs90A9kBh8CCHqyUOI3UQBDhLNIwTKkmB+GhRdCzH+OFIFqpAF6rGOIGXFkySFcrPz7yAGQrTGnrEFSJXAmkPE8aAJPSZ8J0CGKwDIsIhO0VhweDHMSDhpJ3CD0THAEyh/zGSpZEAJGqaMGWhonhDAMbfjyzWMYTQZ8xJGf7/ERMgovrcSy9Ayx3+YSicHhQI4o29gHxEjh1Gju7Q4ZUoIUtYYi2SD8UQAIwYT3r8ACi2k0UUE+XghAAcQIHUDyBlIjIlBwY6og59ydlU2Iu84pzxohupA5sQ4ougmjcMoyN6YSPKYRA6nuLlgtn1DXasF4TATBbk2Q4Mi1UJX7KcjEyl1SKgjKGQDjyk4bzpWmVoijQYoh4awRlCAUFCQSO93byh0tRgjR46pNjY2pscIzesysxEVNG4Q7j04wAIwUoSAMzcYygFJJztQUzZlIQ0yNvsgFmARiQwixJswapRYqPwlzEEEkouzk6Oy0aeWAmI5JZBB8FtWN74TeSc/wNNrtmk6ORvqIat4VgD2KRwBAOOYAgNuGSFIMA0rNfDIOWbtZgwlKQ4ks3r4MpBTo1F2qU88l0O2BsO6MlaSI2aJSOfHI8IfE4A3RhhOh6mIKRVRgHcqZk6lk6lIGQ9JoFixklGUhqhJEoFSYtnXoFjAsqYGEbAxI1lDCafZIJietimzRpiekmAjSRcrcUp8Yn6OIfGmEdKaA9R4lAo8MkPmGY5EKZRMOVZieaZpMFUtpDfHKatjdXsEOdtuuW//IhsAlIwgAoPBAtmppsspCWUmKZbukjgsYpYvmV58ktqPgrh3ZMQ3kBfkkDkNVldBogDIJclBB9xUIltiEFbaP/gKSzBCAiTDi2HYZ6ZoqBJs9lmZgxQBdGANmqBNWBCgb5dyzClcoQEH3ghg/qORbSFKAgT1txntnBDTCxlwE0ocQRoAuGIiGRZEvgnpEyDVbUJEcKoIGXNKRzXgK1MeuhTrTRXaOhTUKBoILLocRqWICUMglYG7gxaksLVnfmN03jhcJQYRsoIkgqojf1LZtRojlLMPgjnuFCoYXrEPEQUE2CdFqKJcyiBfJkZzLwXrljoigronWYUfDIUr2SeEf4lD8gEGOEEH6HHOaBDF8THD60eJyQQokbICoSCMJgDT7pKApSRYtWNLyyA/WwCzZwmQhJAUYBERoREHoClRWH/RIqqnTiMID/w5DtoBAUx5QE4KqISXLdkhARG1KrmJlmUKjoEa0isajHFqBPAKlbKaioQVbFKAw9IliBxwjk8SrakhKjwA0XUDU6kwgP4amRBQ6g2KkNQIq4qyjhUybTqYRglhN8sKk/aKpUJFjy0TbRWJ+qo1rJOVjuBJb8M6x7EAJQGx7cmTCsExK0M6uhRCmn5DaoC4b+iaqxeFJ8KV8NVnZK4VGd0DDitVU5tbMPskANoj8w1FeN9Qmfg10tRrHA9zmVk61yd1Mu+U8feVMom2g4xKcm+gXv+waI6w02trM4K7dASLcwFbdEibdIqLaCd3Mo5bTIC2tJxEzhY/93gzBDfLG3Wau3WygDZpdUJ0JPa5aoakF0WoB3Xom3abu1vVF4BWkHgXGDC1J8J4mAFxi1c+B7rESAJqiZYmMT1Nd8fcaDmkR5Qqe3hIu7QTkMq6iLuwMi6TeIuMtqqJWNrxKNZ5iImNoKeLGJIAKIzxqJlGmbikm7plhyEoc5yEctchuNFIgcNPCWN4qvcZMFWVh6YBoPJmu7u8q6foa6tqK5lUFh08QsNJCfZzK7wcqdtKiMO5W7vQm/0Shx6fMaTIoHTJNo3VAd0DdKdHmgsdoH15kqNxMKOuqh+lof0qu/6DtcAZOtr8IMCpCvB/SVpjRbBRawKXGoVdEF6oP/rhJBFvAZFuDqBOawJIOgO+yrwAicuzRKCADJwBEtw0jrwso3tBGOwnzXt06ocPWbwB4NwyR1tbO0ABNfsBUfdLd4A1pVB1e7QqpSIFn0f4s3B1qkwYWCdRWndCRgeYWzbDfcTEHcRIuQqVDWdBxdU02FtcY2whXnrx+LU2W7JDs+BKFAxEacTEqxebcQFLjhSDuCYGlzxJ4iFlhAUz5bdCtkDN42xPQHL2/WdQrVUIUgxgzVxCTiHE0TU88WwL32PExQE75Ggs5nfJ9xtCqIPkwJS44RfI9Wf5b2FC+pgHUVRaQzQE8hbDl7ewOzRs33aC+AC/1mBNDwAERyA9ij/U5WAYHzEDwp2HncYoPACgzdFHyDX4SMwWlq6wjMJ5yMX0jJpky+9oPFlQvAAaBPkXwn8oP7G8gBu0wSOUs4uDB/ZjwtWXy2/AniNUn1kkS/FYID6gFjGbTK/202CIJ9koDXwwDdbwxYknN+yM+b12S+PyPvd6BcFiLe0hSg78zYg4IQynxPYo13dMQLnLqzlojVamo6kzAE0ouZq4jVeBhcKKpKYaSVa0BEm4Tb+TTseIwh9jqOsYzFztI2B4cBMR3SA7jkeRIAQnEJfbwHDSEg7jkeoT4RNI1GloyF6U4pRDzD8ojYxrqStTiKO4980weYUiRkWQjyeia22ojcB/+IAOU8N8KGjHPVOz3I8IuHiDBr5pBo1orMCQLXFlfWIHpZY//RxLGNYP0DWiMlah+69mYQYCsw5tsnm4EcmgMHmOGNZq1ou+iGBOlhBv8D6rEDsgmVNSZBuVKQ/Qspiuy8SkxTWWCSwvYVVCiSb/Q2uQCS4aGR/QRnIIkfsflAMEIPtcuayoTZRqU1Mb4tZAkqESUk+mmQVxzZWMoG69QNStiWFnCceBRKeaWkBGeWzHU1HjsBHOgpS2na25KVudMLsZIsXCrcxMDd5bguOWYepuAN3zzRp8zZ0mYAZPcCIpIpqX7d7SCVT0pAdz2MZIKfwPSZ2voh4sCeK2TdhLP9CfncL1L6mV+IKhZTwZJ7miwwvaRsvfaddP+gv85L37pjIusB22wRL9lqGlJCmUqWYheu2nFCaPnCniHc2ckQLcFJjdAr4bxAmUWWZJ3wmKon4httKTbN122wB/TBGi0uLjVE3eGsBA5ATO1iZ866LxswnK7QnE0A4iwfncrp3tDXYHTPahByT5CFomMJG8AhMi9LoSMAGf5fHmfaOT1gpVvoNgbfZskELhtJphKfB96K1igwGl0b4hJizIzpGhnv4gAiD+BK5m7mugBhGh2+mizRXZVRXm/YDipb4kPh0Z7TGnYpvn0i6v7SFhuIbgraXo8tpttxpiEDptnxJHlv/ujB4aML0TNsAuSuSE3jnpyMudyzcNVI5IhJEhp2f+ikcjoBOpe7eFZVDg2EZobnq64iAo0iYajnlRQMRxqQquzmMExjgxPAkqy5GkKx96gGvamkdrKzZmLG/jzzZqydslTKTXoUfulA8gP/Kr63kqy7tqsLidp+7b7d+hFzoKi0Q7GSkAq8WML5TR6qe67sHvLZSjKNKhWVtgqMQbMJmi8OiUfy2unDQSRVwq7Zy6pwTCTd2Nqk3wSbs+bYU6rMlFsIv12WRyUw8QyoQFjSAwWgd2IYJQAITl2FzlcX62QLAbE7tXYOhrM3vVGfw/Cd8bbqYMEHH94K1rJ9hSFf9/zyD+awQv9REoPAZHD0ZXGthL30Ie/3XG23Xg/3Ykz3EbTAHoxxll/3as33bu/3bw33cy/3c033d2/3d433e6/3e833f+/3fA37gC/7gE37hG/7hI37iK/7iFz7Wqb0guPDTNNJOLQnVF97pPS770p5DiIOrvhAMzYIoUENJCAUM9YE4WMPnD0XnZ1O+QwAB3MI7dL5RoD4lz/5fRQLDXVt5mKxQiI/tq0BcvD4EeETnq1buOxfGi4PabH7GeUsxwSX0B487uC8BED/wz5U/mOBQtDG6PC9hzBCSy0D3RwmwLw0QkL8ckL8hrABGCMRT4fGQFMZC7fBAp1TNw75AhP8Jr/gDCBBJEBgAQSwAgg7ACxhkgAow3CaES4/luaOpALrAoBEA9Eim3A4R0EFIAkJSSbABHKgGjnCDVRkDIUCwIJCJBIfAAVEGIKIANHu2AgZWBf2w10cQ99KA4vBSpcdno6A2sBDHx0CCECZGWchgY1AAUCBgAmMg+ikAeHlWaqD1Aup5IiaG6ioAe9Z6eQAYYAOWCira+UIadjpqm3oW8CqWrOSrHKM1nEgr8NxLDFt8c5yYmwjTDC1WKn3wHCOTK3B1+V3r2e09/gwaHr+urE9+M4wPx79w0goaPIiwyjsgMGjkQkHgAI0dqVgwSIUiTxKHNzIqBPBAzwteeL7/aEwk8iMWLQxaRnyREZ5IHTZUokAA6BbHlSf58MDjs4CakVaG5qHzgJFQCLAA+bxBw1iABacWaOtlgEwDRCQGJLBkIEEZS0coFUigYIEKtQqYCWCwQEGCAiwCKIh1AK2RMwwaKLh4Nu2QSwN4RCsMM4ZWrjamWoXZYAAEQAv8JuDX9++LuAMY8DrsIhaAynLLEYg8ebSCzgcMQBhRzvGV05IPBFYbBsxbvxddjyhgF3fZXiPAQPFqokFcCLki2ZkKYUDeti52y1Ug11JHvrxfiC19YkFnE12/7mlAafret3HnnnDkzsb3y3XvsmWGML/+/Sph/sICEUwBwJUCRZcw/0CAJQIUJh1DXKgwUUxOPBBIaA1B9EtGD6J0hUocGUAAdm34l4pKT6nkCAoMaMcTTx/xYZcIL/ABUWhcPKCDCVX8BQF8/c2IYWP/JdKLWvFBM8Bdn5RzwEUJ5CQJfqu58sAQCrhxxQKW/AeGAtoxAMoVvQhw2ZKpIKYNGIjFkqQr0FS5GYW/IEaAJ7dI9YI2iYhn2h6hgfHAFZ6kOaOFaBiWpwBwjiZnoWS6uZ07iZbjpXcGlOHJWyYUcBFIDTzgRTliiKlkpQCAKWk5qQqUqp6gJBDNChDa0OQeUn4Z5mZbUijqq7EueuV+wg5bokgk5pnCmlbA+FQYFr0ABRNAqP9Iknh/qnEakEpeaK1/1HIILk9pOMBFpzEZI9KJxgogFwqi7MTRi9gSIAofVNFgCYJopJDHACHRgY2MNzDbYIkbbdTYKQM2QJ4WYFgxg5+TzkhJJanSKZCeY4ppg3O8Eoaomn8CIFFfDa+JscRw7GXwpHKVEbLEbFrYp8Qv76XxgqGljJjHuS0z6VU+lLBmqgJMQcJqoelJ5MQ5t1rTQrFADVxkm4gmqZ4iO43NFSlDU3VnsXY2A4vEns2fsQwh+1AAEiVl4DgImt1RFq3s5J9rBFB4wCCc/PSQ3d6IBGKnCHZCR5Bro5sEpy+ZCEuObBeS4ArZ+pRGmU85MoAiEDH/VcVPeCCIyAF3NQstzUAXc5UWBRzB5EWpwbBmAyw6MBjQo20pkJbepcMxDA8QAnKfyo4Dey8IWMm7zIqdM2qij0pM6PG4QzV255ojCs3yL1Q6p4XD/wx1ObYPHFqqWd3ggJJM666n70QAP+mqiUHdZs3ea1PrmvI/mSrf/acX+SPUFnKHtgTmBwFSeMe5IoQHY6EOSJ3CyJAAVAMHDcITNELBRhR3LjEYK3M6UAELELEFfmFoSFWYAh0swcBBJMGDJbwQNSDgQgiYICgIcsEkaDCZNIjCEAgIXQwyODwMBaJGWMBTQxLmgM7FRQkKEEBkVpCAB4BKZm/RogLO0jly/3URAWA6VRGnlsUywA8bVHHAZYRyJzRFg0zsAkMU0XCXXnAKAWT0RPiUoEXPEOFja2zSAxgYMzo64hMQKKIXDFgYQyJSNRTS44r6KJrCoOENZWJV8LSRlSJWsWjvqIwAEKAASV4teqIiU1KSUD77TY1jOFrQ1RJUSypa0YfpSyMsGXDIMg5QUbASmxltIZY3oFCBzOQHgyy0phU80yksWlA4ogg99DlrmjKLIq8uNQAEeAIB3IwmDA4QzhskxV8vSAoq0ImIZ9IMnYVxACp0hpgDkHMA5yAnLQ4QRXsmonMxKAwoGOQAT0RRDP5Cpxb8OZKAAgKfBCVnGPR5A5yswP825NSOEQhKjMLoqBXwzElHX0WuprAzNOjUDkY3CpIBJBQkCMQGTEPjTxfQJZ0wLUBKZwSOgjaIUxfVjkYvVUQbaBSn0gmNT/l506Ai1aY+RYRGqwqL9NkgKTMdGMmMCgiNksybuBiJ2bgKCIeK1azQ+idPX6rRl9Luq22N6SkBkaCCfVQLNh0JT8n00z3AQKNJuSvJ2LlTcTZzsYxtrGMfC9nISjaB70ObLJlZxckaJCma7axnPyusC1ZWGpcFrWlPi9rUqna1BVlrAuW62Gya1jasra1tE6g61xYEtrftrW9/C9zgCne4xC2ucY+LXHgYpBqTZS5kd5HcZhKkmdD/rUcznStcGxRAtvvZLmS9y0zsqiK4ogAFLfRT3VTQ1hjRVe0FLzHagiiAuwWJ7z+2lZ++mlO+su3rfviI2veGwQB36at/lbFfAROrslJDMGh102CEvLS0zJQUgJ0Fw/OmorJoWWZvD+CFJrEzPwR23iU6uZ38Tre9xNLNP7MRilXo4x/coO8o2GEQ8JKsHRqWWSTbkU3mfiOa6biTMqpbZP3Q48ih8EbfnLxjV+xwZxZK8kh0Rr4e62LGT6RHK1jhDVEo2Bm3OPByWwHhMASkFtAzmltuQY9gnFMdYW4akpMBXaaB+cbvK60/TDEP7nJZvfHY8wscQBanmvkY6ZCy/4n/MZgmT+0adC4Ui5uZLAaY4DgJII9dzIM7rzwAjp+o01XUIqZI0Ew5fsjeeSghKa9URgW3uWBLiJaAWX8iOAhME2oAcWsDcJo8kXCEneqEmGHX6gBxqBVUUA0T+IghMn75BFrSAJnOQEI5QAt2sIe9BSOsoSPi0fT0ApVRsXS6fOWxRFRGExdm3EZLfVAGZzwz74ya0Aveu48fdQeD+SjmCB52ThEz0ynZDHwrKzBCp28AHMEALdnqBqdvkuBvALCaOTcwOHT8pW4KWQct2cnNrzPpQ/TYoeLwbkvkXhBsgZ/AattWQay1184sberaKqBNau7NC1UH+9IJ/MXyiP/qKVW9wwAOwDgMZ7WoBVQSv0mvGWIwNfGRBUs0tKNyYkz18CeiXGJI36JddCUrP5XdC55xoxZzF3U5EXLOXUJhhiw9Sx/rtFOgKgAhEgwtFWha42YLAK9yFRtamYum32ufU7lOWvFM7061asBcvAQsRKRZzXTM353cnKi4e37tNwA7K5JgUKa4Qo6MB8CVtiiqplHxdyS7TCyl9sc/Yt3wVLISIgwwhGj6aux5R8zgz0eE7z3+j3vigZL2S/Rh/SI+SDu7Nix8bVhe5uEE9Hpl1wRJXjbteFoLA8pGFoUZnCP8EjvaDPLI1+1P2f1JY1QJVmO280OeGLnmg6juLjP/aaZ/9GcXF6M605cEy+NsmJBriNc6icEmFfMcDyFfYrEXPnMDnrEVgYJOEsg79hM2m1AyDOMNHcIx5zeCrFB9+JV+THBz9sN6ZFMJ4NcOwcN1m3d9uGdpupc+DNCAMmgHo1EvOhUAVuNqxecCCtgpCIBC7/NHN8M90Bd9+2F0C7A+2AM0daI7WVQmysM8sXdo7uNqpBSAGscrF6R/sYB88DWGLnCFYucdOFIobwgtaSEH5+U9rtc8UHGGZgiBzCeAXkeHYYF3ApF2fjclurAV7KZ4iXE9MLCG++cN2yM8xLMZXnIAC3ARj+hJAyOGqxcqsgc1eWgqr8MwFRQGkXhz/3TIepy4BZ/ISnoiSER1ez8jMTx4AyBGLgjUSVf3iYCYdYyUiA2ACpEYPtPDeo82hVSIALlkSqikdETgAKByBSzgUbZwSWVUWarUGIgmFlyEeiNTS/6XUb1AT4kRSuySC+wHBVXRAKcEf4NVORLzjHchFBQCHnLDR8J0CWlRRyABK1wAgcdjYebYjpn4jtCYANPIMjjQjLDyParXcUWURZySFFdTgFcUC2CkTF30AHexIo2AX5KUTG2EYiChhVNhbWGkeQAHkLb0BlI0ksxxeomyR310R1NUj/8QklV0c7rUOT2jAKOWTOTCjSU4MUewS2vkkmMXAN4ofrvjShxJLv8PsEyIMY63hHeBGJF2EooeeRfhQ5Lcc5DLOCzhVDAxJVBxZQmv4wDCtnqDlROBpVuHZVgtZVN9hVH6NVBPtk1rxlJklVFOEVTS5AloBVNxWZiIuQVspWaBpTqH1lR9uTOF6QJwNQDjlJlqOZdJZX4QFXi6cEcDZVh8BFKikVieUFKHRSFPMmDhZFNcZWR0UZipKVi8VVg4kVjwwE9wNZcztZvtJFMaBlDstJcPxU5URS6fcFJ26Vq+yVBaAJ28pVWH5Zl6OZrMGU4FQIzOIJyGVZ23qSAPNQSIlovDKVhlNVVKRQvkZGRmCZ8HwXTsQnXxeWmClEBvgIoHARz26Z//ktWfjoWf+PGfBapZT0U3BopcvEUsoJkfBaBlCiqhtcWgE2qhF4qhGaqhG8qhHVoQhgZxNpZc6fUJImpa5qVeEYpc4uWhLeqiElqXBqEA1TZXTclYkSlZ5kRhqCViH6NfOFoRqDBfzXRhZ2NfXiVZQ3oQYqWkL+qkRLdmxEBS91BpnAcLriJpxkAL74WA/mBlVloLrSBnkjgNZUZfKHoJrIAKOvpmc5Yf6dBjfwYMz7BfKAhkbLgNsxBl5lAi0nkNtICm4xUG2hClYypggZqm+tBoZ4AKQkZpV0oNNaalT0qpwSVzpEEfFYcjohaN1tEbr1ECi5GLepGE9QYtfeCp/9DicOfAHnLhCQKXFQRXHx1nGbsmcVkUh2ExFq/2lOKBqzqKcDPyaXhlacOBSGHXTiF3BsWhTso6dDBHCZeSa9wWcbgxCqBqGjSna9WaO/lGJycXq1vBrYMqH0lyGeGKaKbKf2NxFjA0F6H2q9NaGbWRrfQKdBcXG9A2c/Raqf16W76Cbp/gd7BwFml1GTnIlNrgeaWHK5KIgDbJd6GoO/LjKwvLpXaih5biPbXimn5nK3DWdCZGNUsYlsWKH7xnJrSXF3wBPa65snXqdbFgelhodVqnHcg6ebdoaRD5CTMLhxWrJP8WBh3bbMCEnzEQssdDPUd4BnySM3FHfP4qtf+oFYJYJnsQGAsIy4gkszDrpwUGlGJQQ4D4ZYBVm4KSuDI8MDSIUwDBAjEkIDMMlBbhiJTQAHq4yBcNmGJ5Z4szY34xCwYt+ANwyH5Zu7YdNwUUwjMuMCSC67Vm27UOOwNXEBIPlX1luLRjB4Wi0n07WIhTC7qeVUBvMBh0OIsXobWfJKawAwP/Q6y2CDV0WLdaMrqgSKbPE4mu5wBlNDtbmSl0G4unwHc9V6zzxHAwcLo2mrwwu5WEpww5Q3xgkLthMD6LCwC9O72JUrufADvv1buboZIn8LuYy3rHSIk5Q4rNI4Why76OlZW20EhWBJQL8o5XBAnUyJRxYZUyOYn/r4S1yJtUwbOTmBBMBfC+OQmSZ9QQgdQaPUkr/IJFWuQFa7KQ+MumQQNy3ThJ/kORhKSUV3RZHxyVg2WOx5OOmdW6Q1mz6OjAYmCSOisxZXBKb9nCT3TA/BuS6SbBW/BIiFDBSEC+MeMnY0lJYJONQnt1Eda+S6xAuTmXUCVNvGJNrkAucAmdWNVRusBT6XmeDwCdnDmJgeXEwYlOhARO7ySYW0ALFldW3PuW45mLYJU67wSbNSGd2ekNIFWhU9zGGZWZfDlWIzYOy7lUlhlRgiycM2VT4bkgilWcc0dYnaObWcyar8lPr2MnmemWcAnINlXI6lnHn0DIv5lVQXVK/0yMyku8o6nMyq3syq/8WRUKy7NMy7Vsy7eMy7msy7vMy73sy78MzMEszMNMzMVszMeMzMmszMvMzM3szM8Mza28T/JEzWkZzdeMzdg8FdUsT6uUzd8Mzst8pHD4oUgwdyxmh4sVo5LVCkA6LDYFtq2loo+1vp14EO7MXkAlLGdxzuHcyuM8MQWhaZwyz8UlEY21zpH1H/jMHwlzu85S0I1Vz/ejxOaXHwtNLGfhz7QM0GCoXmViKqYyWG3BAIhQAAuQALgKfJYXKmFBAu/pWFRRhwOCQl7xjRlF0qg0IJ4wX8AxIPg4o4Pn0rdiOz6Nq3JhHsCH0iZUb42D0ipdGf8J4AU+DUzKAGCEcmGNQwJVPaQ2vTQkzdMJMG6XcNIpTSEEpka0gwQl7R1RoCRpNqQl5nopzQMxENWhMgJoYTnW9wlPfdZ3vWs/PSMJutGo3NEAbYDfQzeQwEhbsHfL+qomUEZ5KFm9SGtxIAN5cg6MLRSAECwEpCTkoSCXMdkQYo7Hy3Sh4RlkMiiN4oiPzdpEcCmhjWAxczz50zCZrQRN4NluUCbctVC0CAFuMDCXDSkPl2YI6wAtjUaRbSbILRDBfRGx3Wm4TQwIVNiGvWI0S1pe487k97VdIz1IAxuT9Q63HbPNu7TsMVNaQ3+wUX4N4QPMkdhcwrnibbdw0VX/xVM9I8Peg2K1i8spkRGhT9NgSlsGczBHCAM0TsiUCc5x9m3g0qPfOpHdrnzY2z0SIE3Yzfspmi22J2neXeeIz+dhCI4oBsxthMocJ6k1OkFIqeK2AvHhu10+Ko7dltbfEIjj0NA+M9KSXKQZqVDjJRDCI7Pck5LcUQNIkcIxSV4zasgrRh48PZ4nF/7PGh7Q0jDQ+CnSzYsADQAK0x08C0lXI968TbILRxvEb2IDSR6EjG3mGBU/d3EAWuSaD8AKc6Hm10tbxiHmb7FGD/DmXgB8f9snYW45IFHo0KDmfR4+cOkaeXInYT7mNmo9XvAWCz4aCdUWDVcAtImDb6Dp/1czGf9m6YIONYTOw8RQn1jOvhkun+YMA1++Ah6lqgsACHI9pG1bhP0s0UaF62fQAO+IYVd+665HClaxAIOCBJvp6x+upK8zFSZAjV+0G8YOEjiT67teKss+FRyUW5YwpFlieEkAfOGu7MSu7dUoTm1BgpcFBboeA/WZ1d9jBOVe7yRT7NDYcB+O7t/uevlu7dzecPTO6+De7Juh5bDer7KOoWcB043V0QlR0UYa0Tna4RKq2w7PxBCPof6epCaKEHLNWBvvWShvoNxJ8h7/pCDv8jEv8/66zdzMIN488zmv8x46zTYfSTsP9EEf8j7PTUJv9EdvnzXv8ziP9E3v9P/JBfPSQJtno1EXNGaQlc7SkNCQ1c6dhVHJWBBmdqM4yqLaZF36scrCIhdW0fDgJcvSMNF8axAMLQv6/FkgOhIR3XQ1/lwqn/QN39HRgjZV37def/F19WA1Ollfzz1h3/BnI4UADXj8cfhK1oUNnypvX9sGsXlzf9GK31naVjwGkVDMlvHEovn+GfWpwHQLYes6vSJgve6/gNLv5lkyvQI5Lfs9vdVAjR6bQgIPx4RThNRJmNJ3odS5ttd51Ndmbdcs/T1irTpenSeBsgqnYxgJP9drAGA4orfYMSCcMAJsPvx3gdSJNtcvja9DnSnjTzOzSv3pBhuSYtTAHwWbFtT/He5xSnX8IAAASpIgwAIFiKEAiBIwjrgkQSDqQyPTwC3hAhAAgpzCAGiJSIkBIGdYNBINUdCFIARcuYIt8VhSrYACjjHWgUvrrqygEwkW0DmAwQgYDDg+nk6AAN5AyR1CyZVB0EFiQIJS4s2Six+OZMzM0g3DQSBoqOgoaencYClq6dGcwsncwMIZwacCDWqRw1CRaS9pwo5sAe3IrcDAkNKKEXAD4QEDwICagcPVkl8NgkCCXMAYLxGAA1RBNLdcJLeIkk52lBKBgoAcXc4A1CBrlMD6kjQUBnIG3Drx4Mq3M592UCMnwhO+M02MPZSDQBaEgXd08HoHiKMcJayc/wGABoCkyVhnMoLaN+jdAgQO8xzYx0plAQjjdhUSplMikHhGcqBiZY2dOHRBgUYSJyJXuXPdgiJDqsOhuae1fsDauOMOSQHX8Bxg6S4HPAMC/0FQUuBAvYNEQg49SUisNJ9Rxrz15fcvYH6pCK1CKyqi04i4BDsNDNgwYl6K+zFY4MAb4SJccBRBrEraHhkD9kUMV0SVPrSDzDUYsFAE4tKBbubrp5oeg9af8NkkejeHAwauCt2BhAPCMSgP0tQ2osI4aa+J7yAWUWV03c0BNP/pXJwwHpfHQjMYYDwA8t4AnzIOB/uO5OOEirAq6nsO/dvS5Dc+TTi1CPpUdtkp///N914g1X3FHoNzFCAGce9Vtw87PVBy3W/9rSdOcMM59iGIBQ5mCoWhRIbgYqq4F2IqC04nWAEHyYJKTnN1FeAa0gxhz0QaNvCGAeLRoUA0Vw1BUGM60MaPkEYQCRAjdCCUYUmJvILgXl2ppZFg/vC4IUci6AIbV+w4AEFNORBQz1NsbtjUbLdVJUiOddV1oooRcnjNYvVlmFCY4h0lmGknASlkjA3IosOPAQoFpos3AmDWT2yYEMiY0pCzo5eTioRWNWiyQumGvDhyKYup/vWZKKyKUqKHLkrWXC5XCLCiqqFABh+KAjxAyFHLqKTAAgUUQANiCARgLALQEGLAr93/QPMJmnIUgUADBQhwzm0GnGBApSV5Mm2SPE4GjbYMCODtEjpFpG4BDZxg3zifNFAmYg8k8MkDBuCz5QEBQCFvOjQ44mm80lU7Lbk7GMtAkEgUe+wIEyMry7YBuimes0s8oC+/fUSj7T28HnWrnrUaoW5SOVhWQAwvLFvACfkFKMDJLFcrDrbp2jnIr+OM9UK2Gb+o5xwOCGNHXg6iSta446I5Th5jrNsWzPc8HDEKUKh0ogP2lpkr2bqC1+rZocSASRNXioDAK2jBPYIysH1jWNmgDPDK3FG8fUISUwRQbBQ9DFCPAzjQ0LfMjQq+QJC5kQTAcvm8PfgnTNCddQPt/yjZwOR4s6MF4EokjowBnEtywgELLEN3JZQbjgfjB3VB8wnKWvYt6GfE4LiiDrhNucBGgJ524glpnvwPzO+HuZ3uDJEEGYMrYbsCA33DRN9ombcF7XE3ITD1UrhwAOgwXN6o+U0oEQPqxFsu8wKZT9+H64TPoftCcg//h+jAEAC4mOdwc7gEDoYnlsmJJQAGc132/CAvFyRvDEwoQAEtIj7bSSdvHrzZiD4owsA8yE2+cJVjSjTCFbKwhX5R0N5YeIDric6FNrwhDnPIQhQGgoc6ZKH6AEM9Fmnuh0Y8YqoY94IWom9wJkQiFKMoxRz6UERTvCIWs6jFLXKxi1784v8HB4ePMZJxjCwDIxrTqMY1srGNbnzj28ooxzG+Bo55O9gBFqIgU6QuPGnLYQfP4Dm0jaKKLfkjHhawIzsyspGOfCQkSXGw2ASykGnrBxIDqUJQGNKQs0EkHgYYyVGSspSmnGK2UPCJ+jFBD3zggQ/OEIYxdK9dlNDB3BSgiWcF4VsLsMGiBAYJObhCXgjMRAMY8C0FmMdvjIDECVKwDCf8D3QQ4wQOvOE6lj3TBGgQBO4oVwLCFfMEdTglOtOpznWq6kfQoIFOltS0GmElGidizIKWIZd61EgpCSFGVXAgAPTd5Qo4yYgAIOCAA/EznmiZiSdOYTVgrOUiUTDIFRr/mqXlrGctSBLoQoDBzpGStKQmJYfwBmGrkmHJPze7p6smUxcBbsdOsqlLntjjGduEiaY2i8IN0HM2FSUUB5Sgl0+JZiiAqIdVNTQpVKMqVThK8CRIkueJGgUPmKZNpiP5wU9t4RS5qIJUiFGHYYpwL/a4pE4iykmnupSDtToFYkX6l0jx4tSp8rWvfgVjAmSBgGsaRRgn6lnGsPUCXhDsRvRaK/jQQS5axGtehGHa1zDGrTBBtghqOQPIKDdIYckiAQazbF06C5vyIAhe8sKn3/4q29nS9ofY+WbsBOgI8dFvIa7j6BJ6h8vS5bYHHN3W8Z7iulcMEYMC0x70ivgF/+N6LyHYcxOxnuu7ADSKehekrggCVo+5te51Q3xBJWur3vWyF5IqxNVh0rvGEra3vvYlBQLmOMc63reFRQyQL5QIx1j1t8D3FaN+zQhKAzO4wQ5+cCgXLAgJi4m7bmXRHkuRR8cQC1Kg+Ckp5DsH8IhYVSRYlAj7OIdJNocUmISjJz/UrLzNGDzwdTEiD+aXFc3YiDomC38/TIobi6LHOoxxjC9TliCDKMMhLjEoAoYlUYB4FFBuzJVBFKUdpo3FsA3Fi98YY8cYOVczLtRfwrzi4ZWCx0y24Y8lNQoiN6gXZcYhkilsRQK/QBMwiIM4AysHbojmDEaVhNJcEQQluP8ydYcuxQIIA8tNAAESPKnP35pwCGeW4RpZWGwX/NYGCE2hChlNQ51GbUFm4k2aMMAWAtAACSUg0AXeHcIkhgAHgYDrlqNbz0vuN4IEsHZu+hL0CHb5ghKI7tiE+zOldUAC1so6EriNQgGeuawRwJoE2YTtMQ0NiTE4AQqflrUaYGeIJwRIExZh9hweQINjGAEKSdhCqOUBaHeUISYyIEQulc09P7u70kKoM+x2/e5Z9zmZvgQmjvjgbGIqIJmIViT3Fp2HPTia4fiJwVS0ba2CP0IdyZAF9dZdnOUMMm957kVZ6sFnnBBDrB6FJ5dQYk9qxMWgYHlGkUYh0nn+pB7/TbHZrISGFPpMpSlGfxSHosKMdPgrGUmTekIXOmLVDIKg4lqqn+oCk5pt5ctLAhCTRKqEdw2kILKzUctvTvQRq90uX7duDio6o67LnCKMKuhJflCNa7gFC1VHyktUE4+yr+kf7gCGDTRFKI6UXUlNxyiwMX8TYdScBk8vFy7K3nOia2sq/5yHOdp+UWaApl+sGD1idI6HxldF70QQvQgOkhNi1sYj8UD9CF9eigddWFKz6k10iNCdDRnAQixVPmda1FK7CbVlL2LVT1FhnuoXCjU8ZdKA3OT9TTZJO5rhEb2mwZzrX5KlaF9NblzDVLSEfSRPOJt67ikC1sjf/Er9/1FRGQdjLEehYV+YuAerbF96hB8/UNKLYAge6EQXHIEyHAiDKIiQnF2GyFPSKaAFTtiLNJ8A7lTy8UJTZcaGsIIIUkJkLB9+2EMAUkLSraDL4FwDUgcU0FmuCN8oPAibpcx7bJlYlKCbIEZb3Al8PFGryIrSTR4rJB2gsNVtDMpisIdW8QGiyMgcXCHXhId+2EiY4FSGzEkYytTWAdv3qYIAPAleSYlcmcnUsENe+RzCOUk0NN4c2BXriciWoOEckAoeZomY8AkhJMqM4MyR0EDSLcGZ1FFrOEALFEkVHs2XpF9zsAIHvgcVfiAIJd0RyhNa9UhHzCGMuMsdjMqnlP+KEo6VMwzdBULBJ+YANDxAMCEimZRLGOmZJ/kgHswcr3QUPbwW1rRGxRgLstwB1sSM0viOxUhfqSjdthwIK0BMwECBsjCL9fFDzhDCzlxL0WwWPwTNoLzNN0aPknwhsRhj4O0HClxGzHQMtDxgrJ3huQhENLILuABjZb3h4ZjDILnWCejfEnyLTqQjxYDGHZhWlQgGwBQPq2CWLChSSTzANdLMNorjlDBMRHXg1uzP1HAXCHXjlP3MGF5iDmQiQGwj6FlgRCTjPWjW1E2WDgDk6n3NKeaAS46DMBjk2FDWaynkwXhi6sRMFJxR10XNJ+igqvBgKCCQeQ1PLb0A6yz/V4XsToU5kFSyA3epj26Ng+KUQgxlZWzBT/nEzhFYZeOMQfvADlnS0PzwT+zQzeOYEFz+16/BzlV6HhU0E/pMEDvkT91kZfMNDfcQ1+kkgepkZXkxF61REA641WJmWmzt3++0g/OUxLZtV3e1g+4ID17uXwadgXlATlqOAPngjxPBzgL9R6ZVEFksimfCTuXElhJpzq1l5W0WJoDh5mlOpvvQ5rdspQtsX/2sTHJNZmQWjnb1DRNIEFe6zidcpiBQpWaqZaY55xDQorSJxHE+lcvpop41En3V1iZBmHkCBgZ6JyeF51Qx5SkFEW3Z5XnOZ4C5jXyKwnmtl3vSJ3/2/6d/khSCJdg0sOd/FqiBHqga5ZeA0tFUbZiH4UG2xdcIRajZvMCb+YKK6YCDOhko3Fl4XeirsCfxISiJlugIOeCrqCeHqkp5gpCHrkpX4aCdMdmKhqgvPIiJ5qiOpkqjTRoNdFM0qYDbEBprhVu1SQK8tYLA/YESuFrS3ABybA6qcdsENWaAmEc39Bre9GgPUBo19aIyFFyjiRyVJg44zY3Itc4ZZNQ1hOWOvimcmkJs6IVGbRJLRERYXIHsNV7L6ZOeAp4KbRkqDMKcKEPX0cvt6ciXzelKjMMdRBQIdt6G2B5I4V1HWQRG0AzE4AUZxKmnfmqCyKg4JJUKleABLv8fBIrIEwaK6OwU+L0MYyCqCd6HpOBJUEVppCJIRMQgrSpWo/DGc1yIWCgoV6gnqB5riaKoWoGVOdoULNaDTgQiHNYRvZCKCrkqjWih99kJL5BVjE5fFEbYi+yqK+KTHjJVuZIDQnSOICCru77pMmIQr6jWZ7nJMEIBRBYjxfTjNYEgK+RrvbqDQHQM0ADLlNSAO6KFT55AY12FYfFKaPWLiCRdvAIlaq2WjFpsSUBANA3dfb4ryP6nbtVSvNyN3dRJ81mlcxmQV2Kla7aCla5sPZhHnVQO9QRO/hBTO/RlEBEAdQ6mg0BnVF4XzAKnLA0Q55Cb54hXpiWtdQzajkT/WshOLdU+klKy0TtUrdZu7RoZaxvFS8txrdiyQz+Urdme7SqOrdqurX2dBwC9bfWxrdzObXvtJ6Y85oAJw1eOUIb6hZppKIgGBiZN4ii8aNnoIOEWWeCyw3gtLmDUWBiSzd+WhOMKUiAYrgtN7hKk7ZdQ2V9kGYXWqBFskd3iwWX4oxtJ2U600Jh9kt5kWS8MLicqLgsh7uyGAuZaUe6SWVJGbq5Mruie4+VW7gdprie1qO/KqS8k35yRLnj6AqTy2SSgxZeS5gjQw6PJhER+qapI7cbxwd30QVDJgb4kEOzYZgn4kqnZEt6EWws003Al2799b8c1BbT9aCd8Qq6F/8/kkeyUptymRUHBTZt0qFzbvBZHDPD49i9vTcIVlI8CZ5OWqlsAK9yy+VpJCAOb0g2+uYC+rQW/QdwF6xrLETBuEltAcNyR9lksOel2CjCgedu26ZLFNZwyVUIzGXAUYCkxwVouje8Ek6mSVEZgvU0J7EIEL8sa/qWozVLEeY6r+SgWWBqoLZIUlS7tRBuf8amjPsQBVMXuyd409AtEEe8vyArq2d6dmmQX04RSNIWr5KlzaF0+YV7sAd3cJcRbjJ1jHciJFCo/+F6i2oI/DJIggxR+4F4xTN6J9GEFDrLn9Yj3CbKkcvEfamqQHKxpVB4dmF6/oEVMEME86AtS8P9G3d3x1x1UsxKKIovVMqzDQWmLQq2L4iVqQHVdRPQdY9ie5eEIH0tq3+3eCORgF2eFKNOD8M4dU0AdFmExhFYRBJ4HcpTF6vqfZ9wqgZLCrjAIryYfvUhzGhKCqxTKJnnV81mzyQhHQJKHV8iUd7AVAxKqjM4K/9WRA6JQ0hEgay3GH3tFFUaEPreYPCNI0qXq38kLPlAEmqWnhLCzU9QzQEB0C0bfiWzSPyvH+uUJCXrPPKOfpGF0Ad5FsOJNdKhfoeXz+lnGpFhLrN4u88YH9zlvCMmpfIVKwLhVTOwLGGJJuC4lE+7hl5izIFaiOKeNtdaQUEdGEf7iqeSXFef/kx//oiFqYyIezRoG3epKHj4HoUfRyjOS4eRBSVe3dKYgySLa9NWt6yMvtFfsgy2AdZJcdQqyYRIa3ypfdB/KVI2cVReWtSLm3sGKNZcURbkm81tb8azkNRTM4qKoFZDg4ks3YeJOkTMPpLgQxsxtTcSKxB40QTPmi05LbKpsc2No7L22Y9aIU8gIScPWgNdgDFKzcbzy5DOGTeDBY524s1KBD0byg0b2LpQQ5Ioh5ZdNR0N6tWKBz5JRDV4PbPE01lHm0UbqakdqKMeigEihgkhCimRFzbOAAzsI978I92x/Nq8EbK4KdjXWpCyoRMbsw2/f3j6qwr8498DMo8Za/95beLfHGLd9B8gZeaPP4GK9go2t6AxcZFFlO23bmC7eys7tWAd4OE/t9ED2qEpYRmV1BtcvLXb6ZKeFZ5uwAS0bhKZ85lLMQmfLLs4GzU71WG+mlSUKmOxcqmZ3/k1ijthx5uduzk1nEhcom6zxYKWM+/jgeCbQUs9q9vgJvOwWQu1vzqb/jJjkEMbjBGZiwk1idiWF8xbNFu2U/7hyGhBx2s/nTI7Pmhdn5s6R805G/Q7Kgs7kXLnRijnloJjcQI9v7sA3RGVbyo+CP286jecLwS7dchHydlECZtnVxmllPxJ81uehM9LHelF+Clghae2jTzqnd7opOdDZhjo3ZP+zp5e6qbvR2sAt3IYtVLFCnAWGg4qCirVuJZH625ix3+bY4sra2JAN5Nbhh7j6D3phqozoqXu6sIeI6G6r8grZ4+L68iJS8GaKCJ1Z8oJIsruY195oYR/72gaMAGYcJbwvHwgbDV9To03vAUHAUW1TIT7aKZDB+nbwCEdcpkwBW6avNADLGDgAyjLpCyTa/syLmKrwo5XTmC5w+JKpCeuAvNUbxN8bF3hwwfFbFfgby6wwuI+7C1QbRWqcCjmwwZEwHwixm3o72zYKJqoJXWRdOK8eLNd1n/4H5sneC77xo/zyPMTcMGvjox7AmIDkR0i48bTeIJVG2aGySYAUYtj/njzgBqYW8gFBHjB81AdKqn4DQc3jscqf5FwJ3uiViCMv8zGn3gssCr6jvNzOamrdn50IiUaDhdtbEb34383rh2Q4dDioNEsMAjj7QQsAQ7hoSIbdVERMdE3RNxTwqlPwKkT/oQBTYFhTIklmx/Kx/aq6g/OZIwzxhwmOdLuqPdtiPqg0onoIBo2Yojs0It1niLTefSfCBmJrqBrUYk9DwABUAw9EILQ+qOF7TV2D4HrElQkWtlxvIUFEYuy/4hm+obSS/k7HIufvyCY2frdvu+iD7Fo1001sDXzbI8uQlk6KZnVbxzzSC23DvmAsDDeBtyAYpa+EdpMCwzsl0mv7/z4xr0d5q6PigwAAJA5wIAAhjuVpoAa0igh0AEEjBgJgFynRYDATBHY9I0CxKBRKjdLgqFwoTA+IoaCgHlcHG8Dh0AkYPZWIZEIBDNeZfE6v2+/4vH7P7/v/gIGCg4SFhnsFCw0IV3BjAQEPb3GPAwoGOA0BA0CJAQcOkJIzBg06l5MioQElM0eOS5gPm28LAQuYXyIPCyuoD5oKQA+tuHIFU5wACG4zzDg0KJ43qyWoy25cOZK62g0P3pgzB71jbr+0X88rsKiw1QCJi41XyLcGBjmMqUWa1puounX5JmJBj0MIEypcyLChw4cQI/rhIbGixYsYM7LTpbGjx48gQ/+KhHhtpMmTKBkWaCAupcuXMGPKnEmzps2bOHPq3Mmzp8+fQIMKHUq0qNGjSJMqXcq0qdOnUKNKnUq1qtWrWLNq3cq1q9evYMOKHUu2rNmzaNOqXcu2rdu3cOPKnUu3rt27ePPq3atWwJAhB/7+PSH4BmBVAw6ys9VA8QzBLREUBjDE2YAbgd0g0LRo2V/NkBbcAOC3lWQRB7oEUDB6TuAhLeUcaJ2H4hw1eBDQ/qObjoEEtgVVdpYgQSEiHwU4ZgfkjhI7z/kg7xMd+vI8W5DsmS7nup7eF6vT6a3Yu5zgpDneyY7DvCEECQhA4EGgvn0j9gmkIXBFQH3uYUAwAAT/BOyWAgEBMEBAOQHkt58r+pGGIAALENDAAA2ooICCDFxRYQMKQKAFZfVxo0IMAm7IXREJCPAAGnQMpwd6K+B2B3iB4DgDQcetCEFzhKyYkXJ00DiHeN2pl4eQeSB5pHt12GZkHUwGwZuBEDnpzA242RilY1rOISWUhfjHUX0rNOhYfT9WSAB3/jFQQIOxiYAmABmioOYMd+4QoZkHjnbQAG++QYBxADxgIYkEyNkgieUUgEkXSQpBBHwBJIAJAwwEsAUkmsrhAHAQ9ABfAnGosM4XCiTAABGoDFAccgp0AeOp6gVkq6QQALdEcTAoMAUOs+ADXABACADcq84gqAAC/w5YkUhxkhigSAILIJDgcq9cq8OvkABRawMMYMIIucEOK2sCyG2SqbibMYNCq+HG4Otv4RbBwALYitBqAigo20AC39KLrAOalXDEtAlUKyxHB4B6xKr+xvtMrduaAMlqpPR6xC0Zz5lpnd0OrAMCzi5TXByRsBKHtbGojCplPTggic2kbGxutJSoPLLGmZaMrbYwXoLyakdfcWocowZQqr789oIwDa284TEOtsAocqhlTlgjbg0ea2cCEDiAYKEzuCmgCcoJAMSdin58KCR22rgnoA02agyJRBA6HZqEKsDfo/7Vx4qflR7QYjy76DBcYyYwQAqiPORTEAoqDKeCsv8i5CKA5TjkggIwKQBBcho3KKBwzcgxcIAAZaehgNtyLtPLj5StqMYADDxggANEFCC5skAAnOi3NZKWQPGYNKc6DgEbN0AvBfwIuwOff+FpCoZdAYkArzG+xOoi1I5AOSJwTizw5b++/AjN+4s9oourwL7wpMW+oyRKaL4DD+ELwOh0QBDxSGmAeOrBASTHJ+Uxz0qgy1YKZhcGcRGhcl/IlgO8p4PtrQByAnBc72LTHNIVkArvMx7pKNKlzmUQAb/RzgrUFwkDMLBcrjiIAI+XwMgZAlBfS9PcvoCgCr0KbagpToW0QKj6PEhCchPbgSCUhAkhIz7yMUyh/BZEQuH/R0HpawCB+POG5cDOaa0oRdByZ6eN2Wg4POAdJJiVOeSoQHgXukEckVMZiihhYIk5Txos1R4cHKtU0VHDGYP2HBnZiZCFbM9z/KiezWmvB7NI0AUPUkckNJKPRFDkxwZFhEwyy4/zWeMMvzCEoDlNOZdM1ByJUK4YBmFMSBIlG61kmz4m4Qi6zKF2lIAgSHjJktrZXac0aSUKlQB3cVzmq/IBB+PIoIGPdGTnNOErXU7yl4VsIWWk+RcZpo+VmzSgDsFZzEd17Uxgi1CNPEUA4CGRb0u4Z92EUKg9BVGIkogbaURQgPj0gIsGONQuFuXFA9jnDc05Whkr9YD3jah//3YE0mPa5ZeeBcF/6dtQezYoBPI953diSNMg2UiRSBRBF4pE1Dkhmbxd8shT30yPHJDZHhsCwZfxkMFwNPUcklKmBGpYISl9ytIkyLRS43PpKpHA1Mqc71mPvKkBcjlTkPZykzoNpkqHCUyNNjCnu/MobhbICyRYQg4C+h2G4NocoQrposCcaU6VwMKavnUFcAQTq0qwGQkKs5DENOsgBGDEv8XzWJjwGj5nKJ8ByZNPb6rQ+8IGici2M1GHkhUBJBFawRlHWwhCQYVWIyJMeDGfmYPAAkRrIqjOVQvaGAP1mOCEqr1BTgsEH4wMQNplnOxEMJABAF23QD2CkxPCi/9NX5uaqATcwHeJXAEbTuCDLVxop5DcTAHOoFPEVrK8lQNuOlAwPcr0grzPaW5zubcSPS1VvURYRPFa0AwHNrei193qJX0aseBxqjmqasB4h6ekKFBmYseVIVD/KAX16Ne8S2jCE8Cb0x8E9w3FTROM2vNh4lLIOAv0LYX61gttdje3Dh7WXkfpgwMAwcPD9R1wR5y+5c0XAJyaw4UpmeHeFkJbG0uTLlTTWRxQQlv9Pd4tvLMxVjivyrmocuO2QQNbWHkJG4vDZlYzGm01j26BCc1BKEUKSjwrH/OIhy2oAQkVz8ISmLDWPaBBoZbFYyCTwkQIIRczR6xiFL7IRTT/YiZlYcCCz3/mcikWMDVXLJoGt7hBO/Ls0VfEARXaorSeNKGMKWSaH6QxBSdtcQ5xPCPUUyuFDryB6DeYgtDAWI2kPm2uW1R6AFVTx6kfvQJ57KPPs/CXq+fFaTlfSD2yLjTT6nwefqCDCHo2Bkfaquxa7JkYBamTPZSxjpzF2dj06LYjri1LbNvCGHcuia1VvQJKzyHa7pj24fjC74igx8V28JJWDJC6KvVbeIrtt8JDIu9y1+YrRqDFwucA7olb/OIYz7jGN87xjheCPTqyA3v8vVJBTEngdCASQijCpODV6UjQBg6ZMjIASZyqD71BeUjnAPA6zFwhkvIDvhQz/xtzJqToFfHSlDRy8xnWFCu2CfmXKjJdk3tH5935OR9YHqPyQsfCtTYJonCHcy7ZYW8b5QPWGxKmOvAIsBxlSM8ZonStR4TsT187Udz1PoPxylegXtkOdmUvJfnrWOJyFXfA7RfSYBvx4ZSD33/FrBk07Wn4QlYQKEb5S7F3Vv6ylamKE/N8tfTw7ILGAuaDgK1hImKq7JzH4KAu0C9B9CaTAyMSRFg3aK9YrWKW63eeNEyFavcMQL64IkshccwuHl/Al3UxxPs3AMd4tBdgylZg/DNnShL/6hvoN337jK1egLiSQ0Wx9XeOcMpTIBvxv6I8LhxOPvi07FRLRNY76/+HSwAv0wtLswPFcn2pch5Z0wMMY3O+R4Cegn9ysC60Ei+PAXpJw30pMzi1k3kJ1xMFQhn1ID+RhEGXwz3jE0l04Dzz0zmTc2JHBWRAcD6RNwMqqD6xYUsUYT690ElBYIO5Azrbs0OkQwCmIwc6GHllwII8BTkLhCf8ox6ohD1AKDrV9UCART129UgT5CKIgglMyEB7owYl5DjU84HP01fRYgLXBC0iMCIFEBhYKD7Vkz/Y00zF1jh4kkZJ+AZTmFNCaAZEVIQzUDvAhoKQ9Idj0Dq0sUOcU4NduEuA9TIwaDvVY0ERhDmz4wRrwHyugED3IzkgxR9cyIIbsQNZBj7/pRg6dqiFJvg8RzgUumRKYNUecsRMuzOLdCCLeHQZcOVkRrBVqeQrVbcLs7SLtBFYi9RNu3RHDJBHuTMcE3YEgAQmwUhjKoAePNVOKiBWZAVJ0Wh0/hOKBNWMvKiN0FdTauQrIAVUzIgM7ZIsHOE/nkA4MHVv3JRXY+WNiRFLRPYc0/hSM0UjgaVTrvQ0+agCukiOhrEiZ0Bp41WNzuQDyEBOzWRqT1N3BLlO4hgPCpl21OWRlSFw4jQEyWh4Htg4VTWLcaRWhLR0KRlSDPRBwAYHw/NUM9g5hIgcABiTu8QD6pM8IEUaIjUERlWIRPYGDpBSyiNIt1Rr2ahR3Ihh/2MQB0YJToYYjnbEikIpOUToDFWjBni1jC25UpTmOibwLT8plg7Wg/UIV4JWVmmCaEWJPfwITtGBUq1hSyFkiD0JTlIlJgqoBTkJk5BYbMBgEDbJVi3GkmPwLcOIYVq1kYS5AnPJl5Upkn6VGDYJiza2CARGC0MmXD1gYreIJ61XC6SAXy9gNbonBjmwBvx1k7/1hpuwmjGQmm8II9uFOca1DMjFmoDBXGZJZNCFQ9oVm32lLU7Amzb0ZxoGBRXGlPElnM6FXo7hP5vhm1pomzLAWxumYDWFW5SyjmClBg5VDjhTPvxjAP7jYCjjdT8wA+J5BFaABcpZALpBnQu0YP89QGTNiQxOYJzl4zadQSNpOCfgBGCJIl3shQuqmVy6JT6JUjM6sJs7ACMlFmJJeAYl143iRV7Z+Z4QBKFgQJ18KV9mKXDxWZoWCoushmmiNm+F9m6Khg0yqk2w1nqAJhvomQ0DAX41yn2+pqM5UCfx1jw/yme2kGzhYKODtmbNdmjHkKQBgWkEwUouBQ/oJnnNFkaElm/dxn0NiGzaQ1A7+giscADIw2dwtg+cdzFBapxPRQ66RjEr4WePdmfmtg/2YAzaUkD0VgmoAKYPRgyiwKM7xGjFNmeEmmvC4AqkFoND2qTTsBi30AlJmijok21B2gV4BmnqJmanRqY7YKb/RdodgSpvXqpDFJcOi0ZrRKF3hPAJHpcSlYYQJ4U+ZrF0tQoTJnkIUdarIfFyx3EQNpYWqiqsyrqszNqszvqs0BqtC6EYBucH1ZoHQed1D3GtFqFyeIB03iqt4ooWuMGt27FYX9B2CGGuEhGudjAc7jqu8hoWFyg02RIyoEJCc8QNtZB7/mddw1dvrCcwBEMDgucMCoAukzAsA1hpbLgw/NIwNgoN/Bd287cE0sAS0gcD13KvtzIvouczofJ+LzA6SiQuITuvKmsVLUQ8I4BAX/gYkrg5KYQJbqimCsSTz+GymnKJj4GFDymFL6Q+9ZOIHCmWfxUb7ANkNqYF39Uc/3PIswjURwg0hrtUGYSoMAi0slwrFS0bS8TkRlDjAG9jndVhjlNlnbVYeYcIS0JAkbWEKNeokVnZkGTrCoc0mrJFUF7GU8QJVkqQjkcAjfsYkFbZtYjbFF/bjV2ZgofJlp70VI0LVd/0VzyHHETFSh51VW6gApGZlfHwuHEpBzb0LWvpt88FuEcQloSrlx10uIkbu0ixotapU97pWw9AoZBbSP33ObebmvHwTRn6s6TBYKiRYxxZO5unYCAaYbnbmDOgoL4TXd/lnqirU984nxHqjkBGoPalU6Aju+IrFHrqaaGqCtRmqU0ADeRHp48KD49RQ7zmbWj3YMNGCZxaUv9pAqOjsaTdcqnqFwxckLHehafz6whwmgptWg9z9gx02moK/KvjO8ETN3cUfMEYjBMOl8Ec3MEe/MEgHMIiPMIkXMImfMIonMIqvMIs3MIu/MKymzf5McP3AcM2bMK8mo94sFU+8TsQIXUKIRlYMhbxShp25wcAesM2kcNGVwcJ2yo9wTUr5xhMHCQGMcTgdRtOTKyCQGxtNlMVAXAWDMZ+IINKTBNVXMXXRGgEJxuEMRqZQVBbFUg0QMcPcRom8MYERQaK5RfSUB6S0glksDiecRAEx8fpMwCnGRh3q3u8WFB1CAaE8YaKnD517AYKOMcKSAIKCDyCQhqSAgqtMBv/B/B6wBaDLWJjknG38AE+2eoXxqrHnhGssIwas1EnkjFbiewGlRHL8QA8mZzIByEptex4jUyrZywTaUwmn7QDKyIr0IJCDyBjr/IiQDBbRhB2C6F5lAEwocCRzKC8NNAYtVJjatgeBYUAL9ID2OxS26DLrUwG+fAA8HEeNZfK+8Id0Dwqs1O0TACAg3QGNbdjszUn6mxdKdBZOcBYV7AulxAJ9cw7ifE7AvDNEu22GBJC4hfNGQbQj9EY3+XQO7KPl0LODR1KhEQCpNM/IE0EAm3NFVXRrTDNyazMM8fEzfwGu+E/CzAK1iW8aFDREmwIMoWdn9ZfvaMcGtI3m2TG/8ulHN9MZGZZEImhLESHKG0lkKAbkniiDI/kh6bSGIwVSqNBEXPYXiumHC0SHYTBU0pQO/jTnl49iJ0AirrqQ2yU1P7BRqUJAYj21nVtnWVAG3NS0zGxzHiQ0zGSlbh0SQI9BMGqELqAlTSVAoLhQ8PpFxz12JVMZHYzW4cBxny1HOQZBOTAKWYH1g/2FyVnGzx4C4PxHPCBAHu9s/j4UVl52lPNijyYtiF52VzNRiE0H2GVPN90RX69v4b9EoiNB2tsyDudlc8Dg8JLdh24cnD3SKRDIbU2Ys0BIo4pAE4NPtaNYd6tywRVbGvoPaS91SjtPCit2tpyh2AzmtKDHP/oHbyxtLtKECqKI5bwPQP+fd+ywUBYO8x8TUjNsdZHMODWWUJfsBLLzdw3PXNPLFMSl92mjSq0kFMI8CoLcNcL0QCj4VUhDm0dAsWgtU4FVSu3AuK9QGQVNT1kiy2yEhtT0CrV6ZGl6bmzhUPXm+N9hiFIpWSyIgnDUVCzpSnVU3PwgSF3JCC5ewQzLrHt+eOxUeVILiSK4Km/VSsErgj8QktgPl5Uzi4S+02hAM1UM+Eu0dw77BhtPA6fnD6jka3sMV5cnBCMZcuW3DlcHK6KwR5uk+ef0zmdIA7jlZdu4xqDblbg6ueG3OgDhefNgQ+ogYoDRYCUjnSdQ+njZTr/SUBQbpOtoe7nm75VinXqeewbpDxDvkwar27EckzqUCsO2fE6rfE+bo4ScK4UicoWVcwV+d3rJvHrSTFebjFyZKHsxu7rFf7s0j6vMkzDM3zE057t2r7t3N7t3v7tFyEZgjHukwHu5p5xsE3u485j597uCofsdYCfgpBzWVwRTJAbBgLEzP5D8S4O3BUT8VrEH0EeT4cIe97EgKBzsroMWHwHjvTvZOwQQNyt3rHvMIcHC/8YeFBQ2lwI8D4HSDbvZodNEhExeSB1QDzsfaBz8RXZJxHw2B4R9K6VeqCuKn8HCv8dDf+uANJf6voeO58lVMbMQ53xgIWtm+nx0b7D/9/sC1GGfMoXM2rAL+4kEQZBA7YS9ZdQsTGzGgnSfv6nec+yCOeSfAs7MYKXNBtLIaznCPnQZMhXAly/qNRy9sThK3a6r7dHLuYCA9d3AibLfnz2aqTXrwUb9k6g9xC4Aozn0rDyAhm4K9Ul+OqgWqx3968rM3FggA4YG1SvBgO4eQ3I9bFie15vPtfnWtzhCLDnK79iPN0nM+qxfusLLfWZaE729eAi9gmLQ2WfLoNr+lPQdxYzL4hXeIgPNf2i+XYi+X4HgJ0T43JW98SyPZWcEB9/8U4fgWWYOuRjPwdYEUXd/Se4kizIQt4fSUf4PXAYVEGbPSUohgQlA7bdQ/972V5nLYmUaWB0CAICMAJEARjAMIyEqoxpgABCorJQWhwrwJwGjtLIZ0LVEqdECghALAYwlC1GQt0WNyEgIHK1DgDF0MkF+wSBK8opExjWgAXtBGCWFAI7wDF1xY3QEfkQTr0FdqUQiJEB2D004FypATQ81Kw5sPwcQEoepVyZDQ0wPIiOeJU0Dtk5ziSpLDxCFAhAOMDJBSyKSXV59bC8Dq3+nEBR3nShyg0yjrmOkBXYjrG4bD4ytOidGNCyjZOXq4qYn6eTVKYXorGsuhyDrdvfd5G8F8ULCDAscHBCHr8uInAFCJBgzbFCXtqZSsgg24gCCxK6aFepnot9/wL/8jF4rt2VBgkGiPAIUKBIQijl8NO4Bp6lkwd5+YOQcOFHgQUYNBgg5gqELnp6ieQYU87GgiQLkvASMcBEFQkhfBlHTwUDiRRVgjRYyEhBAw0Urik0ommmLgsDYDWLtiZKSkzTcrpCcNIDry07cnooZyzFtg1Z9KXar4bOuewGr+iqmAhfvwEBXJuHbm9UfJ6PpQOd7im5fZMIbvWsmhxM0z5WFYhEa+/rg8yioivEBOIUEmAaDCEiE7OdoqZjNxA34pIqA6RjOIAwrEVF2SKt4aiib4ABZgJAQTUQ/UC7h7erJ1+roFtJIQbWq1OKo/ta8JNIA8Odf4QDSUm1otNR/2/UHWedF34UMQRNOrSlVltgVBIAJiQw2I540pFAXw2SOBgfPwaYsRh2ujknB4IqKDhCJC2tAGIQi2k3Tjtk7EfdfCECcMAp4rjAnCKUdbbaOqKVQ2Q5TylAwxWuLaaNJALUI6SQrXFCkxcPiNDff5M0gMASQxxAQ0O0/NNWjgyIYAAm0hUA3BOAdHPLGlHMMgkRWPbh3wgINHBLN88NUMBPBvD5JgB4ahnLALT4cEoNBjS6R5c/GHBAACwEOmh5IiQAJgKINkAoCkVdgQCGAfi3CpuURdomDQxUemkbj5BwAIbGCKBjmg9o+U9WbPTqgq4oYOJCoQi4AKpBOh7ALP+rORhQgAJ42WVJKWs8kIAYqOggbVqCwjqKpDR0uGWLQFgaD7mMkvmnHMw6y4irLHKHrqxdfpmjkmspAS+axD7rYrqq/EsEn37aGMOAUgJoj5HjTJuQKEmygYCSclg8hgxFSAgTw6oNoGTG+TxBgwIGhBPAAiecTHLGZkniLXMtW6WyGO9leNECKfQV6Fl9cYwKDAUMcGkyF6Ogc0hP2IzCwn0kNOFFQKe8chdnBVpyjhcpUEDGB1ykpBoB0eBA1E5Ts8O0l1Qt6NqpjAA2f0q23LPLNIAdSyZkB03JWUO0XHUK00qx8ThFA520yoZPvUbbGm/YwGZ70hBHlzCMrPD/IwtcruJZXVuOAAxmS8hG3iLvS0LLGNOAgMoOiIl1EAktcHNv30neQthpU8403zA/svaEMTRQPDqC3+077Coqh3HTJAuCzscNDyn99Ndjf08BSmS/Wrndg4/9w+GTX77556OfvmqifV9OlOrDn0j44+tlPfz3myM6/qWmvr//NPsvgAIcIAHDB0Ct4cNjBcxem+DWPfrhZoESnCAFK2jBC2IwgxrcIPhUtoIPgvCDBeMgCUtowhOiMIUqXOH9EBDCF35wKCycIQ1raMMb4jCHOtwhD3vowx8CMYj4cCEMXyhDISIxiUpcIhN96MEiitB+TZwiFatoxSv6D4LqWIfZ/3wEvvaZo1kMU4ByzMSG55TmfBAMU46GIsbRKFCLFREFGqVUAFGw0R53PF9eEpa9Dr3PHPgpRwGotZo6rkWB9ujjOt4IxrWY45H3eGP55MhBOcpRILY6IvYkeThG4sNSZ1SkGd2hRilegY2EWQdpLDmc7LUjj6wk5R/ZEMjpARIfgyQHAkoBSnsgspT3+GU5VpmOW0LlY55kmCU3iElUFgkdFCvVtBggOqqcIFsJsJoNJlNIhaSglwtI0kLwwICuRGsnDiTHAtBhKccoIAEJoEElAgeD7lBFDGuwiDwxEQ6T+CeeVblCOafggIVgxSgKUQMDhoCzc/YCoukEZ452Ev/H4sGqkFHhwwJ0ggAbAHRP8lyY6BpgTSwohAYdnQHOvomHazZ0Dh69gjatlqRJkQABI+2DyIwhiIWAQacJmEIAqgmOcnpCnUmYzBUIMC0lCOAQZQRpAlKFUgYMJQBBOEtMn7DT9xSNEgDZpkiHmoSQjuEtBVjeE3zKzwT4UwFhJYFEB8DV4BT0TUVdxmTiIDE2KKCaaUoIUiS6JHkGpi+peOuEiopNg7C1lyl8ZiivMYb+LeoR0XAEKYjDJRHoiCuo+ISdchfaddyGOZXYRicidJNmPEIM2iDGn7i3G2Y40A5M0JA8GkEL7FTCmKbthmrjiIkqTKpQj+HXElD2jNT/ZdYagqpIUYYz3DoBV5GdTUiuMvRc7SQgKycCxHNZIQ3M7OAA170GIIMAAwxdhh22XQRseZAj/0S3KImgAy50sQxVOEMQH50vraQBXvHSljH+3U4Rfksq3dKXDexlQe6+w4ZYrKjCHGJkIpDi1D2QYBs/CcN5vQCiEYQLhZTVI1zdUaWlJBIi2SAsYIg3l3fQ2GG+SaRbruIPhrzWAQyYpmZGgpOfBIWTRYOLABzyK48YEscYoUwrA2QY671SKpIZKFS8YJEpD4cAOYbyKHlMpKlUBVYaKjIhtlyYFTxFzBiRsS15vIKfhGRTRBDyNAcwoX2g+SUygkyg9ZyYNKOM/xlsFswnoYIGHwOJx5OQTwTZ4hI2rDKQx6DNYhg9WWjWj8X9a3TAvCM5yJQgJIWokCGPkMAdG2Z4VzZTmOZJBB/1Qs81gE+IU9XkwDz5xcHlxDtCAqE4igA7P3gAe5ZrJqk8DSpMcJNw7pLqJQlbgRqy8JlJOk4lsVlAdc7OeVxtplweShK2Uka1tlRrGtwG0AN6zow2MW+cuGgSUCCyJRpbIlLvQ0tbcrYPLEuqSq/B4HYK8RTOMA5cR7g2T0jOqEm4YnNsr3/TZPCzfjAu9LaJBWQUlC9H0K1p9eG3I1+rjpdzrUNp61D/BgnKHSAGNxmrT2XalKgMcPA81QBNAv/7F02qnfJHOEDlK2O5m+YalXXtiQD9O7GczjEsNS2pXdYyFNXrufSSE4Hq4poXka6OiZ84Yc9PEta/sE4TR8Fh5UPoVlBs6QmcLiAa7SaIza2FM0efaVf07hdWzc5ze9E27TlH2HOS/oiAP+lfq6JQtOpOp8yGuhKXp4Xj+eAv2Y7jYGXq+DHOucKLl8OvCaFb/0bGuq3pzSx8g1oAhjCy0A3tImIgXXDcoSSLdC7dRb0jDNTbuUjIymVN+/vJZOZAwtXtUqvrXT5aqvsv7z4hruCc/q5ARqPF7ef6kBDzU4C88TetTR0L2t95j8DBlK5Wu4McG87PBVUETQ7Ie33/3rpGe4cmB1tFxfxN3DiUXz4gHwvsTE4hjeLszN9dAczkjgOizBS0jOvM3v0pX+2gDRtgn+tRg/TxTPIRD98QDfh5n/kNTdFkDfb5zQSSEgZmVe/QTHx9msOAGg9tz9JgUTERk5AsUw+GmpSchxCaEJ6dXg5uURJ1nxGWQ590T+Y4YTrIjR1x0hRuEK+wEOphYRd64ReCoQ49ERSZghKG4RmiYRqqoQARERmuwBWuoelU3KAt3DqgwfXsUf3ZQTMRkxnyEhzCEipRUjrEUxl10iPQES1JSRqYYRCuw/bIWhxKYhPJEhzV4TEVwfU8x6b5oQq4j5QgACBijz+Uxg9m/0gR1tIr/RELkOI6OOIjouIkyuIGwRRMsYxaXVaXvNNe4QxMOVQ50RNeRFUMGKIWBAAYOM5CYFUz9MLrldRJrdS++NxCdMFF/ItLOZDjcE5V6RXm7BQznkg4QI5QwUBdOAAmnGMEElY4Jd2AZExgUYUISBQ25iIUeBQ+aRUzThQe6EOWoCMmzIlHUZWe7Ek12SJK5WM3VcXLIJVOUVSHxNNJ3IFCEJVi4aMdhMwsaiQHRddmTUOJCUNxNYiDFVh2TQJ89V4f/AF1lI59fVgB0ER+Vd2FbQYNZBhoNRt12EBzUcZ+0cCH2QrL9INPIgiq/AgJaJhowc1r2OSGLQdOBv9DrrSDEyjDS14Xw13Nj2QEUxCYPvyWRyLDE9DChJ1kepGWgwjcDowAHrwkVYqDOG5kXF4QkxyKX6RGJQwbdXzZMTYIpgRK2m0RGGjDkIEbrPmAk23iZryWnPFlUz3bk7kZkFzGNWiZV8TBe9yA+ClFuUhcXpZAjh0DXjYGNXJEjnkXZmKGTlpbSwBedoymF6AanHmMXFCjg7APpEHIawaJXPKmBDFJvkkcla2BZ/ZIcGzlJKybIaYGGLwbkMQkJ+yGInHig/CganrIC4zbmTyAOECbhHHHJhCkZ6UmZ8JIq4VEaA5nEXJEdWLGd9qVdT4mttkInJ0HndEnUaSAZwL/WK9dZ4zoRW8CaAH9JuK1RNMNZ6ttHbL0pSDoHX9CCXX0Hc7RVaxgitaJHVJ6iUh4HcnVmZ6xidlFWjxaXdthghacSUrOQYVe4mkEmdJxKHqupacAidyxgYnqiHHOykyyz4tNQqfoC8jVXaMcl89FC8o5iOsISi9F3q/cgYx2YIBC6f6AoNZg4PLQDPCFVS8ijfpRDeaITHjmH/4lIP4lEt8sGQdahawBjz3xh/ZdWAdGHwvsH00pR+DoDM8ExwJewQlmjRTSoApuTgBkX+3R39/JDEBegfvRVJ6KAvwJDe8wIJlmzKGiQAC2Dt5wzR2hiv74qevMjAhCD6XOQSdG/2mpDlClYMP1NJP3mKKpXpH8uGqsUpAakCDDVGH5+KmsYlED6Wqv+uqvAutGOoc/EGuxFit7BmuyKuuyVtJbENazElZCMeu0Umu1fgwXkgPpROIKkdH1hKIBIqvpiOIi5YWfhdIckqqQIBMyVcy4po8L5GEreoa8FpMEfauMkKslgszH3OH05GElTtJQvOINVo89+ESKsZAoeesV8mGruhgJxGI5ACysmc+63sO9CtBx1kC6bqwr2iscsivHHYki1ivD9OvHxNIcRhKxOewMYas5LONlVYw8yUFEqtTE7IFSiRMM2Cz4tFNBmhTdyFPlyJVWSQQmNN/RTuMakKMqGP/VD6DTKaZU0qCVQnLCMKoAYgEYUmiOL3ZjWtnaP3HjNznKRdYoUJXVSoIg2SJtCgyA1ioUVdLshSkWPQqUyAEqEUTjOwrWTyVExZhM3/6n2PpHXnVB0XBPYJkUO44TYyWNFnCnYrVMXiHLXjXtkqDKSYEtPVUVN06kWUWWT6meCjrdFRgjMl6VPimWMypA0MoUS2FONeXpW7BBXd0VNQytDb1s6HWVzDYVOPQBJ2AVMEjXdZkCKrBWzGJPvDnYWgkveeRCkx2CWEzvKvikeTlCh9gBcBEYWc6B+fHCInzDcuWXjSQvecxXfjRBMpTReKFAedWYIViBiYUv9ioI8Db/1TcMl3a8gZloLFOmm0r60Wk0ZYcSGISZFzDEQhUcr3gk2E7C1kvCxlpG2PXqw9DYwvlCMB5A2IHd2kE8SfSOg/sSQUvK1jfEZPMOR/mSMMex8PPW0O6OQyGBmknUBVowma0IMGPGLw5Lq/hwHGy+BVZoxEoMhD8YsUgEWsdp70Xw5abQmUbZCVmUmWkg4xD/2EgYMUI4RmByhV/Eb0YksVSwbMfZsP2UJkYgmVBoqBz8b3n+BabBsWPq2ZIl1LHFsZMZWUHUwyrYMWT6RRCrARbXMaSpmaI5pzBFEGUMJr/Np1/u8YKWsJXJp53MAxbHsBmu6iNdiKVEIh3EnLnZ/0n8zQ/HMQEpmxFyzEayGUhKLMxzsgG1aayn+YBkCTCKRJqd8SgyypqeqbJ/DqG4OWaBpMeBNFyK2EknO2YLLE1UdcMqtMMbt3Ecyyc0K9AsC4DA7cWKwIZxcALE1RuQHIivsUq02ckp9zJOaLMI7FthKlwdLWfc6NRPGiYk38G/SXK4yTHgoXIm4+A6iMqw+K4+gIuaxBwqBF3Nfp2dZMu2rBMzeWXQwZxDt4OyXEmWSAK+gChNdB5S2h42AymF2cHn5XI+m5wnNLTMbYqy+GglBkvgAUzOGYpF50rhLWNMFvQyj8HX9VxR0Jwb52hnasLa7bM1d6g6LykrkB3UFf+C6NUWD9w0bvSK5HkCiEZ0maQ0KmzKVCfbOdmBC2zes4XES+/ZzSEzpQxMZpVJ1yEoWYfYb+1DVj+0immyEorqQLdp/CGf/1mC9Lhf5ux1uIKMkpzpUAT23z3OyTwO8Myp1rhgRfyM41ig+Vmqer3g5NSfl5Kp3Rz2ZD/OXYcpBZJM4zggy+Sn8Uhq2ZzNf4aY9jnffQWfo75j3haNgvIP5EAg/h0g9C3C/KEK+GWODAYdakNPy/B2XcrpnZaKzhj25xAf7xw3LuMfn4IDDADK+iEg1pDp3ixPYbOfZpNMbb/PBzZgYPtzwSbRDq5oCgkgtR7ACKLP+zRTMKVQRpL/z8C+d11SkQz3EKeqrAnNtbKql8oI9vQo0AGlQ27X0H9/TK420llYzRTxt7VSeIVXa+0Za4bbAMdaeId7uKlGDLSKONdeEb2SQB6qxsQKkInfA3334T3gUw627DAhYjKJDzu7K2tOD4jk+If7OPqwuCLbg4oHUJDPkseSQ8gi5bYeTvewIqo9EI7/MywZ4o9bOfzwrYhGIz3urJ7qQUspFRRyIJoWAdze1L6wLUKyDJ9YjE3Kk9U449yqgRR3wXlSLTdWrjeaFTOaCjX2LFgxxJ37x0H9VT/2wT/mQzTaFVWgaC0+rdkSekJdoDxJQjwlxBHv6U6gAjA6TVhdbhf0//iVi/r1APCKtIPxngKkYHDVXdcl3GhqeldzRKUMqW9YKgN3TUdn0UQotEVyhWdGEBgYXK8EZ8nz9ldWbHCiLaEAG6WHnRtJZp1mtYKt7wwzrIKJuUGBwYL1UFu0UJeC7YKAzc2okzsfwXE0jxkn6DCCbESObQLseAFBrhKR9MQt6OZhhFlBnHFbuNZRX+cS97EI+HAWwycZL/tlxhOsS3MuMwkXL4QeGzwJHNpiUGygPvFgRGYNzHi5czw+CLX/qlpegLIYbERIWI4laOAtc4GR/HIRHsa22UchdPJUMts4gDQavHIEoTJJYLMeE4V7+sfCv0/DnwfES2+G4IhomP+bLJ/b0zRZx0N9J8Ex1dGoWvyDtdHoHdACAiDsmTTLMhIJS8voYXjcvMBKWhd0OyDLqIH0h5KoOIuAXPP8Yw6d/dhoV8HJ4/Eox9FESyNA3S/LrQiMrIjGOOVIJHw0rb39oUd94zPMbHcg4vwfAj2l5ky+CiSbIuGONDnQZwsP/X3N/I3N8mhrB+qwVsDpCCb34hS3KHR2Zxxgz4QXG2jh95Ip4kxppCYPpfaMcZ82oVapycDNCe4Ml0p2zrD+HRS44zM/Gg4s/GCCjiw/ELFW81u/LELhBV1EqLxq9l//94N/+Iv/+JN/+Zv/+aN/+qv/+rN/+7v/+8N//Mv//NP/f/3b//3jf/7r//7zPwgA4kiW5omm6sq27gvH8kzX9o3n+s73/g8M/g6CoqBgNBYMyQKg6AQwD6UCYvBAJUlMpejgGCCcXQFVlBSMkOr1dWAAsIvxefxUCDui8zaJaARAdMc0AiZGZnT2tCXCRmI1ACeXFAdodlIWJfdmwBYFxTngQMXkhHT3JOk39SWQKrDqmvYliWBolFoyWPIgGZdmlgTI91pmcJl21moyJ8S1uab7TH2DcDtioFCtEyC1bTNAME4gQE4uEHCuNu4gOD4AmUAwD15yDoGtjg6AcO69bxy4cwRGKBiXRQoECAEYlDNHzhvEcQymGVioDgIwfIsA/4gj53FcHHUi/EUEEJDAwHMGEYq4yNBhkX8hI0ZDee4WzIbl1MUz5+0iS3VqgIpYQM/hAhHqGohw6A0A0gRKa7L0x2BeAicfxyU4MY8An7DjJpLrSmBAAwLY/DkIGAAtPALeCiy8iYbBAAUMOo5IdyNAGwXTvnmMxw1GQW6SSABOfKPgYxtG2ZQ9os5BKIoADqYl4UAlAId+AYwTNE9NZigHCEBQYyAe0daLL/txSGApzoQPmNCj84Tuk7skHMYxQIBBcG9IEf8VXhNgwdavpcguR1uE7RG4davj7TsBcHHxQkcdQRQ5hN0ieqs/oC6OQ3cHthFd3o+AUwBrb+078P/AON74s19/RIQmnhnJORHaUuQVkNou5GCD1AIF5NHFPJpRcZ8/X+FEBXmCCIAgFA75QoA7V5TwmALxHLBAAA3EMYBeagwQgIUlKBBAAAkZ0EAApDCwQDwIANiGAA8c4F9csY0wQDQCNNCAGg8kmcUDMlqCQCyOPRCjJTHOKEeMFpojBhdBIoajhQU4F6VHOTqBgAGaTTnnYY7FJSQaVKrBZElUFHFNAWbiJQKPPoqAI5kjHPkEMLAFmZBk59Vg1AinMZVbY6adCIFDzoVkXzkmbEogTkWWJxoJ6SWnXVppAhCgAxCIJZVrDZASnF4DFAUdUu68RM8I8/jmTX8sQif/TmYkhWYPp6/Aapqs2NR6qxNIQbDroMnJIuJoBOhy32nbdptocqIh9yF6nSKVLAG86YcTAwo0ABV/8rZHL34AQOuIayFFSdqObBULQLYm3CetCLce0Np+4fpLq7ofkrSnCA3ccsBxyiEgXn3xaNmLHH0dUFEeEGqGkgAIFNglcwscId4T7Qpycl8va4zAAw0UgDIS3I6K4xLrdSyFcrvSikw5umiUR2cje1NR0lLTCpCNyPzr4KgCMHBEzhD39ZhgHkGgwMvu9IZCFgX05YBTBiTEqGxLCXZAAgcUYLalOGQaq7sgmSbjQhO/Q9etsfCzqVEpDVxCQBrFKuBRBMDI/1aZ5Ghk1k/MfoYGdDjNRI5ujn3+NQTzQO7q5nfQlCvmtxjqeuesM8zpAmstRfs4k9u1IMWc0sSw4yneat7ooUeV6cSnoYVNccoVvGnkpjbcWVqhJTQx4DiNW9KowzVkDwIx+p2wJOKwyONrDkRrdssJj/2EN56aL1X0/7LpDgT0N7AqsE0GSogxm/lIorslaccE9jpC+iRREAcsZQG3gID6ChK/PDQgAfbzWlQEEwZGaeaDN0JMAkvzl/a5LAF1YlEAYPSV9bxFEnExTf3+JrpqucsPhAuQi0CXDTE4ZESbWYw/7na9/JyHQyoRSeDWICCHfAUUPvFeppASvQIIzP9hYjEHB/t1uqiIg3QF8ccSceKZ1y0mYHSRohzQUMUchqtg7uJgnKgIunBRJwpMBJY3DjIsgKlDi+IRDiBFADB/BWg/7ArJApDXC9cE4FbbkIkjooA7hiGHAQxYD6OAaMUcmgAwaknUAqiAvocUgQQPSMBIYjGq+JlNEiEkpXM04kkC1u0wIRSSEga4y5Yp4JQ27Mcj2dGMuEFAi1t4mzNNs4X4JWAPtsxYyzy1ChLqqSTHPEErX/kEvogPAg54gAJINoCZFQGVN7QBGH6jqTWqY1WolMibgFiSKbXqHuVAwEKYSE9xxSVIoxMHA5wAj8Y0SBLGydGVUmMOX93Ci4v/u1n2qrSWbQAFeMP6QolCoppNQUUt0lncQaulvn91qkbjcqgAIPqtNIljZhm1Hg9dGiHW5Uovj1SeUQ6wkGv8EydSIIJwgJoPf/pvecZKSyv3RR6I6GItF1yPP9DGlzYUT0NnCAs4DFChO4TyPBj7S1QaIJsstMZmTBmWLvYihwQpRwooSYjZUNaXG8KVUXopgQEuZglOhmg/QAOmnuxS13c8IVHxwJVjRCCePtFVKjlq60vkZxo6ddCagvkrUwzgWQiVEA2MfQLdPLIN0XoCayUg6F9/clK6oq8GaImn4MpCOCjhs1p9PcE5HJUSQK0lOe64zzyWQhAAzCMKB1GA/wPCkoAsmEUim9NRCVjaW6MEaHKfBMkYEfeF4TKguKY6brVAstx0ORe60qVJV3rbOh4+1yt0m1gBFHArCCDRjy8ZLnDXmCkgjcNRFDPUraL7yXgcZCsBa9c8suAA3DTgDAw7B2JMQuGTCA9wZYWjI1hoAAYE4CBMCcAYNpiA/XxYRjUbAAed0kqAtAGAHs5bACzhWBK4OAHOoXGiOKg3w9YoAAgO8YgL4uIecSUB0UJxalHMyMs5AsqYRYCIY7RND8tvx4jZ4AZH6xEOBsAJG5MHi5UE5GlI8CltABmRszBbyMh5znSus53vjOc8cwN/P/CUniEz1z8LetCELrShD/+N6Dvntc/iS/QOwODoSEt60pSutKUvjelMa3rTnO60pz8N6lCL2s48NAQKVaANFkAsBqvVwaprcCkYlNoEhFmsDNLWDAIbpDBAmDUMcF1rg+ivJMOuhq95UABdy0HZJwj2nbVkj1S7INaj/rQ8T3ANzLLAsCbI9q95HT8YeJsGa4wBtSOnGhlMCQUGoHa4f3BtGqxb23G9iZ+fEe8gjCIT50Z3D8rdgqBtgtuuagPAjd3vaiuKe1v6w5juoKUGXCkttyjPGeq0TiLBARuQXkOjJNKGC9spED2jEhXeNOJhQwoLlUVZkcpUw37YyRdQeoSharhKAAmi2NpBwIilwPH/jrZHRll4UZfiAaQ+zXLnOBrWlNDqlxeWpEfOmVnk4jbhN9VcSWGaOjFh1HCsSRxNFf/XxWmUJxRIHSVq+Vn4rjtMs/FK5ly/8dDJxCQvLby/vqS4R8xekjhEnNdep0LeRwWhNcRIAdqadZucYLakcw/aN2/D4JneJ7LLSdk+J2aNfvUXHpvYT1XC2cvlVdnrQjvwLHs81hYlJx3V/UY2qrYJ3AY3uZ0WaSGm1VaY1JpX2HABw/KfJFZ2hGWilgQu6sdmi9mQXzVmxHlYSvN97u/MbQz5ylVD86P/NY/pqWYuAowCvnJvEphqV3bhSrRaCbRbSGZoKPNEcZH5tbBB/0xvooXEeRxYZuEUOYy3ZjXzUnJiNP3wM18jCOIHf8DnNMNXfCLDWnhAVuWhYhaFIx2jHM3XfkVzEbTyM0EjAENDKyYzNvYXfHFQEMTnMAAygrFVAi+DBMpRgmjFSs7BQkwjgMw3NS2TN3vTN7dgcr3nM0BzUPn3NhDjNHEjBadFgwwIMpiQF3tTESgzNnszTexAhMO2L0sDfs2nJSEWf1eDTi/Ue1N4aqImACoEMi00g+fDH6e1RgWRhl2DWRQ0Gh2hfNUEfSEnG0XhDX0Ya32zS5HnK1gWP2umh7+QiN6AQQsAJMe2GIChh4umMXTYTu9TcDZUNiQCDu/mJbUQff/o4W+AgT+NWEBTolVxcEAFIXHqpylWgz8WBEFa4Bzxk2/BNB0fg4ctA0AMVQT/p0KcOIsLdIf8EUC+VnoowQTUBnpSYFEoUQK2uD4gFBc40li8qIzC+InF9IbT0Iw3BkyPQUv8g1mLkX6VKGMOc0FAxTIPtD6eEme21x6uJD9tCF+dQUwYxEN1yBSsqCfxE2I+cw8eRo8BeYiCWEzAZIgDWRQJInwZdFAntQoSORIIcE4RlgLsmDQG2YmzaI6xhH8k5CmiiBgoU3S5eIpRgUvBJBiy1Ib9SG8ACYzs0AijlIsGZ4o6hhiLsTH4eJLpcCdH8BjfdE2jYpOCUXq+FAr/C6NVw2gC0WhYsaZKqhEL6oQJ6viTKFGUSKBNACZOISkY5ShGKQWRC5RlagkYurgFB5Bk0BQICUlwowZXquUEJIMeaoVkusGCUWBEDXGIdNMQpVYzJMOJa4VZ08eQh1mIyDSQbsNd4HQUqXd8k/kv+NgjaHBaxeRcTAE21+WXnsg8cwVO6CMYelkzhqAbBygVKWk6CmmOvdUYiMWJb5NYa5VOl+VYgTlXknUHccKa6GElKhZrCfkEIrZLiFVKckAEYpRacsWbgDl1c9WcQOMR0XCbNkht3mYXJ2d4semVl1WWscWC3Hidz6mQuLJaeolIqcWdLgRZoAVYiVVM65go//dnWUV1chjkVtskGe0yAGvYaRByZjGGj9kgYiRmKHYUZtuwRvmwSzFWEtP4VwBUFwu6GPHDmDd0oQTViVzpe0EBZIGYDVKmJ39FZEg3Vy/HH15IZNYFMs2wAA46W0nmFIb4jee3AKFJAgwmFS/GJsNmNo/RGlEwZAjWoEWmoWXioC4GoSMgocuWAClmNSUApETWI2Ilnsg5GtwjYgjWGUCmnnF1ZmEmIw9aTAkTPedHZBxYBTWKYIYFHyMQY1I3K2tAZQYEZHDGjWP6pt8IpQiqC0sqXbFWgivKKFWKGBQqouoXo5DXBslWpRMGZLNDZcjZI/J3bPaYGHr4A1HAZ/96FmgqAKpCEAWY+HZ4MI3YZjrp9wwOIHSregJrpwIoo0t0Jqs0YHXN0KqeeirACqy4CgRWpmR/1nG3WqpBEKY8t4NVIKYrgImwKgTCiaU8twDRkgKnSq3VYK0xUH/Q2pnCGqzkaq7niq7pqq7ryq7t6q7vCq/xKq/zSq/1aq/3iq/5qq/7yq/96q//CrABK7ADS7AFa7AHi7AJq7ALy7AN6wJvoD4RK7EE6rAVa7EXm2k5IrEbWyOdirEfC7IhS2jvpnYey3fjWmnDJAQHhykJp2480AaBMkqwgSghRrEii7OeRrK1arKj4QmqWml1urI7UJcywLI1sBgyyyJYqQX/4pmzTwtqOwuVK5A3iYINuEYCGtkQ7mCoUqA7ViqNxyoEvaq147WoPMYUY6gAPAI2XgZZRDYQO3IvVQMyHCQVd6AAmPFmL+W2YYa2KMEjkWW2XWtGjCendjWG2XCpP8ZjhasNfIMeVlAnqiMYX+UdNwu1mUtpUutvKjCSViuaciBD8YCbL+UE+HhSowoEAso769Fun2Uaecs3twB/ylUH87mmTDFRX8GeXCMI67E0UmC6tvu6zmgaVKCytkm6c7UYIYSbsetAjuAIMsRIDQkQWbJZ8bNULvgvPKe531tpnBuSKfC5KJCQMvmJiaqlz3AeCYlN2yib2oQjkwSZxLlA/xsEes7UGOX2ie97n10pk3+4njTaI/4oize0M7HYoYfxTKoAvg+MaeJrv7f6IVh7AgkZi86Yvr/6A+3blca4b/LEkC3jhPIDcGaDWFJgK1RAfHmVY58Iwu7wqLBoV+c5h7B7cMGLQZrYThVhnSb6u6M6ihBMxJImwQoprT97BhbMjVEYn/IzTTvHvrnai1m4pkVKQk6Yf7mLEhXnIBdSNa2hG9kqCFdCQliIhf+7QE78glawgMxrAkvjD853IRW0N7PJJvGwfZazCOVUxH/saEdMb+xGKcI2g/pQeIbRGXXAIxmsb22ByE/wJ0yxa4pcazyyFyMROWvCID1CN1UjB/9tAlrgUGtPp1XERsnOR0xYYyQ5QmG55iNR4XOxqCVwAA7wIao6QSUloWLKhSiADMx5JsiC7GkQ8stAIMFFG2rhFkLB7MyCNsw9+2kaCRnOdsHS3Gkwkg1u98zdjGfR7M3hLM4Lq7EcG7E+Os7prM4AC7HmrD6Yu87xLM/zTM/1bM/cUAbBkAbHfM/97M9RK2Y9ItADTb//bNAHHbU9S8xWUAOQAnBHCwQqu0qMMgRnMNHXJQeEl7VrqMwqANEusARogM0+aU2R1q0xMB08V47H6AInPbM3oKIjXQ0hnQLOcdGhegdK6xg0+80K3bM+57Ir4NAHyQ1C62cfTVuIcdP/UNJOKgApWhDUHn0Dj7HULXBvHf1nLv0CKX0CwGSTLd1o5CvTJ+DIgla0a6TVUx0VOv0XTHtn4LwCdnIpTNwPbFu2TlBri1GjHfYMvXrU3VsSxYUjDNZKCaAjbjpmYas3nHRj19CGL3E3UsEQ5oO3PEQYfNMQp/U1NboUKrqD2oAjYZvYLVjZzMe2sCHQcfBIJpZtni2EROaKabZ5DDBRddEjCdoMt+0JZAIkVjC3OuEiA1KlqdUjDJAF59dXKprYL1WKPwq3clDcp6WiLmwY8NEjGpViVlq4w1faBkEV8dAYhW0h2pxsy9YPt7C2hSkIAq2t4m00dmsQp923XAbY//3gDuf32V9LQeqN2fhYtu6w2t6L1lFCVvc1t3Wg2/adrZ59tYwa4I9b4NdwERzkAG0xq+zr0y0wQHS9m1qEvPoZQXHLDQIqYgV8pVUjZXBlkVybnwlTB3CZx+13NeizZkCFbnulC67pI3ywHiXIMqmLXL5r465Cu05Reuv2ub9zAKWHq1FgkHe5TIDB5Ms6AlOenChzI60rNJpRvBSE464pH3SyFMqXflHgSjjuKm7DTlJ+qDZzujZsQzWeS2xFV42x4gljBRWxbtNX5DcMTHdOsqNXu65UvOT4IeLRzGTDYDtokFbe4T3usnRR3Hp8Czszegfo6MbdarbJSFR9vf+s1aG957OQAdcroMzI2aEGzMVC4MHHWJZRwY6e/no2cin+64LKhz76Kz7lSXxScpY3RxJUzRDrWxC63pJrij7ZBKkmnnR2O5SAIel8rSkC3bxT+uxiVOI2QiR78DZQp74cVL5Q0iOvsdl7ABr2gg1+45HfCJDGvgYMAHWHIesY9Qbu0KHQrmVa1palhsUB6b8V4VlaSr/fCO3UDqBN7Vu6tO/pSDgm7inArurthIpGvpKY9epyVuqeG9SobqKqjtQ80Opq+TKguhg+41mSTIbyfjP+q5K6MVstHHVqUAA+E5stEjfDgj6ueYwwf+zKlzDtdJHqFw2T44euBO38nFn/JRBhw+IpRg+dVUDzaJBVNxPu/7IfKBz1f/CGpGm97fSQxcTz7KMcv/Ah6xYGOUom9w6J+S6NfjLI/U7C4LBv5oNrsKdl/Z5jB3/WuWrcvynz65H3nqLD9inxUeHDC8nLp8oNGU++cz1sHG/CVh8ciRHya8pJmrI3ZQY2yVYnBwUf8WDckbJmb1JAPmqHyuEEYgyVVyL5oYeES64isxXFgZK0uTG1lgjenY36di5d2uAm/eMJPOIRS8GA5vf7TBENw3Qh7vBSWD78ydlOzj83rB83BqAT6zH7FbTbo6LFYEP9vcwrS+M3SxPa3+g/CPUFts8F168nm19mQHULNYr4/1Ju77Hm/v7B7yOMN2JjMiDAFMCTHKQhBAAQCIAKKEtROMAwsARgMMAoYGAReawcC0FAsALMwUJGs+F0gMZNCUAEaggfMIZjWJENxAjA+BHb7jc8HnfJifS6LKAfyphthN/KFpPCkOBAwIMgHmMjjh+gHdHCzc6CE8vBJWQAJZNmgELN5UEkSVTTUSILA19bocElTZtBg+1LQUPiioECUYFCQMNDC1HrW2GPbwHiQBriQySoKICD3o2BMIIvguxJL4t1wI1Ym7hD7lAts97Cty9LbKeB/FRwwxCwMHGtp1vwAFiy0rB4oMsKr2ULGiBSxiKZIh2LjrXRh28QAFB+rv+MEAAvUjJwBRY2bKPxoSuUDmUMEXCLyIBKJHSJAsdy5TmMxXCsEuJmkakDEOwcTJPTVK5dSfbxfGDzQJckTGo1YEHJEdZGd+pszer1K1hGBRIQfFNARJGwamEsWgu2nNu4cQZsdIRELl5HBk4osNIIbl44e2X4DWw4790WLw47OluWMZyucxZDrgx2m5wHMndafjOAcmfPoEN/revIFOm8KgIUZvQ59erWqWe/aUAwGe02mnM3GR3ZN+/gwocTL278OPLkypczGifgOfTozxMAZ279Ovbs2rdz7649mJ7w4sWn9JrY+5vndYyAPf8WJlj2vdG7VZ9VstrFgFOPJUb//z+A1rkHoH1xyGeebF6xlyAjB+IX4F/VyfFgfCzsx18CEGq4YWcJBJAAPDAJw4BpBnhognYgJUCGGwQEQ5YMHkalAAJnFKBHAkPk4FE8qPTYQAJV4ZBAAjooEcpOChBpJJHwnAiPix8G8QICTbpRQgKzIODAAiHGqMcICijQwDHbkOmHkglMdeJUfXWhBwP+xcNmDx4ycAIRSrIIUjAMuBRkE4jASEeVILqxZZcxqllnAHceqUAMN344RKG82HlCKI2OYCKYMe5JZFtHmMYhqaWGlUaObQQEBARlQZAPntjtmGEPLY6wahoK3KCHAAc08MIBPyABwQlXESEAjDlm/9PEEOzx4ICQ9AiyABOoNnurLy4sCwC1baAV0xhOVfTQrkwgi0MUBbTqgBV3pqEuDBA4IMCqtf7CAryrFBDrubUigUkJI6RKwAmrajttXQPEaQC7rEBFzL4AGBHDrxn9QMCmLUB8AsEy3IBWN/1eay8tPpp6MsqNIBIABKDdtdWF1+VwFkOx7mDhCoo0KtFiBITHAxIzo3WsIC7chYSzisHEAJw6rNyyxDgrpnDTREs9oM4s3gE0QirI2PJIevAghgAMUFJW2AE8ywCNFTFQcxVKi0HHxCsYzfTOqiL0tQAOsO1H3RL/fEWRL/jddtRVCAABjl28PcAJQL72RqgpW/9+eTVCdnVXqhbSyt1dHrGR1kw+3MrzDmUhIVQ3bszdNzzgJr3KEV5CO58RBk3tJREmWliVe6bHTQe8nGcj5xWVjL1IAQaZjMXNGVVpmujDv/B64robzTtMCCEv/aKBY+wGw8SCz4QRs6anABvl25wK5vFbfnvZLkdRthtxwlAeczkYMNVQ2kCwXHxBBFBBnRRqcIO7LKBjbXhdsA4QQQAQawQ84IIXgvUCA2imKvWT2AEIqBgN9gB5fhJh8AzImhY8IQpQgMEPSnACp0BPC2J4gOGExIIaPityMvlfD4byr+sV7QUDPMMI/VRCvRUERU5xgA8pGMIYzECBOKhBK6D/mLzEISEBNygFEA0gRCwagg82kR8aTQUQ3CTBG26YxmOYAwiLlKcTmNhCJxxACFccBRI67B08kuGSipFghYLgwjB6IIshrNEQm1BJPVJyEp38IY9MEAZrbtUOPBkkFDXQhSJWUg+0gTJnB6nIPSi1x5UkgwCPvEkk/7CRToqik1aIiE1yIg5i2BJ+kbDIA+hYDT34xyfcklAak6nMZXIFmRvaHIOYcyCUbYuZ1rwmNjNispSxkZLaqZyp0pHNcZKznOY8JzrTqc51srOd7nwnPOMpz3nS85rgGQ8+jVnPffKzn/68z7ykI1Dq/IV/cSlQaBg2ToR+BaGlMAxD3YKA//fFIaKMmKhyohkYjMYFAZBDJ0fxENLZUKgNJSUCiBbwObwMSKSjckSqEjNNuZiipTw444ScaReNWs0zhYmZI2JQU5565aTd+4pRVwLUufB0ETM9TFJds4BeKQenuYlqVA2T1KSiajGDMUkpnHEAuhDBo7Hy6AKsQC8/SPAAe2GXHxYw1Y6Q9aJl8MtN8eRWGIxVTmaNx47KOgBiyFUA+5IgHwpwvS1Q5wCGjYfNDEBXdIDVQhYa60bQqta6SvCvBRjCAeB6BLo4gy0WqqtgRhDCjIRwCIVlBmnf91ZyTO4BOcDT9W4ErMV4lDKadR0MRtBbfDnAAQRdjAQzEZNSNP/2s6ddzGfpNZrkzrYsByCAAJqFWcGOJrqTQ+4JOivWuiaiuMeqq2S/KtgTjGVetAgtbaFb3E3pFbQxGYF3JTvf07I1rCeoElU9OirpZgKx7zUvgUlwW8salg6OBQK78GQD4+oUqjrNqhr4sEJVqcm4kCIoa0rwAoaowEi/EtOQQBQNAaS1BawpxYm5R7lnTPU5F0RFtwjwmQQQI8QEdQAOCVpYSOkBcv5jQ42iprDPdEsNNnOBiM171MS5CFkj/swKa+QRXwygwyuIwYpb3GXNZEioMY6Drq7gi2HEoMhj9fJPhkGSB6AFUnS24B60BQEmpFUFxCDxhouwhz4nYiz/CKCzEUfbgzhtY8nPWcEAfsUQGA52aIreR4uPpWP0ffgFhEZe2SptQUV3eUsgsnILfpUoLaP4Q3cMlIiDlekmyJkhdz4LIETAJas44HhVojSdFfCAFrOay3B29Aw84jJJO81KRBm2ressgDsLTgh6RoMTZGhoRPNmqxXOXO/ed5f0QY5Www6WouNkY3T1jkuQbhcOBfDUNnyuGTnggbpq0KrsNeAA5kYFvV48urjFDcSJJluGQmnSvvXbp9EjN7rjpm55E3x58XA3wXMUg4k/1SC5yJAIYnA0KziIiPNpnsKMiKdELEqDfQtAxN3TMZdbo3VKIze3NkK2FaDlLKZV/9pR6QCYpFWB5m3BHs7HfWlcDIXjLHzjv4FuB5MrBjN9yLdj+mxl7G083ly7mRgYEseeC2ubcisiEGyrRAeynAlaZjFdUIHhvHi7EVWKIxO5iGWciQFpOQiaFRaimXfv4O9EXYRMHxITKPFdECoYC6QInXckdCPiFmcBdRK5cGYkAALIU7re+64DHf+94qYVvDUI7oIYkL6lQCBRN3wn8rtGb+o/1xYD5kVQ9rDM8WTIAQJE3yIL/Z60XdO71HeeuKhhL+hUJ13oi18XpJOa5Eu/WesR2NM2j0boRRx5zlvXib87Fu2sN7zpxaCJNdgsaQPyfm98oPtEN4Fxqvg7vf+Of9UL6/Tu73UD6M1MAG1DzOmAEgGB6ZnWXRwg3v3ElCVOsNxJ9DiAKAwgkY2WULwL+FFQmjEfUDQK5TxWIeWdEUAcGyABA6bfCgTOXbTKxkGXhTxGkDRPA/jC7Cna8s3H67wM/WmMXGXEvgFBAQ4fEL6LzdGNomWaYjneCqSKv92ey6DO0JHObQVhWVBf3AQg6vhOCkoGvGxBtnQf1UGZkCwAP3iIa/nFEuogz8Gg0olBrhSGE2bI+41h/uGOHQxbFHDBLxzhtwVG3dWBAbhIYLVAa2ghTyhJsdTgCvmAmNBh4DHil5EBPbCNkjBCwxHc8jWAj7iSIiaiCUCeSjn/DWsIQagZwF0oQBDiGwQMFgvsWQhaQ6mZRCs2QAkmISPqgCNe4huuwEKAxxg0g2ntYoYIhWcIieeZ1imCnu29jg9E2tpN3VjsIRn84C8GWu0hQDXSAIiwj6dxYpFkRDfSQCviUM4UCY9BIRPBn0ldBc5pIxSYDPYsxCgm4L+wRjoSo9SJyCdKBjvSQSdcAkoJwjR2WQqYHy9YIiTejLoMFicqTEqUwJhpYjMW0TOSSQ+6wDRyC2tgAeR5Y7fxHx4oFnTgiXoVmGWxViaAxl4kl4WA17Gk10oeS4WxGEqmpNQRDGg8GL70iks6Vho8mEs6V0oqFn5ZWu+oFlW90WLB/8BNtiS/wKRTEmV2OZcELSVRwgBvcU/E9AB+8YFQ4hb5fGU8KOVndURShgF+ZVe4ueSxVARbxqBkXZZbxqVREqVR4osZWdc3kKXrnIBUKlZ5EOVc8lVyuSRM7oUIvmRZwgFPeuVYAsFexoMkRdZjEaZfauVNQtdjpUAc5aVKRiZmZoRhzSVlzGVeOha/nGVINscfPtNLSQ30zYbr0Yc7/BNu5iYeBCIaKZYcuKVT5kZh6iZxFqep8KZxJqdyLqcyuVo+iQfUhIVFachDFYcNEBV9jBRvVCeHTOfJaCdz6oVAjedifkVtBshSpcY4fI9xoAZYdEV6ws9BgVNeWFVlnP9nqcxd4lnGUMHBTcnYT7ymhtjWR+mNR8WRR7Enc1wn1SWYV5Wld8lXgdILZY1Vgf7Cfl1XXF6WK/5VRtSVCA7GWFVoWO0Lag1XD8DXCLxWiroBg4bmYpTXDQimclHWh0KRhlamW4UWZxnYiHZEF1BGeVIofUkZDEyOeP1Xc3kUZUUocRXohPklarLLC9xWYoFGfkXpc4XBsQgXki5YReyXUw7pffGVKybB5KDi5DgYsICpw93MV+1Vr5zpFqTpZ7lVIdYpYc1VW12pUwIYUEIWLUxWA5KKnSHlmBmXGwyZgPKGF+mOyDEbAKRKMrogGdxatplAlEERo3kJrmmjYm3/mgB9GLWkHrLY1gogUYb5Gh122KkJGZb1mJxJxIsZohs8KvBYX6qxmAKAQg8kwq/5QDRAiqjCRJOEWbOBCKualgRGXBP1za6oGpdJaqmlnqMxzMsBmwjcyKGFIuyFHNrhatEhmTxeKtsMm9NIqvkY46cFy7C6Ta7hmT5tqsTsGGHFajUE2Qtcm7tanWfUGMXZXI7ZK7fgq6ttib5yy1QR2YsdWRJUBdCQAYv5gQROHb1eDsodIA52jsV4RzJKDdl5jB4+4eu8XVpBi0lSxB8EEvq8Ac5FjRli3gGEUgxoHXVoodGdnSaeJAXJCegRz1DU7GdYWZPVHkz4CMMI5AsV/+x0PBoO+EJfmEMmKg28hGwvEkFYXZ4LmCxdsCz2fOzwEANB9RT8hWzU3pafvJwP8I/VtY0DEQHKko5B5OyRGlIJTIXKwoG9DQAr6tuozUTOvlrAQc7AgZ/BeaDnjODCxS3myB+qTRnM0Kd1uIT9sV5ajGwi2OD3scaOcF4ycoGOTd7ouSwO8sAd0MGddMv43ZYWhhrw6ex5Ui7hJc7WmNbqQk5XTBMDDYO1IkRa3VaktEoQ4kuXJWPtup/1icH0UNwOcu5njBzXNYD9IYEi+M4DIeTy8QC63YnrkhXoFgb4TZPnEkPddC8anFqL9V5ZqQ2D7GdfUGD0qID5Ui367v/dlFGeO7DB5U2qS3yPRhavgpIKD+bd8GYgvmhHV8XAHAIBoIwJMZQs86SBIryLfOgOt5Av6ZpeB6IFl7DBrMFW9FThu8CuX+zVuPDvz25QmfmiGiphDpbu1QSeGoqBLLhoQdiNCk8qaC0k4gKd1goAH+KLBZsh9nTVAr6abMLfAqtZVRgwEFCwbpQhBtvwCBoBBTrxGobtD0Kxb+YdBLLfBPaqFeps0VnhBkJAB+4vFwxcb0iw5G7IRWpsMGIjTyCCQSmHQq6hRKZjC2DD+MxjRxYXPhZQpG1TQArCNL2s9oLIhhVA6DJwWuUIIsLjD8LfKXLLZqjBI+5LLRpBkaX/Y6RkiUH6m5hEQR7l3TXObkFqnCAM4vvI4qJ8Mi+hIzEoXUNGQ5HYojpeQqTtilwJAttgpCYrCQhXAxurI5jRckFgVxJs40Ua8i8bbTgMssR0CYpQMjfOQDhqZJY8MwwcyH5eQSda839tI/1qMyna8TJagSqmASueKSwGKCzHJqkA5XCy1lIyZaEqh33g5WKuVnCOJmnqFVZuKC24gm9IpZBGVll4JozeJI1CJlHyJFIy5kx6VaD+XA8s5obmc2juj1Vapl9eiGo2AQ4RBGgiZk9uymIJdElT5i+UZhrYh0sOyGj68xXC5ZUaFD285Ru8tE7qdE+2lUQbVkR3Mdby/4vt7cBjhsFkhgFRk2ZQAouEIfRKv14czeVLhydXq4UmuIWSYCdjIKd1OEZ3zJtlwAVahwZ+drVbE4dB50aF3XNZ3/HkBgdwNmpg0PVb97Vf/zVgG6d3RohJ0LN5QAh3IrZhlwZFVZReyw94rkViB7bltLVGe/Flr8WBxCdnDAdny4F7xoV9TohsqkxTIVN/ksrcNVNgfDZlV9VIbxeaZtpaFZhngZZoVcGB/lxtx8GLqjQIuWJE/2iNShB2VeaByraWxmk+RNhp2Si+MCmQslZy15WWfuhHsSjWLheE2eic+sGLAiqP9tdf5ejjCSl9vdE3qOhPaIZMJNhrAd+FCv8WMYz3kyJXmdYpPV/nemfCEBAobvVVncoWoYLVbp8lLogp8Yjpd3MXbqFW/oWKmuL3fCtYhb92aLBjlREUoJnYlg3JlnxZzgSfmPGYoprZh8OBuIKejp2qry6rsG6DvKEWiHuYlX2qruEYOmTqzFKHkfbAvJgqpLlqp+H4vnSqi11ojIvCt1pQp00qkAGPxCJrjX/Zpm1ceLEBHf/LrMYZr+KApLpZtYYKo1K5uC5rskEKHHCrDPmABB3DoTo5spRqqECZj29GopYZA3iIkStGn2/4lZXYFpwZtHhEqACZlfUr78Q5hpMU1ZlgunmdCl6c0loBK6uBpMMB2LJ4QXj/EAs3bdG+sD127UOgQas4Btcy7ht5lMVpYdsWkCu4R9G+OvKBbTkk7ezeogJCrRXw7BBlNtCqwVESHDN2LC1gHNjarEuUVhxwLWPdUcbSX7ErhqpPmcbBCK1vLcvq3RA6nQTux+Cu7Zqr3WM3OlI9+mgJX/ZNOurN7uqtIPrBgewmYOC02e/iLmjorq7GOxJQS+vsrWEB8B+oCfPm+miB3/dSpNSFr6LNOw3zrsEnTvDmmxz8OmAcb1psoHzARbvDgPTazb1L0AKAsWc4b4xGS+6hmiIH6Pjm3bvj4BAxvOIcwuihX+D8Qv3i0SPHQ8qPrbl3hoZj4AkaoBsm7wrG//ArrmEKBtcJ36yuWrHmFuwvuLC+h7BDWsUZ+kQQP/ENLxzYRXwODHEw4cvXtYESij3yJTAiIz2VyWYN+zcASmGd5/ACazwtQrFpddUHx2GLru+9cAEmDPDKb17XT5kLCgLakyHWc/vQqwEMfvvR0Tze4+Bq//xlMPLax8016qJCsrskzrEOxIA+GqO3bLJQRFoJknPei3KOkPIMtICxwPDwRDPmLQIvY8E8DzzqK+C+S0Q0e/MlZ8I4wr5AIl8e33IqJ2AeiYErT0ImW3yd4+MsT+Q6S3MzCEHyHz/r9wNEZtiiBrLpBEslQqO06+rU5f7SCGM5HPJ8sD/y/WI46v9jlURaW4hikXhz75CBMFt+Z4CAYRQGAAjmcZiGupoCCqgwQMJjqQrvDcsIhWl4ks1QMp5REBgaBIWhoAR7pV4yGkBE1KZ4X6sTadNhryyqbTo8GKVqbm2GNRagpxx9fjr4mEQMUV0rI2VEW26Da4tueyeIR4NTf29Pg5czCZFHhS8HOlCGWWdEhm5iAAMDYIdOcZhqpCwHCg5SRqA+Q3cua2ptooucxMXGx8jJysvMzc7P0NHRC6nNCgkD0trb3N3QAbkL3uPNCAjkz6voCwoKAcPo8fLz9PX299ps+Pv8+f3/ANGQu/MmoMGDCBMqXMiwocOHECNKnEixIotbFjP/atzIsaPHjyCbLTgXsqTJkyhTqpQmYACCKAdcmiDRMsuqFwhYDckJxpCPAg4GrKCp00TOBzBkIiqwaaXTp1CjSoWIIIEABw4EJHgwoIkABgMeCDrA4EEQAAtYBUAaQG02cCeaFAiA4EECN2DFRlmwQIACAQga+BWC6O/Uw4gTK178jIGVBUgB3AUEAJwBBlTIxnAQgKwJdXABBY6RljI4z0PKxiAQiSvj17Bjy17JegjcyjGa4AaAIAABVmBXIaAMGkmTrqtYmc5N5HfySC1nS59OvXpDBjIK2DIhaPmgAgQOQPiOunhc3rrX6D49fib2mTPUPMBovb79+/i52R2w/8DBgQTuZLPcZQM0IA4CYPGFVgPXZFOVO7ot0FYDWa2HAnIBiMBAO5t0NcQCwOQn4ogkktiLFD1Q4ZM+vzgRUzZb6BGGK4ZIgksKmaVX4o489ugjMurMw1RBPxZp5JH3eREPKEg26eSTUEYp5ZQa5ZTclVgKReWWXHYpVQBpZYnle16WaeaZHN1mjJrFcLZWSAqIE8MQMJKjxZyRZLNLMQhUI5ERdR5DpBQ6xjOoR5Qp0yckJtS2zJ7SOGoCXIvaSdIzShKizAGXWsQmMZ9y4kABBWD20QG6BQmApN4EiSciAhbKSaUWORqoMawSkag8uX60KzKLOtqrMb9Gwyqlfv9qw2k0qsJ6azHLahRqJNMS45gJCnTKWwIJ6HZNAueAiC0UAQSQQAkIOMAOAN9qK01fn9XJmgMkpVtZVwlEYVcCC0RxTblRGNDtXQwwkKE5frEgThMLQECXuOy+ocAI5ZZlSrfXtosWFYZpnO66GvNGmBN88WvCwEIgQEAAQnjL7TkGLNBAAg3wtvLIM5TbrQ0LcBuZxgIHcO1O7jBwSwE9b2Uzy0S0I7QAM9esCrfZ0GvULVUBiIgB5WbIm7o4XwOWyA0wQBLQA58DCNfy3RJddBOrzDQBRevLbb+VGRWuw522U3YJ2TbwUtKR9eybCQ50CwEKE1dW9wnd0gUr1ZP/PuA1CylzW2jQd1VlbgkFHzww6AaL0DW6Rd9igBBzmRtZRNUSETsRCNKXLSIEBAxAUNzFxPp4gs3AgCplGcA7AENv0xTxXbN2GXclhKeKEIKocjS2t0BQQgEvxltAewpkwxpl6s4AASLgDEAYMG9yf7xj6tsw3vsxFU+/yIhoFUX7J0c/xLwwcoz+JOM/RDQAKYDgXal2F0BUIYV7ROCP/Bhog+GtilrnsEsUzsW1ST2hKVbpIFo6FTyoEe8BsmhKCST4PaA08DvnY8L3OiUwtHToFnAR1gq2U70B3KI26iiW5LRSmdMocHgOIIzzmgKXHO4we1Folgi9Rjc8wKAJ/7nbAiK0ZwM/mOABNQvSIMCoChiVMIzi+N55KMSCicxuUoeKxFziODOdmKtcixPP7oSwsnKxJkh3DMDiupEeVdUGHJSpDRMoAwjLCU0tEYSROvoDgPaMTzelKkCzcPOV/gzDARs6RyDzeL4kViZyiwMkKg9FnGx0RZAoENYp8cic3eRKkU24DThGeZVQOqtRu7EltYwDxyCpAzM1HIDBHtmc/5VxKQxogJYAyYRVIs2PkANXJM7HMiaUIIfOLCMjsRiv86BPBqzRpQx2ic5n7gac4kxVoIwpPug0oY5v2JUBGnBHd+6zn0GSZUDPM6yHvDGYydjk1hwAAQciYiR3Wf/VMAD5Om8UUl5GMRBJagPGGp6gAZeJIiuW5051kOUB4rhgovqTPDjaAIwpbUNVelPREUb0TXSCEU6J5S2sSA2eF9ypOYEaTkAc0INCncFMIwnMo1amgLIjJm5MaT3esOMc8eNEeyrpzvwpYHhBOpdQ2ahSCBgoEtJ0wOosCFQgDsCjJnSrOaM6wds4NUO3+aNOUQDPVbSSCFT14QXzpxvjNVQKJOUiIIKk2OPAaKvnGyggsliRg77RAOfQDLa0NQBSYcYuK0DhCQyGrX4BxZ2gBYBouXHRcCLPgqvyg+CQBwXBhRRV2bDYFMqnSZ2SyXnDgwkBYmobATwABQ6QGuL/VkCh1Ir2K7pxrgGCJN0tEBdy3HNMckeLgoZGgTXSXU4lvTgENnooMHcYnnT9AwCylvOC6P2KCbxL1+WQRQXXKlX1NGuAiqZFFeLYJGa3EFk5qTeiKGSjys4DJkQg4LAB+Gl3vShX7BRgtpjB7RaCKzusLgwIDUjv7momAOBml6+xLKf2Lhyo+953sLo6jmeBoVsDrNgdu0vjjZvA2/9KULIME8IB2BKihVg2jjNxh1PZpS03RQaMLBtE8BBXLqxdCsoKgAez6nWp9FCyURIiyQHCbBQwWW3MUb4mp0iCUtt8BqemKowIJIS3IUAZRliWshHybA478zPLXYVBNKcc/6DGWe4tX/wzCQhj6LYQAWmCI0xvqJHoKN/ZwSTRzaRfcOimlWB12CoB1KZcVYWBCRiabEsU+vxoJa+wXJRWraIvvJYmgPrCnRoz4s5Wgk5rOrNkjkt/SNKVikZY1exSw6bfbLkvtqVxjfv1Fgz0X101YMqyArWTEYHmLHMt0jzrzLfPouZUd5Y3md4C67oirss55MiIYYqWeVE9YPajWAfpDGHRFGhpIbkbUJgjmuCNmLMQYz6y+0dRFuIuUKOJ1RxpXD22PfB/I5TfGM+4xgECJjGNyeIbD7nIR+4MK3n8SslK6LM68qqVj+NOg9JTkSNBq4oAShlEetVAZk4MI/8UVFnumgikIpEpZNSo5slgTbTIgfQmKbQjhqyHq2I+Vz6l/CG2UkaudD4OfBNDlksK+p9k9Utm3Kbpx1C62LWBdhKhDFYRNtvWBnZ1hUTdal+7l7kCFjl/BSYIfd8C3UOH2eGsb2Fo4RvEDDOEibXOYjvRHLZetrFxte5cXwMZ5fFnipKl9O1ya9nktRmzqC0NZ30W262yVrN94c1p78kaw/jGOZjJjGanv+DiJVY0qOF+atjYXb3UmrLUIS5yPHf9HQ6/La1VxnKr+/vl0TU6G+gMpbTHmBgIz7VyobpiKITAziZWen715j2Nc7jzcEY7sLGL8kiLnLpDneznZyj/aO94/9iqMwjM0+l3w8BFEDQRytQ8GwY9sTU9yLNqC3Mag7AdAtg9ZdRC7FJP5CMOehRVWQUMWVQC9BM/LRQ8nqFMKHQ/BodY+/NA/QNjANQ7A4R5ueJXKmQK1QM6UYRDGVQzHWhOMIRdBMSCOWY+6JNB+UJAU/RBJ8McLHQ+HlUtPTQq4PNWEXIOVdQ6PCCCHCZr7YURT7AeDyQGQXJGEbQ+wYRIRahNZBQaunFJxECCxtNAVMWG7xRLf5FJVkVEWlQdrzRIOeVSV6QRUcdJa3hFAuAw/XQbjgQWu0JPaAFFKoVJgrBJiMQAnkQE+DRLsKRHptRHh6NKtNRz8qQK/58oS7wkXjHYWdGkJX34hwxGTJdIGdd0OKboTJkkiVKVPpKUWyKwCYsFI3rlh/t2HpQ0HgXITI6SVwb4TzsjKeTjS0wFhFJAiaNShrWkhruRSFX3jLyUV0OFYoNViDrzDqlYd4qxXRcXVikEiBjFGxplb2CEh8W1YSIFjyWVDSeVUnLYiC21GwUAUwvVUEkFUStAWe+VVJxAGbZgjm31fDHmUqcIA181hk7QFCZkjVvAUG6gG2Qlhwupj6lgkeAQWFhzVecxUNTECXBVM/eogM3khwRZSaKGRYuQKJyiTasIWUvhj+okXoBgkflYdkLFjeIFT/QIkbAlHdv1FW8gQf/yFQgIxHMMEYiv9T+ydQ4JcAvLAhe35Wg1xluA9FsHKFzXhRvHNWIRNGPVBV2lRSq3QF0I9mnXpT/3lZTvQV/g9ZbiRV85NWA21gWHdQsWNlvW2FmloiE2oGAcOWHflQLDNUzd6GL5VTBR0IvAdFvvETOIEJiZ9h78hRTHKANxwpYwqR1BNgMoFFzs5V5BiDSuRFxluV2Csz/VSEyehGOPOCkThWdvmZRK1x3vAVRXqVR8eT7VUWjAgAB0lgrdNm8NAXFeRh/DJTk2oGRIIXGTdmYSkmVqxmptNinMhoByFjNg8knl8mSKZgKk5iZW5mdR1m9fcW2g+Wy95mjRpWj/DtdogWIOpAlS+cNPWBls6ScEFFdstNZs9zmfiAaenjZ/9TdqgMKFKZNuqtUWVtFvaHZlMSWe7dZ4aqCeWxBh5MZur/YAl/ZoEuIHyDEMGhow15ZsBzp/B3BtBmdrQvArEJdnorhguyOf9Zce+/kA+wmVJLcPdmhvAeF1AaFvDTkbSEoOSEEW+0OO06EUzfBzQ5oRCOdmBrFwCtFw7PcaXEoPEsKfvLEja3cMZHelarqmbNqmbvqmcBqn+REs2bgPjjIX6DB0RCd2IEcsUkAnzfAHaQoNwyKoBrF0a4ICi5I1rUMv5KgONdIMXPdyWBUoTXoZUiqnE0GnTUoPjmIv/+TQqUr1ddoAdqogqbohqswwLON0qGcaj4vSHlTVdkx1UAfZp5hSqUtaDAIwlppqD7KHbt5pf1SFmfjnL/4jGtUXBEKDEd/iINzCfp6DecxqNCZgOMcYMKeTeWEjfTpDfTvTMHSxOl1Re/NXrVhzM5wHWMgneAATeqGXN+UnNYnjfUQgrsNBM79Xa/11N8jKoIazho/zIXyjFabXfOw3fRf2aSE2ragjNNWqopmzM+wKS8kWeoQHbVTzoqtgYxTLAttKrjqSer13sG2xd6rlr/oHrTsDal1RNmpja4GHPpn6q92wgwO1Kn8hHv6SWwwoTIAwRmg0QeZoOtfaKUILYP9Eq0QpIDVi6IaycxpYKFFaxEgQkBU9uFg6ZqQnyAJMhALVg5zQqFJnuIvAaE4vGD11+ITXyGNMm4DbQSgwULYiNBKWiAKe8RWalbQsJD1x+4c7OJEu1Vd7VbTiZR53+1EncLVL+RZEuEHRswLx84R4GD26s1gACAhhO5Z4Z7P3cIk56yjDeAeGuDPgtDb8tDMDpSbFuH8skLqOBUzcqAqRIVDPgozY9IqpikkSIouxO1g/R03g2E+mmpgnKbfd+I2727bBVBtyhbzL0bqBwom1wVAkoYy/+7x/eImr2EQp5k7shLxwgbiu9ZPlBJLfu0i7WyrSxFzYQEzCCw6lKyv/0eG5+GBYEui8bVAWckJSQNsEjeVO6fQ6WbVNMSnAzXsyQ4CTCpVX8IC/rbqFwESZwGsMwuu/xduNx8uKsyh4MFAz1ji72ou2FlLAuAMPoIQRAZyzzUIZ+Nu93vi8u/Q6h/sWBYGTxWIeHdxRFCk1fmFBEPy757JI/ps/Lme/5ECYmBEYNmOklUEmwZmVKQYIO4bAvUEqfXKZFVXFA8WbDIoWrdlvwRSap6XEhnkHGpmuJemL8+VFmEmDJyYZWHkO9GWX3WiZlhBcHUxbuNaIpGmWJWZvUqTHFtKZTWNabkMw3TUCOMbClipjhekEY/Gb30tNV1wAWZxeF5INsXmv/2GcwzacvOHRx5o5nKowY1o7WucRxedwgg5QU0gcDxQnIc2WN3YWUz/ao/M3bhE6rL1xVBoKDLwsrLZcbAyjBua2au4icTsaALcwoGvhcAVKo8QcXY6mUIdWobncab7GoPhZoREUzYz2TW0QbDEKbjl6SHoDdyg0ztZ1aoigngs7bSQAor1syxA3fxRnZzwabetcf7+MFJyhPugCMy3KCyn6xTtxDgFKf9EpZmQWpM2MFKCGnGBSCKxDnetahLFsJEUMEUpKBE9ab9Iw0sypLPM5clYqD8fT0T8ygBQRdGMqpMsw0/IQo+M5coM6D/t00i7900Ad1EI91ERd1EZ91P9IndRKvdRM3dRO/dRQHdVSPdVUXdVWfdVYndVavdVc3dVe/dVgHdZiLRuoUAwE4dMa4QY0vQWtIA9PsNb7oNbKwBVwzQsxMAwxULPbcNbykNfJ4Aa4agOCVRIHQB/A4ie0Sg+J7RADQACOTQAl9tiOzQSSHUsEcA7f8xvQsTIf8ti+qgCSTYWS0tiP/RaVXRmP7X87QQA1Ax4WBAHSU0msbRuQLRmXvSqSvRS+4diY4dgroDI1cxmejdqAItmW+tgQgDek7dgb9tjYIdmT7RtIwNnLDQGEUd304QCOTQWRfSG1PRfOrQrGzW1mNSmpXbulzS6h3dyOfd3ITRi7TQD/SnMCkn0c701zsE0AEJBpzh10sK1c8S137E035j3dchHfXNRe+k0nmr3asCwFDkMz8+Zw0iBxtipxTwcqjStMFF4MzIxzTcBqtroQhS3fPLAKjn0TvhEmA8nZ2t3gtM3ZWyDfth0i2t3aWIHbEbQyfoXaLI7aWEEARzkDC/4Avm0AQv5Fjz0I0g3aSuQct+IbglEV6l0zDOBdsM0K2yXdDN4WXFpiVtHYm1DiFQrbn9YZKO4cqFLbJWbfkMEABLBCw2XkjpIA7Q0DvC3efMXagNEhPB6mDcPkBPDKdo5Adu4fN24DWPE9K7YAmt3Ybx7nQG4XBIBAQi4c4h3pwADm/9xj53tOLwuOCHROWb4B6ufD6CPg6KZt4AqOlYYBHo4dGY0d5UBcEJRBSZjsQ6tmFSvQEu5y4pExXTrBFFmxBVHgQlgQE5h9lXy1alTKAj3+fDm+B6GxLUqACVZA7CgAFNPIbbp+CHxBLvPR7TExjS5Q1/bQ5s1xjIOOJ/od51cO4xch47Mu3rei3Yr4P6M9XHcN5HjC5cyNCHY+ZnCeLgSu4I6OEb4B2ssz2SxC5EOe2Q2g2SpzXVz+GfxuRXiukbet7rI9EmIQ8MRN3/adDXYu55Ah40ju6MRZYnCO4jyQ5DveFxrfKCPD5UjOVrWN70VR8YwJVpp98iOf8/RtFf9gUO9C39n10pjSDR7EaYnDNegF7vQ2k1IHkORcru4T78wdGvVSU+8iXduHs6TbYTxXcRyKOBrtgDsjJdDHxeuUaMNzURcRVUVw/1+A0xeMhzhvz1eCsS7m8UeKaLfIYwVkkRalYg4k/aFmwYu51BaockB4vxZUPgDRuhAe3yjs/tiNYi52DtrP4vH1PuvdRxfg7dhcJPLi/dh7zvlArt2PzzSgjSBfxReVbgOsjeRM9NivU9+6IuO049hNAfa0Xdys//upotke/2DDrfnFT/LizQB2nlLLPVz+EucTb+ldEfWrUSjVn0+3X+DOP/Knr9/TBePM3djS35gjr+ORneL/0T/96FPb0O8bCVDwS5H7NI7a9w8CBAIMxACgBAEEhAAIRAAYjEokBZBAAEToSicUqmACKGZEGGOwCOgAB0QJpmQ8BLElYAV4NFCCQeAUeLEEiIZ2cfIOzGhUYxDljstpQKEX368IKAkkfCkRnQEgKKAojBC5aSVozfztCQJEEo4tcHl+goaKfsYcdnmxEDhopQQgELgd4cmgCJGYHMQNoBk4tMyoLJUsaOm0rKK1qAQYkMSNPMgQPCww2Og4yJQQNLfYMESpaDUTGRAwfCZMo2R3LrXMDRcvlTaqwtAWPSj8oAWjwMNXSZqLWkcW3PtBhkCYGAPMiTOHThiseURi/8wJaKRHqjm9fr1yd+DcLWXJCm7EN0nAgZLiuCB8FDJVCwh32GlT0U2aTUWwUIxEF7CemAE2Hp4zes8WF1meNtVBgSABgi2YuugaQsSLoAIJFAhwsycNGV0v4MhZcqAag5ZFvoZN28UZICtEJjV4wCWRJUsA3cQ5gMlSIkwBAA/IpXUU48aNiaZAdWyejAIPmdLLZ66QOnJEHCQG0O6UlhfyWKZCZqxgqBsFouVjACFAAHWd4LUIQ5rVO4ZqCgFk3ceEAAdhJguwXBH1RVoCIPQkGkBvARtu/2U6MuzWgGw9bTVQ9SoB7R+CD77M/fsWMeYozD3qWADhkICgW7brA/8hOX3u3lfzd0QMKzUjxH+ZJXDAAeq8AE94pgAgG222dfQgH9AFeEJ/2y2AgA7hIYAQbd6wp4VbIzmABISYeKVXInNdxQAaN80lGlhK/PHiGQgcogNaYxXRiFZX5fiCAYUUCeMhPE70zgtgoLCAXpBoVcBg9b2AiVhF+OWYl18SsQ122CnzUj7c7XVDQQip4M4Sr9wAxSk33HKDGWo2yBoov/ChwgnmiERAD/AMl6KaqLynjgpNBoTCAz+0mcoNY6i5WAw3MFCgmhHeAEF82Hl1Qw5o5lbnMgWE5xZCqxwxnJGKkiSmUyhA4GaZBDAypwlwnkqDDSrkakupt+Z66TL/pDLEBQKQehpccj+k+N5PUggqH7S+3pBrqCqMyiawPjRpgwGyDvHKTngoUYMBUw0Q3oUDPFCDAgoAt9UC9B7glQILJHACGYwk8kS7htbibwC5AtCAG5kSoS+/ZpSRgF5JrtAHvLTGF+bBLCzwBBdeuZGAAZgI0IQBhc0A8gAidwmmy4wJVtpFHpWWHAyeCeZWOTVHkXMoJs4sc8xAj1yaDiPTyIXPNNi8NAzJIS0FKzXPscTInjFNI9BMGz20e3yUhnPNQPE2MxdXE+GzlckNTU7ZghlgpVtRvycAOV7rbBA5RdssRmlubb3zHWoXw/cda48jdUtrJ1121lLP4XTh/02XTffOWDMOtmcjK1izWwykWzUfODczMgxF9O14CoI1zJKC75XeM3NovE4D1pajrmBLBgjW8+46zGhzdUnbDjsoURdwt5E6JC+4FHm/HL3001NfvfXXY5+99tt/zMCo3IMfvvifIIQ1+IiOz33L6bPfvvvvwx+//Ns7Pb/99ltpPvii3/9y3P0DMIACHCABC2jAAyIwgQpc4AERAD0Gfmkx2JsCBCsohYy5zIHgo2ACJbg91VkweyfgYAjh9yL3GQBh40OflxRgvhSKAUIAvIqyMPiJQ7CQen5JBA7tsr7GJCKHonDhKGioPSICCUxCpIcMR4GAR/zwhvxDgv4Yc/9CAAaiiSX8YHeM8YIC3KcIYUzeGPQ3hhnFrWpg3IUiJqEg0IzAShe5yQMC8zw+LK4ZdQxNjQzQjFw4gEbjYqNXVvEmNwrijGLkY9rgCJQp2GF0ZRQDDHRAhbkdwAHR0l3c/ujITBADeAPA4EjsdjoyPgSMgSzKIxTzwIIhgiUuaEaWZqAgxKFhDDZU5SROmUY+hBGYqUyAIdUyyhhOEgZdlAobaZA804kheXH4IjGXB8xVwiAXNtRmxfZ2tOTl64+QPNEoRdex5DyDj4AUJPC0yYdqMpMXz5wD1JgXxtcVII+g2CPgllkOHeTrjmu8jl2WwM+iYHOLLnvAJDSZhgL/uIKh+YpogkrmgAe0RRhsiErJyLMEYkLJKLt4QFXEktEDNKkRAsDoa8LggEI4gBFgYelcluXH6UyFCxfdBEq3VIsmaKEJLIUoAiRq0JL6S2IvZcJFMyoDZpSBoQ1iw71IkAC4zICkcWFBGabAhnll5piBECoDFECNE6xBAPNCKUlVKAytnMEhI8iiMxTTgB6kFawNowpGz8IE8hBVooUEQ08tJTEywMBTGD2AVB0aiemwgDzLaskBerBTNzJALGeozhPB0QWw9LIcEntFQXko2cFQxRc0GC36aJOYlSFAtScjab0AchbQsiSzGtoFZGvjCghQdlDJoShjXQpTtxJh/6bgaGy0GpGiBjAiL4FNkJK4oNzXNLS5Cv2ScXS2IzbEJa1xuYoCtOvZ6sDge0SAwJQKSgMHeGwAMpXga4zyLBY0YC3UqaOMuqCuTOxiE3goSxILepXvtkGCvYjvEERGXkNRFjjU2EMfSOCOqyy4EkPAghbQhwq6XmIGHI7Bf0OxQ7+mwIdD8EozRoyoENkWRqMSrxtgHEuYTKmiSihvd4Eio+LMwBVCoosy9aAjNeTKETXqUodSfOAGPeJKKW5yjcI0BEusQBOhjfGPEoFSLahWyEjwlxxobIdB5VdKoKivjHrMBTCgqhDgMHN1l8Dm4uR3u9GzDA9clAezlGWaRP9azIfde5G7zuAqC8iLavvgaKsxYBW9nESHppK8SAtYUPVBjM70tdUrGlgJZwh0M6PEaA3bdtA1uoph/EFkLZ2ayCbQRVO2UtpaYoXWPJrVW29caCknLFqz7hJh/EqkMkyzS6A+8qD5zN6S6WIEL0JphPIFF80mYwxXfgMsb1xnHuYS1XN5Efr6MoQVHEYXeQsiLAvThGeMhdoZHTWy2UjpJ6oX0pJGZ5/tzIAnLuBIJKi3sU1Rg307u716dkwUHhBkNfSIR61TQl4++sdCGDFIO6BEigv6BDd1OxEKkG4DkISlLixoBD69g6pBzWpRQ7xhS+CKuG1ylYp7ocKKANj/q14NjBgSub98qLWTYW4XoRcgCkYAm7LcBNwq0/UP8CUC0t/kDnZfReJF0LoXrRstcNz8AQ0PQGWVDiToNgRHcjkDlDKhlx9B4hEgBjfQsZwJuXPB3FOukpOWnJayB+mEaLet1oc+crGXHChYK/bYuZCABrSUEYX3kaEZ7ygtLhwUvoDtHgTWgBR5fhUQ2BeEGLoyvWQ8QvPKgcWoAV3aSAt6NWhXf59DB0bMvgH9XYEBPKUyke11X/0auApb/+RMlOHzS1h0EirRBD08h/QdJz51XSsxn2fi9Yk2mbzotZcFEOz4mOi+yJqgMHx4It164Fj4NWwOBfyB/Hb+igJ2/+/e0HNsZcRXy1egP3qPbR5VKEITdAyQRAM1CZ/B8BzHeIzfQZp8eUFZ6V6DhJus+YoToA+0DVKK/R7WsBtd/MsAOsFtzMEBxhj+2V7C5Ar4PeAEBiAGtQutTAn+gdh7mF+bRYwNZZ4oLM3/KE7aoIYg+NEnWInSVVHZFOHNNI+hAWHyRMHdnEg9nY7U1A2NyE3tDKGdJccS+mD9iEEnOcPsMINnVA3rAEQW+E4RuA0YUqHfkEJLfJE3jY7ZaA7qfALn0AMczuEtjY0bPoUT+pJauAc0FQ8euMUziU2nmZIz0UPr6I7x+GAWTmHttM4UFuH/+GDz1E7w6Jwg3tEUPv+O1QDPIxlPHTLiRfwT2egMFKKAZwkiIHohHr3H4MzOHL7i/8TiDmpP6oEPqOmilTGRl/jiLxJjCAlAHYjZdq1FMTIjEVYR90wRMVKiLTaGDzbjNUIQHmLjNnJjN3rjN4JjOIrjODKGIlnQGr2MB+mZBmkPCU0PO14PCHGPO14PPPKgDoKJPXbQDtLjNsKQKGzCMyJQAFzUl3xg9fQQEGnPMN4hcoECL3pJknhb9ETRLmKe9DAkujAhDThk+kVjACXk9iBR+kAkAWWJJTUT7zhUUdCOgqyLGynCMS1fKJ1kTGKSQ5lj2oyTLWIiOK0R7fgTFeBjKamkTCoIFeSTTP7/TyA84SuxxMV8gR0R5SQuEyq9wFSCwiXNIu/YGWh0wwNoEkB9EidNBWoI5VPEgRKsEzM9whrRUiW9znSs5P88ZXyMQbwojR1ZAhXMSDA9pcLNohQAVL5QwSqxGmX5U8N45QGQgxzFpJ8J0wNpW8o0w0+2kesADiUNF1hu0ljupBR0x+IEEz0QEj2hpDxxJVDMEsrJpDJhECqRw0EpUyAVkuicZWTSwIn8UVWmUQEUJvBcpAA9lQE8lotQFSO0yzEm1VeIlFoRA1i8Q1cNZ1T1UgDkxaLBiyvWQmolmtH51lRcVBjMVk7ti1pNkVxplVjA1kvhVl1QWUZ5AnFc33XJ/9VcjCfGkZWV7MqewEt1StZehSd+ndUXIJVVMSdQlSd0fsZXzcB9IsFzJgdIhcFw5shxAkJ7GodamQJbLQJdFOd0tYR8AmZ5qWDCxMsqqJaW5ICDAihhTQSMndONDFdRUdeCaqhdSCgJAJXddQFtnIyFpmdSxVaDYsEigKhGKacPBBeACYKL/KcY7CeuCFheqZBFLRYSrNRyZVdhLUGCzqhETV0mOICDdhQzoGh3MhABUNaPhdkX9cB5oYMTAF3CRFLenVuEOQoJ3lqvfRuUySCVSIJyEo+tvQd8iVuXGVshOBwoeAGU3BnUMekmHN8SLUiesgAG2ViMYZihWtic1v9B0mSUlgQYXtRppqJcu7lpXdBFqBocwxTMlwEZnTVqGNAanCWeZ0FSFllapG6ZqUIWZjkJnVEdHKIpe12E2nWcmsaYzmWYBVKZIoCXT0UI86AD/NUVmwaZDRXaqmbBFhyrc/EBf+GZd4nOp0pFtJ5Z0oGDlklCz1BBDSYQV7zbMZEbpFrCVayFNeQNj75ciMUYMPbpWBzjbORfYOQrfManqYHloaJqjeAFYBKqEGJaLxVaugXGpP7MIDycnfYdrC0s9kkBW+QNzRVsYhysYswcMNbrB/4Byb5JC5AZtKUTwa1aorECZ4WIwE1FVQRCP/yFugHs5QmcEdGbWaSsXZD/DKIVFI9Khqst2sfa3QmRWtUUmrwJxrxKG/9sa8tmRTA6w8FtQsIV2MlO7d3BmMUmRtZRhVUEZwB5AeANXSIIHPBV6r0qQRRYK8DmHEd0KMr8a7fNHQVqHKVVCd7+CfR4AcnyKMVIRQBMRGoSakwVG6SuHMYqnp3x7QK+bODhmuIOwVUY7hKwKoA1jOFyXZUlicCx7AmMrsz1SV31BB9MXo3ElCc8XuSNRSCUXzOsHBGcboQIGdxCVMxpXCsSq11EwUoga4007WrVrLOu2OzexcXdXhgIb4FB6qrOiNfmheUZQoGZbo+sFjOQLuoYXZ0pECogAAHeRsToheldnyW0/57CGMXinZvG4Iu/JhGPSmB/vUhZ0UvSJUDIGAD9MoyrEirzwd7ipgUqNEuEmA8s4Evu+S8LVswAr8zIeCcLsqAwHEz18U+6FYLfKrC4ze/CYA27NEDKYLDIGHA3hAzqQszpqeofsAvslYP5dYINsy/yDUwX3EuNatSfqjBd2VQHvkMMi0aTlAVUvQD++W6/rPDRrV7SQQC8VFa7JC4iuG/2NZ8FLsi8dAIUO0q/XN8XsMb6jiD2HgbB0IX8XcT/ESntARnnhSARvLAPK98O3G0La7BUSDG8IpAaLeJ09A3YpCHqHM0hkyIotiEjcuFNbKIi9yQdVuElVyoeXAQYTv/yHdFlEeBqba1O5EhhNoEi8sihKWsnEKaiJ0DT/yyh3WiiIi5y0jDmEoai5UBT5OxO7wRmSype27UOK5riD6JcNOZTYDJNIBYi7tRN0ErNN6miJ9xyZbrNHCQh6+RSOfjyF84yJX0hED5QEqLiMCuzIU6izqiOEIoNLA7iCx2y00wjKu8MM29XRjbjE6lPuWhr+CwjOWoeAVvPEo3P8AA0SbbtQVePNSr0Qg8qODe0+1hE9XxkQQtkRFcPLmP0RnN0R3v0R4P09ajjFsljSH/CSC+QVnqCPi5cSSsLI+miS89PP3Y0QUt0QpsYSvsuPlpPRVpNsOi0KJzY9Ni09CD/ET67jBO4x1FX9PUgNZj8UJf8ozAQwyuFT1HrUFC/B1CLT0litJq2pkrDsjXL0RgkFFDIpBOqEWjE4fOoNCCJJky/8TShdWic000MVG4qnm/yZhmp0mDmZljK7jKV5SPa5COptCcMtSuxEjW3JlhPCWO75lYSItTQdW1CsmBnU1qz9UqHBma/hSHJJTbp0lPkwpR0Ehwek2NWEixrNjBbptVk0irVDl+2RDq1RGED6FW2Zk2qoV+/djNxklVSEnHHE/Tkdd/wTibJ5B/A9m9epmG/9WfeJmm2pFZ2hWlytJRWZ38KLsl4z3RkFz0c1vZ51F0EKGoNqa+01ZEC42Xl/1ZbcRUjgWgNKEim9AKQMUF2mpV6msF1/smZ6ugu5Ih3W9V6nzRcxXeHUil515ESiCiHSt5XAYxkPV1liUYWYBa24axncfcL5Og7eDeX+phmATi0qpVbiWhkuUKDX7hwdTjl0UWII8KJ/0EdCIKQqlZzpo1uEcKDtwL5igFZ9be/bNRygkV+woiS4/j6FQFxNcAjZEqQ0sWP5PeO76gZGPh6zoCXImlUcPnRrWlNv6qE6SnJjIqbLV+OCUa++UB7AVuWxYewdtuflRiR+S66tpGY5eqeSpnfXlAVDFomTxiPKraC37mLrTkKUNesJnq3otsjWOu9EtiRdSgSzBUsGf+r0ph5gR3Z0UE60UGJmCn6pJdZkmU6XWz6XuBaYEzEH9hd6gUMm5+q1/otnHbqngYuteE5isfFom4qgzlgoINYYHS63ZkrF+B6rFfCfJF5GGqsv4Luyqz6WMSVDA0smkZtPNCslXmaWOwameVdt1snIPOsn6Oa3+4s2xZMvxo6x8ZYuOeasmXb88r7sMmF1X772mkbLP1Itnttq7G6pgJD1x6twM/7CKHDvPV7lcMSwHeshqkas3uktaOYrXeurdktl92aqmmM0bZFkz3tjnMbXax7sfNW3d3vyR7tXFC8o8XuRqOFzvUtroHu5XXp11mJDCUvx9ndlvim+FpZsxX/wQq0zOzyiJDVq/ilO64tvdrRPHLebyVZ3XoF1OtWXXLpPO0qgNKtQNUJ3sgtLb+3nZr9SM83TOZ6er1jQtZHruZm/eClQdm/HSyh/Y1dCa/D+v3K+guQ6LRW2bf6K92a3JxiHczp/WLMLnxNhOc64NMXTNRbYOhOrxQUfp19HNN9NSz9C3VNxRdfxQvyXxKcQOoBcA7EueWLsR5rVxw4TL/kXido4PIl35iCA0q9pBajO12oeyC/yx5R321PvZ78rB7Evq+s3uivnwQnyPHL3wmZ4Osr4B4cRgP+yOnfROe3BKiFoN/Csb3k74vAsQlSf8cowaI9jOoFcMR7KHQN/5/dtV7fhfHyP4XRYQL8TsznGl3gejEIJANAkkswNA5QECOwNEoQAMMYLyKAiA3BggweN1tAkTjYXsDGYsAwlAAPUeKxJAEFNYCBoBQAp+Sy+YxOq9dstYB0UAIO75LBUJDmS3Q5WSC3VyZQtxdHUgcgIAUHSHZYAAi5yJdYqWQgdyBl8PYmiMcidRgK6kkSWXA4l7haJ1BQ1ukXyYhoWeKISFdSO0VIEprbKyl35xXrZVvnittolzx1XLrsDJYofPsLHWyrGCcHTEY9Z3ygsOKKCisdratYBhormAoXyBj6iZ+ciV7Wxw0RnlHhwAU7xQLWKl72EB2MRiyZOkFc1v+1uYgxo8aNHDt6/AgypMiRJEuaTDPmZMcFCmZAVKmSpUuYNNsEcFYzp86dPHv6/An0JM6gxIYSzRjJ6FGSSpc6fQo1qtSpVKtavYo1q9atXLt6/Qo2rNixZMuaPYs2rdq1bNu6fQs3rty5dOvavYs3r969fPv6/XtxBo3BhAl7A4w4seLFcgM4IAQ5MuQETQ+WNbCiJAI/Gl/0PIBAUWVxKkF35uh5Kuk5oceaRuPgMOOpN9fUVqNARgKyCWTzaJ3mNhnhXhRcTMmzYhE1y1Fq7FIxI3KM0092ydhc0XU2CnybqS50u6zds60SP3PeDAQSDepkegR6gKYBrfMIGJD/CAH+nPrhOKBvwgLs5HIAgMiw4MBjsQTwQIKx9PAOGfq1NkaBDkg0wIXl6JfMhH8EE0wsFsai3AsDTqHfEwfukUck8Ni3Hwn6RXgAAYtwcV9+MU5RIAJAFKCfhgO+VwYYBhpwAzM3cPaNgTzI94iNA7lYgIMOlbMEh9oh4mQuGRZQQAKPUbGkF5pIoU+OqCR4IgtBxhLKASLK+eaW38zxJQldlhdVemX4+UsXy6FAxgAJIOBADQJcMYCiDAzBQCxPcIEFTQEk8wACAqhIA5QlEKDAom/cFCYCDzAwagMPqAjFjlMoIGCoAABhAIM9eGHrboY2uBusAshaQm8AQIAF/wR55LrlcjaS0QB+hNZWkQAMJFDDFo+eGkuzXKQmBn3SQiqps5UGc4WPXjyWKAytMcCkFqFSBoADD4h6AAOZGjcFqKICgEIVlnSr6bSXMoAAApHOqucIuzqwW0UItNfSFP4mWK+KoWKLwAImhGYtuKWeaglmAqTrjwwAqCpyuhXpcGym5BUgHp9PAToFzYgI+gKRJSgLQ6VJRHdTvYSkSxN5wThwQhZkjFHETRmTUBu0isZcQrPRADGpqFlTtlxvVpeBzqoLHLDb1oTUsFyb9SbMryeKJpDMFl0EzQDb+d4MNSCojrzdAhTCod8Wuz1ANcJK34eCAVF8lzDZJKy6NP8icPOArwIcs911JzXYSwhyDjTgx20FEIFqAcaaHovceT/d9iOBU9FAAQ3sdnB8cvcQLiHwAmC0zFDZnLcbOKPB8203AU3IozcAp9J1MTSIdmpasH3ToKO6bacZByzAALsIB/DEkuDfIJ/123fPmdgHMGjc+EuWeEZ0TWMfHcLIyy/9GPcr3+VtQPSgqTFQRlVnYNoAwhQqFSEgAC6I3BKiU7/p2Wk5RTCg0o5XLfKlpgCGIlbrFPcYeCkgQ/hSXdush6JDiYEFBMuYAXYDwBUKAALL4lf4PFU43wUFeK1Tw3pO5h4m8cwfAIgU8g5gLFTU5Dr6i16RqCcA1kWNftf/aVMyRogwFaFCiyxYzulIgMVeJKABAMgNFrgYCSeaiUd1y4LUsmdCutntU3hrGxKTARG/Tc9/MgpAG3UmwSThDI/TMaDpZIQvOtrpAWTsmeGK4MU0FrEQU8BUDWqDwnp5z35zi6LGehg8w41xdCbj46IUJwU0Qk2HfaoMD3ODhBIQago8I9sMRoA8HjxqAZ+ECehMIAMaKOJR3rAgqRLQEghcb0umGwISmfWExf0oAU/oTZiqiaRHEcoJUDiMY7xAgHlQ01CaU9riphCDW/IAmcKsXxzfkM4d1GwBj+mkLgfAS2k8SgH/80FKILCuwxgSmToYgOJS0MtAKuwISRgO/z3rB76kwcAJO2gVoSqiuJb0LlGGCk2juvOoBqCKPb18JwIVoMwUpoBpjfRgD1a6JQRAAA/jFNYBGslKp/CQh14IGZPUsQtU7GMd3mFKLxchCIYMA0vCgIWwyJEQICXSDgPCxok6EYsk+QGr/0hGyNhhCCU4ThYGUQaLliGKEAXjHJn5hZyGmhDZuMg9CClA7Xp3pUkYxBcfwhIr4vdWaXijGOXQhSBE8493HIMOLQrli+Dq1MN0Ah4sMAY/TgEKfAxIQDmdmSsrg5YAMI8jIsinGsYWkuxoZrQjkcmldLKcgv0lgmgobUJhssDOetY2oD2Liz5Ch6KeZBVfSQpPsv8BGOKmIbg7aZNud/jZ50p3utStLnqoVZjsptS63O2ud8vTCcmIlxAv+a55z4veuehHg+zVYLvSC9/4ylcs7muvBkfa3L7u5LdrwMVQDguUyd4FwBiJRLuUm5yNIDgeEVLrXpB7EWdQgrFt6C1Vdgrac3SkO4ZT5E5EixspFDJ+OUQRa3kgBw5jBJZdUXGhMkLbNtRrCGVQ7U7AswYbs5HGw7EwjIeymZGs5gwurtm/QDuGLiBTXiJAwFTRAITXdAXDa0BpiSsR1AOlBBA4FkpCGaKLUGy5RgwmXC6804xk3EYYx3DrE80QoXq0uZJDjtCc/8CZeoxjHqRBjoDHwY7/6BiYGJxhiI6VpgxCU1UiDe5pof9FZjbMYo7rkMOhhfMOCmvjIYOoQ3PI61hNIzYNk0Y0nh0855u0+dAE0p+dakOPRk8vxlmhcn+3M8udUdMJzYKAEmozTVh12SS/tMGuYzAAX7cu2AuYzqIaVQOYwUpjVyABo3AwQnYZAALUal1Eu0CAXnPGR0dIAQMCYMuLMkA3Gh2tCGI5q2hKoVOHsoFI0c1OXDKAJZMDlY1q824YEuAIMGDJa0sQzy29sFGhWTiIDZUbjXUvAF/A3AhogISGiwDECX+psEqAtF0ZOwcsIOh0vLc4doW82kVgmcNDM3GiTXFW4uYBCqxJUI0l/1yM0y7iuQ3AEihsgts1WCA5EWjaXJNg5ViYeDFrXhsnoHRUDIX5z82A9DFgDQJHIDpGQ/ofJkxvAVx3QBJRdxVbCw9FuOCZG98ABCIOuyRGc/v8ECZ3MgirIpaztgGetrZPc6oON4GcIy14NyPEou9FlGTrYhwJeI3habUJ/GsZb8Qu6JEAlRLdvsZgeCJqYR5baughTb+e5bDL7gq7OPZQPyvSM0iJ40jXEDMzHb+9UAF2tYPtMzQ52Bchl8BOWO9htyglhpMFv3iZqTflehY+rj3O5wFOMKPGxM+PkcF7I6vzzsngVWR3HBR7+GGwAqRhRe1poDUtzX93IPDxw/87g3/05V+HEW8pANilOOr8UQRI0CjRd0IvUEGU9kgvYDxnI37bATPNMlJN1ENAgEJtgz8dRioBAIFwpyfnRgPMY3YXVS2EMSskaD2s93ZbMnCDES9cp2/UBBE9ACtqhH8SVAJO1h03oTEymDQdFDcmiEv2VHwPxHUYBwNchwUhKD1kN3vLIYDP4glFSHBMOC5lwIPZp0jzg0LeJz1GJkHvpILv94V2sjabZB7RdWvMYX/LdjKVMnckcR0oWHwE1GEkkEQV0QCjhQ4HkyTkcXdtwzp9h3hZ+AJ6xDt0YE8RNAD4MoSU9waBV4it8TOadzl5s4jBMwbqhwaoVBHKVgL/nmg3q7eGd9eJ7YJKcKAC+UIiNNiGNggHGlhwHLOK9mZaoJgFxMeBS6A4ZvAAP+QF5yQxqYdLfhh9u1gGvQhls2hjxjQyjLhM8HMGdKh1r4Y9oOh2JsQvM1BraEhqDDMgSqc0zIgwE/OGI3FwcsiB5EgGvpI0iqMpslIjn7Qk9vJSMKAAWEAqLXQwg6hQkkMEU9OAEsM1EWgq8HIEAtAsh8MojpIp+yhLAuAvUPAGBONU+JEgNfMAp4KI65SRZNQDHWkEiHNBDlCPpFh0V8B9DKKRfrMoVSgmjMSK6qh3xtGLSvCSDeBE1MSR3FcEdkU6y2RBMRBFCTQyu6GSZrgp/0Vpc8njMth2Ru3hZEnJMFAjPTdZdEGjfa5XL5mSUm+0QIDQAhAhk2CoHE4TQr8yjUhECQ9QQ2nHjWiwXp6iKX/gadoQZCZSPjzRH6NmIm9wl1xSIFYYG61xAP8xLg4QDm+AJJryCRcZZFWiITawaTszmT0CODIiVqNFBFGkBASgH3KAAjFCGpapCGISmZ4RZJsZZAWCBUBCHxCBJFDyGrGJDzcgBfhkIOLQI8AADKvZGrTpBWVSmK7SRYPJl4DZhQ9gaaiQIX+HWBzECbY5ajkSZH85akSAmGSiIbHJJNjZIQe0mMAAmY+TIUrgnTKCCxxknE8CEX2JYniCI+/5Gv8cYni/kJeSOZ+ZySUI8CD3iZej0Ebr95Zw8XEyMx08lT1OwWrzFRWhciu44WOtdWK0MaBvgRk6JD1BxgZS5hRDxqBUUSdqIFw00YVVwX4fiqIpqqJHUV/2dQP4xReD9iEEJhILxhcQJmRggaMfEaE9saMlEVZrYKNMoRE9KhJx6aLk8152MWNVOGtFN6GoUaIlwaEcIVv9VRlF9pC/YKSMs2IjmhMIehyrlGPB8GRYmhFi2hHQmAYLCkZg+mKu2AbluKKF8gLG9aR+lWgEYgal1lNZ9QKiJmp7Og7CRWt4yqebthBtsmpTGmb8YAuqxgg2hqhngKjVQQkR4WB38gz/i5YGesYK0fBnynAbHhpUSqUIgxVpiZCplypU6wARoDpHskpUoTSqo8qpbJCpbKo99zGl7ZCof/Vm9uMHg9pq69Cl8uV0AZenTVN1JSdsZMB0ExVLRWB0wnKt83Zzo/Vt7tKWTKgp1AIEzEpzySYnOZcF2covz+p0+QJ1byB1XcmuVxcsiwhDO+iR1Gav07Nt/HkE+SQtMtBGwFZzHPUo1IpXubBuCtBG6spLMxGvTtVz7toqJCdt+ZR104N0+hpL5BYqNVAFIhewDEsGThey1WYHYNc6D/taLJs68oZOoUFP6nKxGgONbbl0KHCwbzQr/BSf4Wau8aKzqeGx5aps/+rKc81mbfs6e7yTrN3VHJHHgfDzRuBXe9VCejdwfIy0tWRUeQFKBZ+0AFjAeX8AHcAotQmYfMyntW2UktizjFDEfd4GtyUqtWszOwXAeGkbTgRTRpJYTnSbgIeUBctXXnWUj9MXevLSSMdTfYQ4PYzXG+AXd3e6DpKHNw3lOLlUf9YmVr1zicxXeJ8UNqS7ApOXUJS3G0kgueVEQXn2QyapBZ2Xi1obu/lDiF37KrhHDJTxML9Yp3bKAhookeEnu/N3gwRVA0pIhIMRKlLYPvknhoU7CNDRBQ9YvEGJhM1rhFz4ZlqogM+IhcO7gUV0U/KCbtgbgfLEf4MRuDNnQP8XyLxw1kkz5LxQMBjrFTxU6EDF03+1Ir3fkwjqm4sVkRJg2Lkdhhzrs27zdh8eKFr4+4GGE0Fk0yCxUzftSwOu66jDw7MpMYSChIAHnDD2a4RbijAEbL6GGLyY44zGG3146IZLM4vBEAW2CbbGuKVrc4OkW4mBUkehG8KegYw43GPJ0oXM6AAv7L209MIssRncYwMv7JmLk4dALLgG9EJzdIrVmzc6HC8JtcSOhYxZOT1XXDUzjDBoPMWYiDfe03ucG4pKcHyVlAJto4lLd1uoW7IKABr5xMZIfAZbnILRAcK1a1DE6EAJCMZTII1t3Dr4dDAtzDYRGYGC/EYROR3/VskvGSmKEzWUoOxk2YiQG6SPqfMPyhS4lozIUqkrOACV0RtTWAm5dMOV4ruUfsDKVLB84EMFA5mOM+WOv8KAWcw2L7kDR2mTVZhLQulkYWKRiEmPeyMgU2nGCDPMF0MZDjCN0pKR9wjMRcSYaNMeCSnHuZwCpTwF/7Ep0QvNI3MhIgDPs1KQuBBLptNwFBkq0IiywYK+CjO2OGmDQ8w7TCY9FJmAojxV6rjLLfAC/byi4qCaSjACptGb+qkI8jEd6umc3Hmd5Ume2RmazgCZyVCi95EJwDHRkolY5ynRIO2bMnJAtGSXYuUsfonRWlICKw0km7bSL9Agc2CYrIGZ/+/pnlWivx5dx5f5ntpJxxMiIviRmnlC08cp1Dx2H4HJ0hZinlJt08rZGmpC1E19gzMt1r3gIe/pmvzpJq9Jz54iDXWgocOJBRb9CWC7JoyJIOuJmhStDUitWqzJ0i+dnfap1SttvtJHyR8hMhFjEmraYlGUsFchL1XQLkQwX3TaBph9EpXdUPzxSZy92B1RJXsyEhq6FiG6Fb76XnIyX7+qYIcbEqy9E3Mt26ON27mt27vtFkOKBsaqp2Th2yLxtFrxozW6pFEx3AlxYJhw2x2x3LwdEqgNEld6Bm5KBiErG9jNHXAKE9itpWUqp5t4pmOdph5h3cFR3GrIHEFhAP/GsaBNWmMESBLcLd2pSmei6huYNhSZ5lx+hap0sBxc9QiJkB4CftLJXasHkmWhmgtWVV6ouly+ugbZ4N9eSqyV8BKHBWbbkaluUGkZ0Qx9CsAM9tysoOBLIOGJRwYyylya2uKKJePzcJuwfWh/iAagRmq6ENiM6t3xZW6X8q82u29IsCC8BG78ZHbUsrFLA7PqCj5CAEkMpQQGC8vwtjNUvm3dBnJDa2/nlm4j8DS/60IqS7BBm61NvnNZjgS/RnZdaOWPl+T/BncF6+U3OHDGAbRHe3ODhTbHdoSiVbOlyUCOHTG0snEwpwQp915ai66OzBJd+eYn23SLLgXs4nH/SFI5qQFxThCOPJDn+pQCj9EsJjOyeP1yYSxyCVcia2tmJRBz9qSFm45O2RYHdfNMazOtLQc3UP6slNwoiwe40eE3hje2s0K7pUl7ipQxuktwS3B8z3y7scd8vdCwstwL0x7sf0sCkYK3cGM5obsgiNy1a5s6pGftiJSNWDftH5zshjTtLG5IbotTgnx+rSstANrtnXmIQaAuu7fU72fuEtO4o4Ivmls2CADwGVwpqvBDtqh6BWJ+1UF+jYDAnuvvR4O1zAc/Vsw8wyfrWvnw7QJ95sswGdlL2LcEDAMm9C7niz0o/4s/FDQCh2wC25t4OAK9PSTC2iG/LojFFUEc/xdYgbXBLipAOHHgRw3gwGq78/w7v3Uk9DhxgR+8pfE7PPJewjufC6wINDJ/HSrZSECwgsKEgwB8W53Lvwk8cwpMOTm4KcMEg+rCOmxP4YZTHX42Thdfgix4hS0oguk6NngN8sFzd35T92C0cThAOO8NIH/vg4qw8zzbwssRyMReMD6MgZZQxsy+AI18G/P4OJ+vyDZsCzwMOcRByJAUiRgPxefTC3c8xI38OL7YxXPgthrjJ6sfw+B29QnD+4usxXjd9Z8eHZd/HYx07Ahji+tDRrw0oc3R+fHCxHUAx7gOi9DPB6m4KOcR8ddYBqDYtHxvi8tXP5zoRKYTRp2bS/+kSC3/oshOpvvoRu3K4QQaA/rYA+w5o88gIAjMgzBFwSBmARAAvCiPsAhOAusE8iQCYNEQIBSAABAwGBwHPmDC8QgwA48H46BrPo9JXXTKXMIEiccgAHsQWoEFwDGoGZEuGFlIVNRuOSuWlg5Vl53PFkAYldLCQ4PaHYzdixJTWALTlgoQZd5Q0ZaAGtndAYSAgcEmn6gmww4AwpkjTILRA4RWQdvWUh/O1gGJCZCd0lBDpi0ArtYCgtlDLWQvUhqAmYAC5WY1kYOCzTY2pDGM7FVDotTj0VVWK6kCREsvUwoaAxCZcQI1jLASmADskqYgxzpHoyzB0QPKTitEEif/Uqxo8SLGjBo3ctwoQscBOdLMOHBQr0DJepkIlmQ2wCQiHgMEuXSgBYGgj7FmwkAJDYiBJTR1IOAZayjLn9i+HBiAQEeBp0sJFpWKU0mZJGhs1mwR1OiWooKuKpAK1YFSlA4MSF15NdNHn6RAOsE6tebQA091wh1gAEDIunq30NCR6etfZoIyPYATCsjWenSJ3KQpYI6OB4sByvnyTCIRp0RnZmoqLZTTFnKaAraKFDHBl2wBfNUyWCcCx4/LzLn68WoQszqCKo0DUGoB2XuBJP+7tXLrjtKnU69u/TrGiNhhUNru/Tt4jAEkg5fiA2n49BL5qOcorD38iVmsv49v//8+/vwbB39fqf9/fomldxlYAH4noIE66JSgd/xVtyCDEUo4IYUVWnghhhlquCGHHXpIH3oZHdDCF9cdIMgBAqT4IYstuvgijDHKGOFckmSEUHfXkeGDXwv4NyOQQQo5JJFFWijUF18UIIBXAhrg2AsqgsTkRAZQWUZi/HyRAHlGevklmGGKOeYACQgBJTYMNHCQAgdJtUBiBCSTSyxUJPDXGxAMIMRBBAUQDhxLGACBP+c4MCaiiSq6KKMUkkJJlOUAERFCkSyRwhrq/MldCy2UVctXXoCkTqOlmnoqqqle9Ch35EgyqRoIHNpqJQJAEACudSThwK1V+INrqOYcof8qscUae2yRrN4REURqNEBTJ369soWwqhjQgHBaUosst916+62jmUDqqqiiFEAqrZ7sIao7gagCDR/arvEjuPXaey++0vGFR3RHtYZWL1nNyxVwtXFW1280BRBivg07/DDEFY2XX24RW3wxxhmrl1yXGnv8McghizwyySWbfDLKKeNX1BItu+wywyrLPDPNGr7xMs4D6FMzzz37LKGwFAU9kQMBNHBaf/RedCJ14VBXY0YFIHjR0BMBh0gSDjZt5otKS90R1BoZ4E+JrxqoHUdVE5VApVvkGJ4BHZcBXtwYKR3JcHILqTa1ZRNdgCkxTxf2qncv/Q/YhlOENtV+Wx3/IiVaSzd2jEozbrfiFR0ttOP2XZ4R3wDQQ9Hb4KldunWh8zvR26rL6LrrgyTxaVgKBKCC7Scww/YCJPrDwD243hmLAzLIEsDwDDAQQNzCTz2RDefkXsTtLfhgpu+3B4/8X7Ia78/wC9yKQAHOI4JDAKfQ9uuSRtAGhwJ/gW8EAgT8aYARBuDK/PsNJKBO+W6HtCCMryzY0h+wYjG93JFnbMh7ypMWwLUmIM9TCDjg/rqngAaogDYKuIYaHJiAp4gvAE85yAgRcRDgVWJ9uPIK+wDQJg6mglDMc1/8RPWn6rlwYitkgiwKtYWDvFCGuQPCAYT3jwPA4VwEUQcRJ2aH/zb1MCr2K4tUIPGCJ/mPVEE0QgBJIMMEsBAquCLBoAo1v1hcMRZsA+MZT8O/IbIvjf/g4v9sFIRfcYeBdvwS7DonEVPUg3aGaSIBtKCAQ+nuJaJrARmGAJhX6OwBdWOGOkghyfpYpFJ7IkgiZchISB5qdJFEIiXRWA9aRGST04IB5USlu9wUYHQfFFU9hkeJVkhSAOowQwvuNAD3IYhZSDhALzOJSEXOqic9gQA2uOQOF2hhmEc4ZjIZQRB62MoBnCDIM8klBxjMpwwI+QsZZgkHdR5hL3+AldkmwUwAqNMMsHSBVxBRyEOZEJMA2Bzj6GECKwEQBov0QplawM5o0f8qStK8k/5iUBRi2pM2vSAmu3L5F0pENDjWtOgRprZPdinooRuNg/sgNc/YwSiQUTuDRZTlC0iIIiJksB+uXkCKayFvIdzZH+oQQQ2ZzoGmSIDETYHaQto8olARwWkAckQKJNhKiUEopRv2gSv17VIN3YnUq0awAJgoSFK0ugNRt1CABeSUXDctgxqM8dWlUpUaL1hrW5n1K/X1RE088cWtelrVnrLrBc2K5zdrFVh/pCAZWvAfZghzxirAs6uIQAbLDjUF7R1BgiRarFfxIK5WMesyy9OeWE3S2AKlNqt42GpidTbZ1lZksywMWmnvINd0URZMLr1IAVIY09FWIpb/vrQpE3hhmExA4C/xEJfeJjJU4goKIcdFanLJQ4rmuuqpcpuqCNo2yca8ygGkmgRcHwkDaOa2AI7QDbmMMTrRLZWhOmjArMAqykjQQr71gCYp7qSdF+CXtOUYINYUQMk5tK2isttmucyK3lqJFxsKhiWvaKIKSPa2FZbdghw01YBUNLIKNIxmTETb0Phexn1QeW8ZLqxWGNvBvGbrhIt7AuMqlZik6RWVYZMwrhay9EW/rUhwhSNDJadVH+d6SnPPxYRwoOBQ242b7eLQRCqjRDzL5S09mYQt0cUtGTLsXZevXIAsq4IgXG4mbU4gDCgcij+3SwISbDwCIORiSWrw/5E2S1sYG5fVbEEYQ6Co658C1y+agJtPIp/MLkB/8pMjINcdGL3FV7g3AVqw5HAgCGBL1PkpUYhOPz9pB2EsaWcTJsOp9TKbQSkBBQxwkpwXcdgCXyMYECBhDjacRMraSn6ljsQF2WjgV82ZNlcAgnlnDc3MQFsd2ELJL3fW52Yb4NlxOC+ChL2Ia4fCrC/Q85AjSb73FenIFEEgrqRiyHNkkd6AYatUrjVWqRQtAIdaASyNBgq8aqHfcKaIaGJRb4Xfu59M3TcMDM5w2gjcfWmQhsQlO8y/rNlopyGvQf9iu40zgwr4iw0VvILDVLC1d1s4uQwTk5yUTxwSAIfKI/+mkKYGSNIF+A55T9IwAEjiagFagPmwzmUFpFoBk3+STMdHzPCoS4PqR3jE0GMecSrkMIc2fwrVo/6XfiMYAW8AWA5PvlZs5RgGDSCR+8wO8RxeEAW22xw12KrzYcE87S1n+RvsbrRwt9wrPJch152ziCe9AfAuDyki5A6wa6HLg0BneqOHxXDKL3VI7kZUcKMrM8YFdSKEY1CRf4afAyhePIIzsiAfzChQqB7peszIzSuUQ9VbCJmBx4iSg/R53hO/+MbvyM1y5rKdHb/5zn9+5JWPs9dbLPZnlU7qhWr9jnwuGMHH9Ny2c/rFbR901pccRpjWeY2Mf/XUR4QDvxD///h8jTrdz8j9n5Y56Fuk9LCgTvb1DXjkX79gDeL4H0e0H2iUn3ic3/cNl4ol4P7FhwJKxOZswQXGBwFaxAZWRAdKIO95jxGgEAQtgAQ5xhdNwzLUz6ak4B5FVeSBjwbdzqygD1/BkglO0NJ1G++4VpkMxBEwEGDsDw6xzVMkEWEN0RFZHhJuihl0ERttytpwzz+1gNEFgV7IYAvVnQP50BICXJvcWQzwEcVJhA0Wg72J4MlRDwPMigThCiIoD/MMwCO0oUEZIdb8DhDJYPkMQsfgzzWkYARN0A9mggGZwPLgDxn9SCHShg0Nhw0BYqy8ER78Cp7YWwANDxseSgkJ/0cUecoSIqEQ6cAM3RrxyMBasc1IhFAG9U8exYElVlE0cZbqVZIBjBM9pYg0WUFHfYZGRUIvykpK6VOmaFMtrY+hmZMbSAMB8EEKkJIXdBT/hNJBAZQa4GIWWKNQPQUrOcsqOloinBQx+tPRCEMpgZM/AdZfsFM/0QI/cKM6gAOtdNRwIMSrjQEaxUMTQZM84k0EftIxYuNQmNI9FOOYJRtoQIA3BSMwuYM04skxkUFFhVs54EnZQIRCogIkPEMs3eM/oZIxshfioONBtaO1fSO1uJMSoNE4YQovTcovmVRHAgE7ESTvTdVeiQB2yRZnpUH6xNZpAc9uvVxT+RRaZf+CsCBXJEREK1hDJrxVC1lWT/3khz1YK3hYeuVW6fBUocgBWiCBOnDlKJzYYBXKYWlLUwpZRYCXpYwBXBhlkF3fUrHKVN6gUoqlq1SNTQVlUYkWKcgLGazWUPxlbwngXk4WWzIUVOnUaF2ObXVYaIFfYdEVnukk3uiXU4YVaCllLSLlAEXEIn1UxJ1XbOXYUOoAdz1Xq7Bloe0XR1mXptyAxR2KYqZX0/0f4xwWVnaXuUlEarKitTnSbyoBHjqY2ajmYZ2mRCSmipGCauqWWtpDBBoWgv0YGQwnPWHB4iBVjoFmScwmu8yFNrwSSuEBP10kPClBjjFnVGpXYyLOhhH/WWX92IMdoybJkZWowXyJ5KuAl3Fy5s+Qwnkwg5VwiTCcyM50m55p24hw2wOgGyJEWZaxirAxnzIeKN442ZgdUxZgKEPxmhoMqCWBqPbx5j9ZmRrkVp9tgYRCAtcMFJl1XCXUkqkd21lC5rdhQ3dMzHDI2c7c2rAt1XOe2y+9TfHExmiJKIJEmZm16DnwgCSQR0Q4KDAdqJXOhzEcKRE4YjB0KJaiJ7k4aIXSpAEE6ZvVV5yhY5wBjq7BE4mmpDaRQt1dWitQGhyU1piuQ3Qw6QSeTO4phAK0Gs8lAePBCeKRnBi8T+MpwdLBX8XV3BokXiioSc9RAxM5XA75UqVi/6IQ9BqgooAQ0B4p/sXJqV2nhtDKlZx/6A/b4QFzQAKrggLA6Q+WeZzWreEJkarFmVBVZoakigLE3Ryu6lEaZB5UsJVeLNynEiXExar7mAJ9wpKLFaqVUGoSaOrsyBxb4c/gYc2gAt0Q6epw/J2q/gA5QFwc4Mq/LdzFhcXZ5arlrZ2oSgLWtUDuyd3RgZHQqRzQiYG5Wp2+AQz/fSCDEOxGlKkM9SlGIOwttQjrlRwePKCJtB5+/KXEgsZIYkgAqsfGXoQ0sBr/ZYTtacjIbocoLIJ3nKzCUojvPd7F0scjPN59vN05cETJYsjuTUjOfgdbSV3I/izQBq3QDi3RFv9t0V4NfFTgyobfB6IfQTxP+r1shCAgAtrH26gffgxN/WFH6Mxfin1H1U7E1hrthSBteyitdPSqRTitwR4Hh1CthLxNBX7H0LStxMReBn6td4QtxpIteGyiCroPFVQQBUmT1wlhE7bd9bjcIYKGHt5q/nxQXLkiqZhBvIXFFT3hK3ZhA43gEnbiGKWQCBqqDKECHFEhzV7hFUpEJloS+JQgFL5cKwLuHZAue+yA7UgT576c5BInEH6dGwkRCY4hDLoC8yxulwSROiCvEd1Z7A7uLgJBCoLu8IJEEwEQFMXQFOVPHdnQzWkR5Z4DJYaRQSxiTORu++BgWLDNn42PJPr/LlIiLhH67SFBGDrqUjUZQShZkzztlzZqAjTiipREKIdFGDZk5LKYlHpBzS4pMDsVmkmKUyZkgS1aUy352UdO0j9phh1OmwXOyiUdY0MOz33BZEi2ypFCq9tAkhE8cBlk5EO2JT5ZlED2o9xOMDT2aD41Ej9xowLvr64wJCQIJItGxa35EkmeZ0LRk73CgR0oi0MFUyps5ETB0kTGBAuLjjPAGS84F03BcEVSk/+iJP3KFGwtZWSmpQz3KlPGleMopW7aFYsBKK2UVln+gxpfZTnkJClAqzx6mFJ5pdkhMeuoFVvBYG7931Gu2DMyMFzdcbn9Y3KpGGQVQ04qZwu1/7F0/lge92ZemtZs7fEZlzC2LIFmTVZnSRMkPzFxYSYooxYDjJWtOdbXPtczYiAmpCdnQiVU2m3zsQqhTRgtUEJ/xdYkg59xxeZEwDE8DdgcY1ctS4pxRnIcS8IAzcUzeJqrKFfABefB7YBkFNiymBVq/heaRsJYldP/OcI0t2Y/OpJ93WIu3Kah3TAyYkPliWYyGzCQFaM1dOeBUUSIXR2JFbDRmOI0s/KKlZZo6lgDOMZ4fi0tmELFwF+GaXJ5KgFtqpjaGi0wZxsnjMiYRdqGGvOJMmocitlT2IGsRGiZMYEsZ5kzq+hLR+iI5FasCUcnp2mnfVqolMHypNeZJv8CHMDokyCCDACGI/ybK2+BnZ5z5BAAfHGHSNdoAYapl2oBkC7C0KUAD/o0hIJYE2mocASOcZA1P8uTpHEoUFgSpymprwHbmgYpVXFXTotKsmWeKzvooI2YqMVEVcdAKPWCrZEYQUxpVsvwm9Lv9xqUpEq1w0G2vF3i1J0qIlzqZPvYwwEMMrUq0qEq0OkboGlc33Hc3Q3QyaXdrkrDp+ZeBlteuvqbq/pJBEJFGsCJ0ulcaavVvkKq5tHT87yBw1ndcLgYtsIVxJFdpjwdo+7dsS4MZoPGI9TZz0Eu0El2aJNruy4rBsLdObyr1tWd1e2e3pUDbPtd4xWq4PnsIFT/dyxU3tbd5sUh3XFrHsCtXa/Rb0a8Dd8ybJ+S5wCiQMdayMKcTcaaCt8yyoBfhH/rt0YgzoFjLMqmHwNKh3ILidSqR2QRS4SfChPBh8o6uIiPOImXuImfOIpHSP05LQTihCq8X4rHuIwXLCSw+FoCkRbUwIzvOI8nSBC1rwmt4QLxEPCSwe4VeI8nuZK3RxeTiz6C0jwxlLwI7JJXuZVbRyU7OVxydHMW5mVcOZiHuc1etFGdMy+7Jbt8uZivOZsjQlffWpthcJOVKVcXphS0OZ6z+YXPN/0sHMABK8CAYWJIU54XuqFjBy4euqIvutjQLKM/eotEFQFMOqVXOqVX/zikZ/qMD98yY/qG3CKAQIiEoMTSFomNX8Rl+I2o50ep30VFiIVEmO2pyLqqcDoi2MJBiN6HkLB+zG3VyHHq3LmL/Dr3dbgH/sDzzG16JPgmI5wNoMeCW8TOhut3uDbnSFeJWHup2LpaGRrCqlVnAMRLkEg9IOxlSMWJPGxTkNV2FEVPhDtgjDs2lHuOJ1y6/8W6d0xRjPa5H7aCSI31CAVgEAAqYIO4I4eVRFZTFMgBEHyZngi+J5zUXEbcpAQioIFRqEhd0EZIzMq9xzvCU/zcMEndYLxtODxLFEjK63LCYUPClWlLBMGzJ0bdkAHMk1W/r/w5tDws+QJA6IVRNP+FsYYfzQOOHLTFPVBJUTBHFKhIThyn0I9G1gg8qZfNwo9I09OGzweXN+381BvFt4PE0ceADUhp1NNGp5QElViBxZvglZgKt3sfNUx4LbADxQnEP0nFrV2QNhjBD8aPFcgC3eaS3esP3o8ZcPM9Ff294Qs+BhYVEA0BFdEJtE6RAGDBkhCAaDgUGqQo8GB+QMyrAGh+UbxRNFzDCDgBA8zAaJPi5euO5kfD1dGB7/LBGaB+GwaCCwCL5WP+6KeGCQ0oGNh9Kyg+/Uh+HQxBUuOKU5gVPxwNoBl/QkCROJSIFGQDccpKCJ3B0Iej6EgDPZRADbhlcDVEUXGwjyjLJNj/PhD4iChwcAkYQRhUXugrgDAA2vX/wP3D9PmDwME8iAIAwXCupLCoQXqsAKEIiYAKRYI8DF2g8XihZLSkcslsOp/QaDKge1KjAsWicDLMaJDH6iXACR4BgCA9KhMAg8WJbJZCE6vweFDOodVsD25wcgB0OSsiJwMqbQJvCiqMOwAFDwNBNStvC2IACQdrJ1QGDAZLb4RznqCilK4rlpg6qQ8NlAUQqoasoWkACg41X1eymakIDWVGeZ6AAI5v0bi6k65Xk1ei03onDQNcSgIDKXAqmgsIJ6krwUULB3gABg4LaYwLciJlDmnY56mupGK0T0C/UqdOdKOBcMWVE+PK/10peNAUwy8M6907R2MgDAEICl3RttGOyZMoUy556IQllGBNBDSA4O8FQWgH0tVgNGkSCpsDMKp0uEImzZ88ZzDIqY4AT0nnAgDF6GqSU54AFC3dUcpBHXZvHlK5pgNBAKdJPI6qMvYXSYYMvCJKJerhG59iy/yy6lBA16+LUjCqAnFmGlFXrT6lpMmaWx3ZdCBebDRNTgZbT/S4YcRn2CrsTrw7EOCBiQVE+sGBAIGLAAY81f1bt1aTudexAZhFWznJ7o+VEnAGjpuRut9NUD9Q7bPjoo94hUguObS69euMWxJmEs6QsHlCK53IwUx8PQYnMon3Wb679V/iP7ngyP/lfPoqXNjTT4TeHDT83ihwyw7R2aYJTNAUQFY4BYRmm08IMqDgY8+sUGAqDphwhQF4QPidhK4QYSAVF55gViw0hJPDNgCqx8WGHapAln9vuRhfDuFEUtReUNGmk4GaJXCLgGLQdY8CCCRQwAGtaUaJZ7V5xCSDDL6hImFVvsIjJVNqliV4aUFEnXM0giSSdM80xwN2bLbZhEtMwKlEKXEoOQpH6SmggJI9vJDAKQ2eU4qeMQbpZ0LXNfAFA4QW0OcAf1aC1jyM7ulfcIfSgJoC5QxqKQAPEMCWX7A1kIlUwrwRD6cyPkZnA4Vs8twJq5YzIyyUDmAqLQvsOUMMkIr/4VOtMkKgxS/skFLqqQsIY4+u3+W554SUElqtpcAmIOw5jO5a5jOe4lGpkrBiguhmCyTQoyZ0KuAgCsIYQAAXm8bgX7oFIABbPlxCoGtAtMyqbxwLvCrHuN0ZDEcACqCr7sImDJyPwijgaUgDnB4GG6IPfrSZAhCgKQpuXuji5skoy6mEykkoyLEX4mxnwJpduFcGrULN7J51LhQlM83z2FzFATkDvYIXRPtMA2EGcBFKAU1DNANhAnwBdc2V+CUOzktbnVDUV9PwdNQEhOKQIOEkXdQXaxiAKNNO8xC1Gl+EEp4a+L293c0ooM111lA7PQPYeivdhdFZEz2D2vhJ/6bEAeFQ3fQpjM/gMtZZOR60Gn9fnnXhLWvdBaBVq+22ZqJ7DmYSfoVt9tJcz81DpITTWpYJKOfOJss08K7771AEoA7wxBevkoO+Lw2f8VZsx/zz0Ed/srr8PgGP9Nj3Fbzz2RuvYPfgE+/83FCEHT7m56evvvShcLz++cln9/789Ndv//3456///iqdRcD/AAwgALnHP90dYHgnOeD6FAg8i0UBAXcroB0YiL0COMCBiwAfBte3wTZBUIIgvB+u7DBC8JVwZQR0ggIS8q7t5Q4Bw2uOE2CouxNeh4ZWcIAzgMFCKRgAdzZESQuhEEQ3DZEGMnzg8OIXwiYWz4J8qP/QOBA4RZwhABxSHMDwDnATKOoAauPAzwXZNgAHOO0mq1saIyzDNoioIXB002JRBvAAjvXAK8OQI0T0mCIHOAARBhjM6g7gvi4cwI+0uuDw8sEDtV2xClXTIyNtVkbXcNEZjzSkHyO3RhPx0Yrg4CICr1i3m0yyj2bMiqjOlQA8lo2PVaRBkqp2NaJdcUl8zKRv9JgKLqYyK5XMygGxWMthWs2PiBOlZppGQFFa6WtcmJziwLNJWmnReZMsTTWB+UsnevN3rbTFM5KRhYgpQ09w0NYfx3lOBYiABCYI5y1wAwRHCe8BoMCnQRzwzhLcKQkOOCd1UkGAGBhAIDdARED/s7A8ERjBBnUgJzpj4QMg6ECHZgjJHBDYO2X0ClQImM8RgjIJMpSmBgkVAhJEkwNEOgUHYjCpGIZQBBUslFPAWEAWtgMpBPwxpRXTZz81tNJKMACGIHIKAh2qAogiQqK4WwRs9JJOnwqnDjKlgRZ2yq7SJGkeXu2QOvEgip6qpgc/UA9EtEUONTAgAcvrgrYQ8IYZBQCuV4QBEYzAIRIgTwY05WtYv0nY3C1kG4J4BDQSe5dz/AmxbmiIQpxBFnLOJ6BfkKwhk7CVsgJkHcQImH86G1e7zGoaK9AoYyICjtbkYme1yUUXNHIpggTBIGlQSxIxKytQKeq2qqnR1NLw/w3YQskc8RBNwSwyK1niDklAqk3HFjuIHYnpUlIC7vKKK6tDzKcP43DszAaqmzNpqhc4gK0hhldXCglvVm/5kYMKJArvFva+bOrNZLCSmHW1ZSdYQY5+H0MOnvAAUnpADhOMhF3aRGlWDO4daCC8GAtFZXbDAUYZozqFCSuHOecYDGyMM90kFgDBRRJTceT4FgZfJjPN9YgrRIGcJPqELx12sGKwYt00ffY2I/7ki2cQlqlIJSnR8SxtCqS9HdjQtHatQmSeYVokXpjKU8GvlqtzJRY5yUY+aY2XK5GlLj/mRF4STQC+REjODrfBIxLtJEib4+naKLVnqooKRLCVNv9LeB54YPCNg9Ik8ejWYuH4A4bcWegXTQcnz8gRno7LCNnqpmGaaWwSxMmL6DJGLXe+ro91TGgGpegEOuIEfdoTZmpBSbUuiRC13qgp9lZoJFImThrkmwT67no/Ww72SRAminBdq0OwsVUawqUwYlPoWQ3wYwp8QLFm+UZdDbCMvxpAUO2pJUnkiCs5TKAWY1NUT0Fw2DlgNYdojWLaMcWYvUg2CYnJQS0kW0E/elqDXoFCN/uSw1vAnW0AlIu5MZ7VuEGhsHw7JB/IUsK4p2tuzfhLEOT1j71pcPBTWCkBh3rUnzBR4FFr4mMhE5twlJ0Vkx0NNu7Kk7ceMuVi78v/QSR7i8gLKeyexyRvhoNIrqu2TMOpjm9hm5vdbGc10SXocZOzHeemvrmh1c0AnGbIKawe9KXBUUHTZIyEpuA3iEQ9c8JEXUK4jnaxEX0Y2/Fc7bJydp0lgXF/e93nEsG907lxTlv/G96UoCBHUa6Nad97EuxOdcbPY02D8VriqdaDQr79av4M3dQLHzWlD44LYSu8y/m+OfM53ueod1MSo5cT3dUDUjxHmStaX2foHTH151s9E6gXK+tF8DoyIQdHcU981v/+vmVQb+7UxgTyPS+FxQcf85/QvvTN7PjRz772t8/97nv/++B3IgWlx7eThDFmusE+E8rPBFIq4YNs/4L//spPj/Db//4WXsIPUVJE6a2QdXEFPUkUgOKQA4U0ZSehexaiU3fDRFLggGyyf5diB1P2I/h3gd2XNF5QTbM0NXqkOIznBWETS1UATeunRUuiSKDENsrkSZbTSntDIgkBReEBgsC0RYjHRUGxR6MUB3hyAKtUCds0Bjr1PWmHgH8HTYekR5NQeLoRRXdUOn+nDS34hEPTRRfkPNokDH5mhJpxRakERlEEM3TXR1HUgRp4SMJwfkmXHyoANvKAgXKYfdmwV5IwVVCVTsLRAMNjCjTWTp9wCnpQaNe2Ty3QGT6gGihVBykgVAxQHmoAAWkFOff0bxaSAFfFVuQ1VP+6AYjfsAZ48ggoeFT64h7AAoQKBxwrECmDaAkh1RngAHKGwAelwVTHhVBYRYsPwInyNAUe5U79oVqzhVtuRUcSoloW+Ak6dAskF14osFffUE8zgoA3MIfWSHw1dxi/MA1xoGbPAFmK5Q75kFxLAGPzQFvHJSXyUATyUyHBYFmQ2I2d9gk6SBuaFQ2KMIEOlnnQlX8lpoqopkPjKA/0YA/mwC8U4Q+Q8WMC8RwJqVkL8WeydVKIIDZX1F5r8VqvBQaUtSVv4WQUgoCXcI0k6XPZWCH9NYFLoRP7NQmjURocRiZzkBoZJ2O/UBfOo2cFJkj+mBfHhRz9pWdhUluT9mP/PQGQoDKOMHkxy3EPrOEaQSYbC+lgDQlkuSFghlFnb4AGHHJtIYWRlBAJGcI6WSmUH/lfT6KK41CSbLllJ+kKYMYR9vEMNtIDQyIiXngfmXZd6fgcluZPcBIiJAAf7uEh6XFin5UlLpKPSVQLA9IJVkZq30JRd5liaYIkStIl4jEbtlGVBNFoZTYe2wEj6fFef6YJM8Jn4WFm8PVoIFkbIulubTmbTnSSuUBHxtYcgXJd5hYA8TIvnbhp1FMP8laTCscw/zZxRWEsBmkIKRBtkZkVK7dn2/YGCmNs9WIxqPITzemPqJEuPQInvjkPwFkvJYEvGzcR1flgGhdwzdYo770DbyfgAP0hS9gGlg/BbpzVKLd5CbpWG92SCQhYMLRZoOL3eZUwgzTDN9M3N+ZTfpDzd5AZOmwTdXg3dWqjd/NgR27DMUsnNkLxdmjXOBxDf2HXNaPzOFQxTRq4MxFKda1zeFKjeEqnOVHDdp5zdH33NP64eI7ThtLFOljSSAgKpJwnOJtDGga6pAVKgEzacwUwdvznpLrTA9D3pFiapVrKP+aTQOp3Mn62pWI6pmRapmZ6pmiapmq6pmzapm76pnAap3I6p3Rap3Z6p3iap3q6p3zap376p4AaqII6qIRaqIZ6qIiaqIq6qIyKEiEAADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Breitbart, W, Rosenfield, B, Roth, A, Smith, M, Cohen, K, Passik, S. The memorial delirium assessment scale. J Pain Symptom Manage 1997; 13:128. Copyright &copy;1997 The US Cancer Pain Relief Committee.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_57_38810=[""].join("\n");
var outline_f37_57_38810=null;
var title_f37_57_38811="Labs in ETOH liver disease";
var content_f37_57_38811=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F64489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F64489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Laboratory abnormalities in alcoholic liver disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Abnormality",
"       </td>",
"       <td class=\"subtitle1\">",
"        Diagnostic characteristics*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serum AST&gt;ALT (ratio usually &gt;2.0, both usually &lt;300 IU/L, and almost never &gt;500 IU/L)",
"       </td>",
"       <td>",
"        Sensitivity and specificity have not been well studied, but may vary with the magnitude of the ratio",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Elevated serum AST",
"       </td>",
"       <td>",
"        Sensitivity 50 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Specificity 82 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Elevated serum ALT",
"       </td>",
"       <td>",
"        Sensitivity 35 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Specificity 86 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Elevated serum GGT",
"       </td>",
"       <td>",
"        Sensitivity approximately 70 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Specificity approximately 60 to 80 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        High MCV",
"       </td>",
"       <td>",
"        Sensitivity approximately 30 to 50 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Specificity approximately 85 to 90 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Elevated carbohydrate-deficient transferrin",
"       </td>",
"       <td>",
"        Sensitivity approximately 60 to 70 percent&nbsp;(lower values have been reported)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Specificity approximately 80 to 90 percent",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * The sensitivity and specific figures all assume chronic alcohol use although the definitions have varied among studies.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_57_38811=[""].join("\n");
var outline_f37_57_38811=null;
var title_f37_57_38812="Diff dx abd pain in AIDS";
var content_f37_57_38812=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F67173&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F67173&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of abdominal pain in AIDS",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Organ",
"      </td>",
"      <td class=\"subtitle1\">",
"       Causes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Stomach",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Gastritis",
"      </td>",
"      <td>",
"       CMV*, cryptosporidium, H. pylori",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Focal ulcer",
"      </td>",
"      <td>",
"       CMV*, acid-peptic disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Outlet obstruction",
"      </td>",
"      <td>",
"       Cryptosporidium*, CMV, lymphoma, MAC",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Mass",
"      </td>",
"      <td>",
"       Lymphoma, KS, CMV",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Small bowel",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Enteritis",
"      </td>",
"      <td>",
"       Cryptosporidium*, CMV, MAC",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Obstruction",
"      </td>",
"      <td>",
"       Lymphoma*, KS",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Perforation",
"      </td>",
"      <td>",
"       CMV*, lymphoma",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Colon",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Colitis",
"      </td>",
"      <td>",
"       CMV*, HSV, salmonella, Histoplama",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Obstruction",
"      </td>",
"      <td>",
"       Lymphoma*, KS, intussusception,",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Perforation",
"      </td>",
"      <td>",
"       CMV*, lymphoma, HSV",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Appendicitis",
"      </td>",
"      <td>",
"       KS*, cryptosporidium, CMV",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Anorectum",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Proctitis",
"      </td>",
"      <td>",
"       Herpes*, bacteria, CMV",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Tumor",
"      </td>",
"      <td>",
"       KS, lymphoma, condyloma",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Liver, spleen",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Infiltration",
"      </td>",
"      <td>",
"       Lymphoma*, CMV, MAC",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Biliary tract",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Cholecystitis",
"      </td>",
"      <td>",
"       CMV*, cryptosporidium*, KS",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Papillary stenosis",
"      </td>",
"      <td>",
"       CMV*, cryptosporidium*, KS, cholangitis, CMV*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Pancreas",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Inflammation",
"      </td>",
"      <td>",
"       CMV*, KS, pentamidine, DDI",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Tumor",
"      </td>",
"      <td>",
"       Lymphoma, KS",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Mesentery, peritoneum",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Infiltration",
"      </td>",
"      <td>",
"       MAC*, cryptococcus, KS, lymphoma, histoplasmosis, tuberculosis, coccidiomycosis, toxoplasmosis",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * More frequent.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_57_38812=[""].join("\n");
var outline_f37_57_38812=null;
var title_f37_57_38813="IMWG response criteria";
var content_f37_57_38813=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F55362&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F55362&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    International Myeloma Working Group uniform response criteria for multiple myeloma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Molecular complete response",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meets criteria for stringent complete response (see below)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        <strong>",
"         AND",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No identifiable allele-specific oligonucleotides on polymerase chain reaction with a sensitivity of 10",
"        <sup>",
"         -5",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Immunophenotypic complete response",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meets criteria for stringent complete response (see below)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        <strong>",
"         AND",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No detectable phenotypically aberrant clonal plasma cells by &gt;4 color multiparametric flow cytometry on an analysis of bone marrow with a minimum of one million total bone marrow cells analyzed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Stringent complete response (sCR)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meets criteria for complete response (see below)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        <strong>",
"         AND",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal FLC ratio",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        <strong>",
"         AND",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No clonal cells by bone marrow immunohistochemistry or immunofluorescence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Complete response (CR)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No M protein in serum and urine by immunofixation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        <strong>",
"         AND",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No current evidence of soft tissue plasmacytoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        <strong>",
"         AND",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone marrow aspirate and biopsy demonstrate less than 5 percent plasma cells",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        In patients who lack measurable M proteins in the serum and urine being monitored using the FLC levels, the definition of CR requires a normalization of the FLC ratio in addition to the above criteria.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Very good partial response (VGPR)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serum and urine M protein detectable by immunofixation but not on electrophoresis or at least a 90 percent reduction in serum M-protein with a urine M protein &lt;100 mg/24 hrs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        In patients who lack measurable M proteins in the serum and urine being monitored using the FLC levels, the definition of VGPR requires &gt;90 percent decrease in the difference between involved and uninvolved free light chain levels.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Partial response (PR)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        At least 50 percent reduction in serum M-protein",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        <strong>",
"         AND",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduction of 24-hour urinary M protein by 90 percent or to &lt;200 mg/24 hrs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        <strong>",
"         AND",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        At least 50 percent reduction in size of any soft tissue plasmacytomas, if present at baseline",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        In patients who lack measurable M proteins in the serum and urine being monitored using the FLC levels, the definition of PR requires &ge;50 percent decrease in the difference between involved and uninvolved free light chain levels FLC levels. If the FLC levels were also unmeasurable at baseline, a 50 percent reduction in bone marrow plasma cells is acceptable as long as the original bone marrow contained at least 30 percent plasma cells.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Stable disease (SD)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Does not meet criteria for CR, VGPR, PR, or PD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Progressive disease (PD)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        At least 25 percent increase from lowest response value in any of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Serum M protein (absolute increase must be &ge;0.5 g/dL)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Urine M protein (absolute increase must be &ge;200 mg/24 hrs)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Bone marrow plasma cell percentage (absolute increase must be &ge;10 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Difference in the kappa and lambda FLC (absolute increase must be &gt;10 mg/dL)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        <strong>",
"         OR",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increase in the size or development of new bone lesions or soft tissue plasmacytomas",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        <strong>",
"         OR",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Development of a serum calcium &gt;11.5 mg/dL without other cause",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The FLC criteria should only be used for patients with unmeasurable M protein in the serum and urine.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    For patients with multiple myeloma receiving active therapy, disease response should be evaluated before each treatment cycle. The preferred method is the measurement of monoclonal (M) protein in the serum and urine. Bone marrow evaluation is incorporated to identify complete response. The free light chain (FLC) assay should be reserved for patients with unmeasurable protein in serum and urine and for determination of a stringent complete response.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted by permission from: Macmillan Publishers Ltd: Durie BG, Harousseau JL, Miguel JS, et al. International uniform response criteria for multiple myeloma. Leukemia 2006; 20:1467. Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 2009; 23:3. Copyright &copy; 2009.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_57_38813=[""].join("\n");
var outline_f37_57_38813=null;
var title_f37_57_38814="ADH induced aggregates";
var content_f37_57_38814=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F80176&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F80176&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    ADH induced aggregates",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 179px; height: 176px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    ADH-induced intramembranous particle aggregates (arrows) on luminal membrane of the toad bladder, an epithelium similar to the mammalian collecting tubule. aggregates are seen between and near the bases of microvilli (MV). these changes correlate specifically with enhanced water permeability.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From kachadorian, WA, levine, SD, wade, JB, et al, J Clin Invest 1977; 59:576, by copyright permission of the American Society for Clinical Investigation.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_57_38814=[""].join("\n");
var outline_f37_57_38814=null;
var title_f37_57_38815="PDA before after indomethacin";
var content_f37_57_38815=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71213&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71213&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 545px\">",
"   <div class=\"ttl\">",
"    Patent ductus arteriosus in preterm infant before and after indomethacin therapy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 525px; height: 214px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiographs from a premature infant with a symptomatic patent ductus arteriosus (PDA) before (left panel) and after (right panel) the administration of indomethacin. Prior to therapy, the lungs are opacified due to pulmonary edema resulting from increased blood flow through the PDA; the heart is also mildly enlarged. After therapy, the lung fields are clear and heart size is smaller.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stephen E Welty, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_57_38815=[""].join("\n");
var outline_f37_57_38815=null;
